Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGRP,Agouti-related protein,42296,0.224687268165589,0.00492331966322818,0.215037561625662,0.234336974705516,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,-0.133126976707174,0.00319938201046423,-0.139397765447684,-0.126856187966664,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCG,Pro-glucagon,41843,0.506499295927197,0.0119630061313761,0.483051803909699,0.529946787944694,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LDLR,Low-density lipoprotein receptor,42170,0.261442511234107,0.00471444358949731,0.252202201798693,0.270682820669522,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFGE8,Lactadherin,42137,0.24496920278806,0.00412808884962795,0.236878148642789,0.253060256933331,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPY,Pro-neuropeptide Y,42262,0.264312138453451,0.00609034641376759,0.252375059482466,0.276249217424435,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS8,Prostasin,42080,0.159370173119452,0.00404831633764498,0.151435473097667,0.167304873141236,1.1125369292539e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRAP1,Proline-rich acidic protein 1,39966,0.147949186315724,0.00377190125224079,0.140556259861332,0.155342112770116,1.11253698007147e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,-0.11035485548137,0.00285124733796565,-0.115943300263782,-0.104766410698957,1.11545038041188e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD4,T-cell surface glycoprotein CD4,42100,0.106063811898186,0.00282774598039126,0.100521429776619,0.111606194019753,5.54006799593393e-293
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF9,Protein turtle homolog A,39958,0.292371312707425,0.00842756552784252,0.275853284272854,0.308889341141996,9.44899683586347e-251
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,0.101806832225311,0.0029755490547674,0.0959747560779665,0.107638908372655,4.68848652538514e-246
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR37,Prosaposin receptor GPR37,41900,0.216459790624526,0.00640584406959749,0.203904336248115,0.229015245000938,3.28152769614233e-240
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.106702976582791,0.00317784770911494,0.100474395072926,0.112931558092656,1.42531580909923e-237
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL27,C-C motif chemokine 27,42145,0.202600535503008,0.00615488700983583,0.190536956963729,0.214664114042286,1.12844043840847e-228
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPL,Lipoprotein lipase,42145,-0.15526816179732,0.00473988471062826,-0.164558335830152,-0.145977987764489,1.43790506159516e-226
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,0.155992620304194,0.00476263245437861,0.146657860693612,0.165327379914776,1.45554494013501e-226
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS4,Galectin-4,42123,0.181680144337831,0.00555547661821886,0.170791410166122,0.19256887850954,7.85448361767568e-226
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,0.160290057293891,0.00497819233575701,0.150532800315808,0.170047314271975,4.6218378115758e-219
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN1,CCN family member 1,42047,0.226199548298454,0.0070810450527147,0.212320699995133,0.240078396601775,6.78848770424456e-216
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.215348821785353,0.00678344676164825,0.202053266132523,0.228644377438184,2.34320517314523e-213
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFASC,Neurofascin,42296,0.0894914444605689,0.00288522660445637,0.0838364003158344,0.0951464886053034,3.3597438683652e-204
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MVK,Mevalonate kinase,41913,0.250972951895435,0.00818579650874228,0.2349287907383,0.267017113052569,1.56126633112563e-199
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP5,Retinol-binding protein 5,42070,0.169951629612297,0.00557542521165621,0.159023796197451,0.180879463027143,2.08973726305593e-197
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PYY,Peptide YY,39575,0.302141140136518,0.00988899119602963,0.2827587173923,0.321523562880737,7.72239608880324e-197
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0711780206630979,0.00234034106975627,0.0665909521663756,0.0757650891598202,1.29966893557256e-196
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOF,Apolipoprotein F,39990,-0.0779997398297874,0.00256630383477213,-0.0830296953459408,-0.072969784313634,3.61880983541677e-195
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,0.100898737185235,0.00335522396591303,0.0943224982120456,0.107474976158425,2.50806961567379e-192
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES1,Liver carboxylesterase 1,42163,0.251753860562974,0.00841597668424698,0.23525854626185,0.268249174864098,1.86059052116492e-190
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLTP,Phospholipid transfer protein,42267,-0.111412718704159,0.00374616789321185,-0.118755207774855,-0.104070229633464,2.16487660841255e-188
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPB1,Beta-ureidopropionase,39958,0.264758313118575,0.00899475167873122,0.247128599828262,0.282388026408888,1.38542033592353e-183
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.237422617916618,0.00810910628502842,0.221528769597962,0.253316466235273,1.13737891218808e-182
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.189638336302353,0.00648678493165049,0.176924237836318,0.202352434768388,4.02610672790807e-182
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.152890306427787,0.0052317911129656,0.142635995846374,0.163144617009199,4.33818877413231e-182
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,-0.0926732097396387,0.00319039495856726,-0.0989263838584306,-0.0864200356208469,5.18079894417881e-180
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACY1,Aminoacylase-1,42145,0.179836358911633,0.00624830543795186,0.167589680253248,0.192083037570019,7.25228443895837e-177
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTH,Parathyroid hormone,39649,0.238289002936242,0.00827336719492963,0.22207320323418,0.254504802638304,5.81545503416337e-176
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSD,Cathepsin D,41225,0.117645756909134,0.00410087763547229,0.109608036743608,0.12568347707466,2.13387877242327e-175
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C9,Complement component C9,39990,-0.164628485389295,0.00573109524264003,-0.17586143206487,-0.153395538713721,2.9617442190529e-175
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FURIN,Furin,42181,0.0935798166260686,0.00328177896573165,0.0871475298532346,0.100012103398903,9.53601137832461e-174
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,0.087952706236259,0.00308585394627985,0.0819044325015505,0.0940009799709675,1.39694259255517e-173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.138719926105224,0.00486711149719107,0.12918038757073,0.148259464639719,1.64310829227845e-173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS15,Enteropeptidase,42070,0.248075338975488,0.00874541132501584,0.230934332778457,0.265216345172519,5.67065842159745e-172
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDF15,Growth/differentiation factor 15,42310,0.128364287489086,0.0045537343251053,0.119438968211879,0.137289606766292,5.39076519288312e-170
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL13,C-X-C motif chemokine 13,42249,0.160607189432888,0.00571325752399619,0.149409204685855,0.17180517417992,4.45448547437602e-169
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.161296775985571,0.0057377779178723,0.150050731266542,0.172542820704601,5.35056985592072e-169
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADIPOQ,Adiponectin,39979,-0.192622251156632,0.00684365395468517,-0.206035812907815,-0.179208689405449,1.46464976920402e-168
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0913264987441231,0.00326514929868637,0.0849268061186978,0.0977261913695484,2.1740940675988e-167
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRIP2,Cysteine-rich protein 2,42016,0.100927797816143,0.00361839971732219,0.0938357343701913,0.108019861262094,1.74283610177026e-166
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGF,Placenta growth factor,42296,0.0726103791440896,0.00260887187121679,0.0674969902765047,0.0777237680116745,7.00896170709327e-166
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTN4R,Reticulon-4 receptor,42262,0.0929859630966039,0.00335719847585152,0.0864058540839349,0.0995660721092729,2.48384841186529e-164
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.102566494660053,0.00370646857960451,0.0953018162440279,0.109831173076078,5.10743869951362e-164
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGF,Hepatocyte growth factor,42296,0.0939833582672878,0.00344211514187623,0.0872368125892104,0.100729903945365,6.9875336551596e-160
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,0.147538108096165,0.00543935063524119,0.136876980851093,0.158199235341238,9.58857727705702e-158
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.122881022724698,0.00454337060360474,0.113976016341633,0.131786029107763,6.96915056581461e-157
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.389284350051244,0.0145906802817797,0.360686616698956,0.417882083403532,7.9569793856311e-153
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOM,Apolipoprotein M,42199,-0.0752340757847268,0.002831506204488,-0.0807838279455232,-0.0696843236239303,1.07746731780723e-151
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0841229527417061,0.00317018489694512,0.0779093903436936,0.0903365151397185,2.52637976194896e-151
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCS1,Neuronal calcium sensor 1,42262,0.0747156288637069,0.00282164895796451,0.0691851969060965,0.0802460608213174,1.02955709151432e-150
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL16,C-C motif chemokine 16,42310,0.135070670363738,0.0051191515804738,0.12503713326601,0.145104207461467,1.06821643603423e-149
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC13,Mucin-13,41839,0.138055959867546,0.00524715175141719,0.127771542434768,0.148340377300324,9.33712197972862e-149
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.143288106215193,0.00546245921708428,0.132581686149707,0.153994526280678,6.46069259718072e-148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST3,Cystatin-C,42184,0.0749914753375481,0.00286130163585637,0.0693833241312696,0.0805996265438266,9.61357134200374e-148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL23,C-C motif chemokine 23,42185,0.110452184512974,0.00422035366708385,0.10218029132549,0.118724077700459,2.45396429510343e-147
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,0.222052130060414,0.00848395477534448,0.205423578700739,0.23868068142009,2.50956671681012e-147
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0805431380395324,0.00307800237835139,-0.0865760227011011,-0.0745102533779637,1.590048201269e-146
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGRN,Agrin,42185,0.0934108712154433,0.00358101621476661,0.0863920794345008,0.100429662996386,2.10651705566559e-146
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,0.084172200321333,0.00322560631571403,0.0778500119425335,0.0904943887001325,1.18615163347282e-145
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.128906756001,0.00499574818590001,0.119115089556636,0.138698422445364,1.20400197005977e-142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELN,Elastin,39958,0.0896031679554756,0.00347627903185011,0.0827896610530494,0.0964166748579019,1.97534427216707e-142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF21,Fibroblast growth factor 21,42247,0.307512850111089,0.0119964848683986,0.283999739769028,0.33102596045315,1.40615641258845e-141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,0.0948983879252729,0.00370250723905602,0.0876414737367231,0.102155302113823,1.65809431154059e-141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM20A,Pseudokinase FAM20A,39958,0.0722991673534102,0.00281938130190498,0.0667731800016764,0.0778251547051439,4.90011665349845e-141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.221577720804755,0.00865946886031399,0.204605161838539,0.23855027977097,1.9645913236225e-140
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPY30,Protein dpy-30 homolog,42216,0.152989481400363,0.00600381434631867,0.141222005281578,0.164756957519147,5.79167864651278e-140
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MME,Neprilysin,42070,0.198075166697396,0.00778924299414424,0.182808250428874,0.213342082965919,2.26016012594954e-139
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,0.0878055477579449,0.00346988384584112,0.0810045754200963,0.0946065200957935,1.72404046325191e-137
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KITLG,Kit ligand,42145,-0.0962968207836171,0.00382164357950862,-0.103787242199454,-0.0888063993677802,5.90370187622271e-137
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS9,Galectin-9,42129,0.0788520557165979,0.00314120922110777,0.0726952856432267,0.0850088257899691,5.89792728979685e-136
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.121746120373503,0.00486224470032611,0.112216120760864,0.131276119986142,1.17436031922283e-134
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,0.0561081610395691,0.00224945913811853,0.0516992211288568,0.0605171009502815,2.62246495989979e-134
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEG1,Protein HEG homolog 1,39736,0.0690266763528271,0.00276301969495241,0.0636111577507203,0.0744421949549338,4.48480934243875e-134
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.0859714407141643,0.00346797099986737,0.0791742175544242,0.0927686638739043,9.67430883609011e-133
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18R1,Interleukin-18 receptor 1,42296,0.0816500104281845,0.00330934972999901,0.0751636849573864,0.0881363358989825,1.53805738044344e-131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTA1,Glutathione S-transferase A1,42119,0.209003914734721,0.00848771998543386,0.192367983563271,0.225639845906172,5.22998395212322e-131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL15,C-C motif chemokine 15,42310,0.106709354776132,0.00436054648738759,0.0981626836608525,0.115256025891412,1.74458824654813e-129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,0.0905087945565376,0.00370924553532036,0.0832386733073097,0.0977789158057655,1.06162383330012e-128
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCLY,Selenocysteine lyase,42224,0.118679523985623,0.00487562647108235,0.109123296102302,0.128235751868944,3.82646178486466e-128
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,0.0963103710884291,0.00398415767295467,0.088501422049438,0.10411932012742,1.85885137119628e-126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.176353094618577,0.00729050354964675,0.162063707661269,0.190642481575884,4.3060623273532e-126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH2,Cadherin-2,42145,0.0853107066931669,0.00353830248579966,0.0783756338209996,0.0922457795653343,8.49655852440091e-126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.106306809119704,0.00440918713190348,0.0976648023411728,0.114948815898234,9.49228549538904e-126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARB2,Lysosome membrane protein 2,41777,0.0796806167569681,0.00330510028713645,0.0732026201941806,0.0861586133197555,1.05575827224389e-125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.220777541184949,0.00919175689362568,0.202761697673443,0.238793384696456,7.85307662391122e-125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OCLN,Occludin,39934,0.106857369720702,0.00444697166046387,0.0981413052661932,0.115573434175212,1.73254481094503e-124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPY,Pancreatic prohormone,42089,0.245544738396813,0.0102992025127903,0.225358301471744,0.265731175321882,4.32485209540813e-123
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNA4,Ephrin-A4,41992,0.0771828475851052,0.00323824854221151,0.0708358804423706,0.0835298147278397,5.2170888568438e-123
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.143257258005852,0.00602202082372661,0.131454097191348,0.155060418820356,1.5879960641273e-122
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,0.0788513219341536,0.00331770822566348,0.0723486138118532,0.085354030056454,7.33744717131569e-122
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUOM,Fucose mutarotase,39736,0.153198066233887,0.00647677792126378,0.14050358150821,0.165892550959564,1.00149620105726e-120
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INHBC,Inhibin beta C chain,42137,0.0937690197124669,0.00398219073744728,0.0859639258670702,0.101574113557864,3.44891900295786e-120
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.299003026220566,0.0127227931725477,-0.32393970083876,-0.274066351602373,9.15788754153759e-120
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,0.196645384745567,0.00839384399640853,0.180193450512606,0.213097318978527,5.66626072573744e-119
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KYNU,Kynureninase,42296,0.106619645905687,0.0045638792504024,0.0976744425748979,0.115564849236475,2.1377918695481e-118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,0.0820702111883026,0.00352155100096044,0.0751679712264201,0.0889724511501851,7.95147471690992e-118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.199706660652369,0.00857271930976124,0.182904130805237,0.216509190499501,1.02759344146117e-117
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.0996749602353424,0.00429846025652308,0.0912499781325571,0.108099942338128,1.06881547676581e-116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.127197454413818,0.00548747673000709,0.116442000023004,0.137952908804632,1.54102499435682e-116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA3F,Semaphorin-3F,42145,0.0620066367689488,0.00267792129851034,0.0567579110238685,0.067255362514029,2.3334232736517e-116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMBP,Protein AMBP,42239,0.0467965798751014,0.00202347624170146,0.0428305664413666,0.0507625933088363,4.20285830052215e-116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHBG,Sex hormone-binding globulin,39990,-0.1089371600636,0.00471731464046496,-0.118183096758912,-0.0996912233682891,2.36927988201728e-115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA1,GDNF family receptor alpha-1,42247,0.0660492163517384,0.00286573610983311,0.0604323735764655,0.0716660591270113,2.42797294142652e-115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AREG,Amphiregulin,42070,0.090673464303631,0.00393487294559437,0.082961113330266,0.0983858152769959,2.85325486427664e-115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.14941678739901,0.00650524167548292,0.136666513715063,0.162167061082956,1.41270030823966e-114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.190530557690479,0.00829691887725768,0.174268596691054,0.206792518689904,1.81145479815619e-114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.128368819043661,0.0055966141831705,0.117399455244647,0.139338182842675,3.23174043614325e-114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE4,Ribonuclease 4,39645,0.0638846007151932,0.00279006380248134,0.0584160756623298,0.0693531257680566,2.11184970241424e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.176872304625681,0.00774433180820238,0.161693414281604,0.192051194969757,6.5267823727377e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.0929243476248355,0.00408014644049076,0.0849272606014736,0.100921434648197,1.1031040353109e-112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAO1,Hydroxyacid oxidase 1,42262,0.282675498438969,0.0124140717103575,0.258343917886669,0.30700707899127,1.10958330917356e-112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MENT,Protein MENT,39736,-0.0545738453382661,0.00239227370513421,-0.0592627018003292,-0.0498849888762031,1.28183173030229e-112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.129102451939304,0.0056681315931769,0.117992914016677,0.140211989861931,2.5440282387763e-112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,0.0707164081508627,0.00311145196058235,0.0646179623081213,0.0768148539936041,2.96444957342809e-112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPM,Carboxypeptidase M,42195,0.0771409506158602,0.00341057300003892,0.0704562275357839,0.0838256736959365,3.20014507968916e-111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.0882634674424296,0.00390304078730616,0.0806135074993095,0.0959134273855496,3.38713474273546e-111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLUL1,Clusterin-like protein 1,42123,-0.101478866676714,0.00449162106852526,-0.110282443971024,-0.0926752893824047,5.69053101349763e-111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCG2,Secretogranin-2,42193,0.0747002545685897,0.00331750043273996,0.0681979537204194,0.08120255541676,2.90332637914803e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OXT,Oxytocin-neurophysin 1,42249,0.326347826828523,0.0145519015293531,0.297826099830991,0.354869553826055,2.03592689914188e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.0890071256781713,0.00396480196835838,0.0812361138201889,0.0967781375361538,3.49182658948328e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF23,Fibroblast growth factor 23,42250,0.113726262382516,0.00508001408551502,0.103769434774907,0.123683089990126,4.7848644940632e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELE,E-selectin,42310,0.113555192793785,0.00507311687354966,0.103611883721627,0.123498501865942,5.03926893837165e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA1,Apolipoprotein A-I,39979,-0.0615119220079097,0.00275877428016586,-0.0669191195970348,-0.0561047244187846,7.93231977001508e-108
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD5,T-cell surface glycoprotein CD5,42239,0.0794850397825329,0.00357814168982432,0.0724718820704773,0.0864981974945886,1.99829714306978e-107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNB2,Plexin-B2,42255,0.0540520668165132,0.00246041916338804,0.0492296452562727,0.0588744883767538,3.77065288082725e-105
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,0.177296064960512,0.00808775198916987,0.161444071061739,0.193148058859284,1.08393778227265e-104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOD,Apolipoprotein D,39468,-0.0934562648537635,0.00425635340321583,-0.101798717524066,-0.0851138121834605,1.36983706607238e-104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.0694549579452274,0.0031726487472402,0.0632365664006366,0.0756733494898181,1.99197117413054e-104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPPC,C-type natriuretic peptide,42119,0.115433115949056,0.00529360736099244,0.10505764552151,0.125808586376601,1.22808508822803e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,0.124394515034026,0.00570961109892922,0.113203677280124,0.135585352787927,3.9962099031273e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,0.0621885739083228,0.00286286676938212,0.0565773550403338,0.0677997927763117,7.32553618893917e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,0.0628501157044625,0.00289563678566703,0.0571746676045551,0.0685255638043698,1.05796401507774e-102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.183667649393087,0.00847008019086215,0.167066292218997,0.200269006567177,1.73333341405855e-102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,0.206718216297355,0.00956398862740799,0.187972798587635,0.225463634007074,6.93255514115373e-102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REN,Renin,42145,0.176638831373491,0.00817559588727568,0.16061466343443,0.192662999312551,8.24885457549829e-102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTA3,Glutathione S-transferase A3,41843,0.165813317677477,0.00778261575328957,0.150559390801029,0.181067244553924,4.59333887873854e-99
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.114595761451931,0.00537487145340137,0.104061013403264,0.125130509500598,6.34771442784808e-99
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0585674244272332,0.00275477927999054,0.0531680570384517,0.0639667918160146,1.0829521821807e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,0.104786639890285,0.00493014922341373,0.0951235474123942,0.114449732368176,1.22795377199445e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,0.0766223053933541,0.00360838279121279,0.069549875122577,0.0836947356641312,1.75309262604637e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.0724509338465845,0.00341736015093789,0.0657529079507462,0.0791489597424228,3.66184101250378e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD72,B-cell differentiation antigen CD72,39736,0.0930245050108019,0.00438305611467927,0.0844337150260305,0.101615294995573,4.97245156575866e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.0712565978463423,0.00336483703825098,0.0646615172513704,0.0778516784413143,5.81809394292868e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.110321756092399,0.00521199402165055,0.100106247809964,0.120537264374835,7.41897956343324e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL10,C-X-C motif chemokine 10,42185,0.140153443479727,0.00663840352587229,0.127142172569017,0.153164714390437,2.22091454361694e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,0.0894945945203903,0.00424753985758713,0.0811694163995195,0.097819772641261,5.39679515107392e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.140580653309613,0.00666778734427658,0.127511790114831,0.153649516504395,7.9588003551939e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,0.0839478853995591,0.00399325191708181,0.0761211116420787,0.0917746591570394,1.42354785484496e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.129249426382785,0.00616349427264397,0.117168977608403,0.141329875157167,4.18777343323125e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0793935088623962,0.00378141983265645,0.0719819259903896,0.0868050917344028,5.13660894780334e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.0874201393544796,0.00417240144511938,0.0792422325220457,0.0955980461869136,6.05930817447539e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,0.0627335855420004,0.00300268127673396,0.0568483302396018,0.0686188408443989,1.97011180063893e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFA,Protransforming growth factor alpha,42119,0.0952147860233881,0.00455883131184443,0.086279476652173,0.104150095394603,2.2959642978914e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLA,Alpha-galactosidase A,39713,0.0827452473795014,0.00395750569532293,0.0749885362166685,0.0905019585423344,3.0194380036821e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SULT2A1,Bile salt sulfotransferase,42119,0.123385506957469,0.00592429039735809,0.111773897778647,0.134997116136291,7.54361434967549e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0748317388038156,0.00359515179303461,-0.0818782363181634,-0.0677852412894678,9.69853066620824e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KHK,Ketohexokinase,39638,0.132875055651081,0.00637320861924577,0.120383566757359,0.145366544544803,1.02711361297856e-94
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.06306106945317,0.00303710677899664,0.0571083401663366,0.0690137987400034,2.70906612159601e-94
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0794873310271123,0.00383076447900223,0.0719790326482679,0.0869956294059566,3.59415453230742e-94
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL16,Pro-interleukin-16,42296,0.0883735695139223,0.00426507002190908,0.0800140322709805,0.0967331067568642,6.23057018292878e-94
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.0723292242563309,0.00350535620124069,0.0654587261018992,0.0791997224107627,3.66568240903669e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA11,Integrin alpha-11,42119,-0.0702001440852546,0.00341293274615433,-0.0768894922677171,-0.0635107959027921,1.3564015752146e-92
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.165768223585023,0.0080661853698363,0.149958500260144,0.181577946909902,1.96058010910669e-92
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSO,Cathepsin O,42296,0.0633907548657206,0.00308619326443675,0.0573418160674246,0.0694396936640166,2.31218883729319e-92
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,0.0818659626438645,0.00398764303654035,0.0740501822922454,0.0896817429954836,2.93851227594268e-92
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,0.0478961642818223,0.0023355546554189,0.0433184771572013,0.0524738514064434,9.06061567829537e-92
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0581472066370662,0.00285726878910256,0.0525469598104252,0.0637474534637072,1.8778889878904e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN2,Nectin-2,42129,0.0633954248563849,0.00312119569248822,0.057277881299108,0.0695129684136618,2.26391091196253e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,0.0752943097381185,0.00371947837806916,0.0680041321171029,0.082584487359134,8.64604182564355e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,0.0700520511201795,0.00346454299016103,0.0632615468594639,0.0768425553808952,2.42937536158677e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,0.114073085608109,0.00565473167600841,0.102989811523133,0.125156359693086,6.83285340109339e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18BP,Interleukin-18-binding protein,42217,0.0634190053746999,0.00316713409440471,0.0572114225496666,0.0696265881997331,6.23081265978133e-88
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSTL3,Follistatin-related protein 3,42084,0.0659647394795165,0.00330003084732162,0.0594966790187662,0.0724327999402669,1.2664587419912e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.101419505791405,0.00507521216358519,0.0914720899507782,0.111366921632032,1.35315606474675e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,-0.0549198533043291,0.00274466275205149,-0.0602993922983501,-0.0495403143103082,1.4363703474347e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAV,Integrin alpha-V,42262,-0.0334835824843032,0.00167684775300451,-0.036770204080192,-0.0301969608884143,1.8344836104228e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F9,Coagulation factor IX,42199,0.0369375094562002,0.00185014837948004,0.0333112186324193,0.0405638002799811,1.99141853894648e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.145331132577013,0.00728053350513987,0.131061286906938,0.159600978247087,2.20344455610066e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_E,,42119,0.0589604420049135,0.00296059476435264,0.0531576762667823,0.0647632077430446,5.30059201151896e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.138087019175854,0.0069287016946943,0.124506763854253,0.151667274497455,7.6502069026186e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADM,Pro-adrenomedullin,42262,0.0525152826932186,0.00263989243377309,0.0473410935230234,0.0576894718634139,7.90104292315613e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,0.154157306321944,0.00775015388872831,0.138967004700037,0.169347607943852,8.42739491757613e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.0691842436729514,0.00348723309692069,0.0623492668029868,0.0760192205429159,2.29857742375204e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASET2,Ribonuclease T2,42258,0.0536065326657387,0.00270488316220737,0.0483049616678122,0.0589081036636651,3.34434993323499e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNF,Tumor necrosis factor,41880,0.0727735531149899,0.00367160136204449,0.0655772144453827,0.0799698917845971,3.46251412083419e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM2,Paralemmin-2,39929,0.077776687100243,0.00391970937087429,0.0700940567333294,0.0854593174671566,3.68824848317377e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE6,Ribonuclease K6,39937,0.0646643839811882,0.00326885978995959,0.0582574187928674,0.071071349169509,1.17606255598344e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.0556025345750256,0.00281477411983614,0.0500855773001468,0.0611194918499044,1.17952561375018e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.212869699565828,0.0107799528119005,0.191740992054503,0.233998407077153,1.38137385786265e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0773834301297204,0.00392162504503122,0.0696970450414593,0.0850698152179816,1.74356158996032e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOLM2,Protein GOLM2,42249,0.0452267147801964,0.0022937416240721,0.0407309811970151,0.0497224483633778,2.34474541921965e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0924619879829457,0.00468697687280395,0.0832755133122499,0.101648462653641,3.62226660030275e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSP1,Lymphocyte-specific protein 1,42119,0.0804132019099588,0.00408571405414614,0.0724052023638324,0.0884212014560853,4.79193440018186e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,0.057820471753063,0.00293983373382116,0.0520583976347735,0.0635825458713524,6.21288191532029e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.114526700142492,0.00582657646125275,0.103106610278437,0.125946790006547,1.42476890893955e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.060340555680702,0.00307720621493457,0.0543092314994303,0.0663718798619738,1.88572951808443e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMA,Granzyme A,42296,0.0671410702096313,0.00342674286469614,0.0604246541948268,0.0738574862244357,2.51010914671757e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAT,Tissue-type plasminogen activator,42272,0.100890119824698,0.00516300420876553,0.0907706315755174,0.111009608073878,6.83994241632706e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0962329831662087,0.00493398444005042,0.0865623736637098,0.105903592668708,1.49950748417152e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3B,Protein FAM3B,42070,0.0693017630428643,0.0035541668207913,0.0623355960741133,0.0762679300116152,1.58845902400267e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.0777989803274423,0.00399027665162391,-0.0856199225646252,-0.0699780380902594,1.6220896207528e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG4,Regenerating islet-derived protein 4,42144,0.100075958603192,0.00514576698036806,0.0899902553216704,0.110161661884713,4.08859030960868e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSME1,Proteasome activator complex subunit 1,42002,0.0712099071051249,0.00366286329064322,0.0640306950554642,0.0783891191547856,4.81184450054088e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC39A5,Zinc transporter ZIP5,42119,0.103987988746156,0.00535533643525835,0.0934915293330494,0.114484448159262,7.33313919625575e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EZR,Ezrin,42249,0.0475945088078531,0.0024521913245798,0.0427882138116767,0.0524008038040295,8.43447471053567e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.206212174158249,0.0106559229688064,0.185326565139388,0.227097783177109,2.57296998327745e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,0.103788303012429,0.0053689576772556,0.0932651459650076,0.11431146005985,3.74562148703561e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XCL1,Lymphotactin,42262,0.106330049658634,0.00550756187576541,0.0955352283821336,0.117124870935134,5.86442428557134e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0542015746902881,0.00280741419377496,0.0486990428704891,0.059704106510087,5.94675564922777e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGLN1,Egl nine homolog 1,42119,0.108658690407843,0.00564396537309011,0.0975965182765862,0.119720862539099,1.6626027539832e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,0.0524176867437125,0.00272737437631078,0.0470720329661433,0.0577633405212816,3.05768674027756e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,0.12708793833311,0.00664146057313201,0.114070675609771,0.140105201056449,1.47879812970105e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORD,Sorbitol dehydrogenase,42204,0.132701130799669,0.00694378317966736,0.119091315767521,0.146310945831817,2.31291189838667e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNMT,Histamine N-methyltransferase,41961,0.0922594711271808,0.00482879318197837,0.0827950364905032,0.101723905763858,2.63489679656402e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL9,C-X-C motif chemokine 9,42185,0.125396936697579,0.00656506391052705,0.112529411432946,0.138264461962212,2.80392153601565e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0854349367284183,0.00447601788601186,0.076661941671835,0.0942079317850015,3.6718487780598e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPL,N-acetylneuraminate lyase,39958,0.0896307900518984,0.00470685914618027,0.0804053461253851,0.0988562339784118,1.3082773682978e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STC1,Stanniocalcin-1,42249,0.0877924443318946,0.00462493073147025,0.0787275800982129,0.0968573085655763,2.49904874909894e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL3,C-C motif chemokine 3,42119,0.113709742650428,0.00599444009860028,0.101960640057171,0.125458845243684,3.26539846906708e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANG,Angiogenin,42152,0.0627118940865092,0.00331213088608739,0.0562201175497779,0.0692036706232404,6.2300108722589e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.145738143592756,0.00772527979014753,0.130596595204067,0.160879691981445,3.44252665476923e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0371071879137112,0.00197745121206626,-0.040982992289361,-0.0332313835380613,1.41583523769902e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS2,Trypsin-2,42217,0.108361020952784,0.00577663052306036,0.0970388251275858,0.119683216777982,1.56113198522252e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBS2,Thrombospondin-2,42137,0.0730783483445535,0.00389912333061768,0.0654360666165428,0.0807206300725641,2.13097326093666e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL6,C-X-C motif chemokine 6,42296,0.142646574288486,0.00763312762138347,0.127685644150574,0.157607504426397,5.62272643850465e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300E,CMRF35-like molecule 2,42232,0.0788954037032737,0.00422245739493496,0.0706193872092011,0.0871714201973462,6.01283215617738e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.0675721545346098,0.0036166792659914,0.0604834631732667,0.074660845895953,6.55492659371108e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.0788021763241829,0.0042226006963589,0.0705258789593195,0.0870784736890464,1.41098387283686e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUCB2,Nucleobindin-2,42231,0.0705834396780247,0.00378739728188737,0.0631601410055255,0.0780067383505239,1.45225811850096e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0626822115951613,0.003365034098637,0.0560867447618328,0.0692776784284898,1.73093174673657e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.0596338045882921,0.00320146689485141,0.0533589294743833,0.0659086797022009,1.76376902118287e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHISA5,Protein shisa-5,39966,0.0489855225019801,0.00262826040398266,0.0438341321101741,0.0541369128937861,2.16278096909407e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,0.127481142309184,0.00685316832003698,0.114048932401912,0.140913352216457,2.78744172734181e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,0.188174777348752,0.0101239881370503,0.168331760600133,0.20801779409737,3.8628966122811e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3C,Protein FAM3C,42129,0.0569044511009085,0.00307520690509227,0.0508770455669277,0.0629318566348894,1.62637312932591e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFI,Complement factor I,39979,0.0363738357200988,0.00196604157068078,0.0325203942415645,0.0402272771986331,2.56332809826388e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOMO1,Nodal modulator 1,42137,0.0434094563979792,0.00234913619499597,0.0388051494557871,0.0480137633401713,2.57008067440221e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL17,C-X-C motif chemokine 17,42296,0.0795394657020834,0.00430788472255319,0.0710960116458792,0.0879829197582877,3.30184121401419e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA1,Ephrin type-A receptor 1,42162,0.0601184679213241,0.003260223189869,0.0537284304691809,0.0665085053734674,5.17005119237492e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0798186055029109,0.00433085114151624,0.0713301372655391,0.0883070737402827,6.11279392514171e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12A_IL12B,Interleukin-12,42070,0.143487324252846,0.00778844384612663,0.128221974314438,0.158752674191254,7.10928061996479e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAXX,Protein PAXX,39736,0.0863398731682516,0.00469441277649288,0.0771388241263256,0.0955409222101777,1.91513658368937e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,0.14215452170316,0.00773932431253808,0.126985446050585,0.157323597355734,2.95434146896513e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F11R,Junctional adhesion molecule A,42137,0.103017979781866,0.00562666942470018,0.0919897077094537,0.114046251854278,5.48231751890152e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH1,Cadherin-1,41697,0.0741524228109121,0.00406158064221159,0.0661917247521774,0.0821131208696468,1.48245956051221e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.126244991224741,0.00691847309146637,0.112684783965466,0.139805198484015,1.71744932291709e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR2,Cadherin-related family member 2,42070,0.121242400095885,0.00666177522365541,0.10818532065752,0.134299479534249,3.89359104844104e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COLEC12,Collectin-12,42123,0.050325842605421,0.0027670698878701,0.0449023856251956,0.0557492995856464,4.80981201822936e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PXN,Paxillin,41839,0.0940368228711369,0.0051750919673217,0.0838936426151863,0.104180003127087,6.71348145240021e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTRK3,NT-3 growth factor receptor,42249,-0.0389276536011268,0.00214444445126995,-0.0431307647256159,-0.0347245424766377,8.74538569833036e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,0.0793102752697078,0.00437313829361064,0.0707389242142309,0.0878816263251847,1.20644275892027e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEP1A,Meprin A subunit alpha,39930,0.140125692077053,0.00771969312220932,0.124995093557523,0.155256290596584,1.32366354382757e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD83,CD83 antigen,42119,0.0632387389965352,0.00349059761816559,0.0563971676649307,0.0700803103281398,1.68587100776454e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.0772903590764185,0.00426978223141208,0.0689215859028508,0.0856591322499861,2.16660871405876e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPT2,Angiopoietin-2,42262,0.0682123861604163,0.00377662251048952,0.0608102060398569,0.0756145662809758,4.38845977520892e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF3,Trefoil factor 3,42143,0.0658369952852403,0.00364762983489934,0.0586876408088376,0.072986349761643,5.56524116518086e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,0.0531379525881354,0.00294415384330972,0.0473674110552483,0.0589084941210224,5.6313696614507e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0541329174276055,0.00300022390822641,0.0482524785674818,0.0600133562877293,6.07732419633689e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRP,Gastrin-releasing peptide,39638,0.0976427189084797,0.00542841985587363,0.0870030159909674,0.108282421825992,2.54262077435006e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGBL1,Integrin beta-like protein 1,39966,0.0717031119767383,0.00399193167583715,0.0638789258920975,0.0795272980613791,3.70855784588459e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEP,Leptin,42145,0.126326528039298,0.00704142936433527,0.112525326485201,0.140127729593395,3.7864837113421e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.0501105283525047,0.00279478458590244,0.0446327505641359,0.0555883061408735,4.5250826620117e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGR3,Anterior gradient protein 3,41827,0.107099753508031,0.0059989549761683,0.0953418017547407,0.11885770526132,1.83229006344343e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEPH,Hephaestin,39958,0.0503755805605564,0.00283452815647345,0.0448199053738684,0.0559312557472444,1.01742340581718e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.131076004911592,0.00738987145990864,0.116591856850171,0.145560152973013,1.34499121796058e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,0.0471839376901176,0.002659038023222,0.0419722231646025,0.0523956522156327,1.68016098213375e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,0.0766328221840889,0.00433816155925571,0.0681300255279478,0.0851356188402301,4.72698426666943e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD2AP,CD2-associated protein,42145,0.112740443906307,0.00638815381073091,0.100219662437274,0.125261225375339,6.17997122332227e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F7,Coagulation factor VII,42194,0.0553317770079338,0.00313922832872566,0.0491788894836315,0.0614846645322361,9.05433542868804e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,0.0759631243978284,0.00431079457740152,0.0675139670261214,0.0844122817695354,9.82611006968448e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL21,C-C motif chemokine 21,42185,0.0682403672300523,0.00387487770960526,0.060645606919226,0.0758351275408786,1.17354809433923e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.066018976918928,0.0037496165433489,0.0586697284939642,0.0733682253438919,1.26637046842021e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMMT,MICOS complex subunit MIC60,39919,0.0798106000248686,0.00452942249835411,0.0709329319280945,0.0886882681216426,1.40714898964684e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL22,C-C motif chemokine 22,41991,0.0921414469842062,0.00524524855015883,0.0818607598258949,0.102422134142518,2.58441960141875e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP12,Macrophage metalloelastase,42146,0.0971343241672749,0.00553203510139607,0.0862915353685386,0.107977112966011,2.91471651566476e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,0.0743168683050276,0.00423832998514366,0.066009741534146,0.0826239950759092,4.8485351887893e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN3,Contactin-3,42137,0.0501985393648638,0.00286421745221981,0.044584673158513,0.0558124055712146,5.09797278391385e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,0.119740531515353,0.00683247617314008,0.106348878215999,0.133132184814708,5.22051826280362e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12B,Interleukin-12 subunit beta,42296,0.0972507790252432,0.00555102585318639,0.0863707683529978,0.108130789697488,5.60535749322626e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.10437350175268,0.00595857048291036,0.0926947036061762,0.116052299899185,6.02185929896325e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MLN,Promotilin,42119,0.158354665307466,0.00904124094931026,0.140633833046818,0.176075497568114,6.21413097440866e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCOF1,Treacle protein,39958,0.0577145463916841,0.00329760296053853,0.0512512445890286,0.0641778481943396,1.0667208250233e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA2,Carboxypeptidase A2,42205,0.117236237694746,0.00672655922261019,0.10405218161843,0.130420293771062,2.67852656821215e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIP,Gastric inhibitory polypeptide,39638,0.0898118309297833,0.00514745395780599,0.0797228211724836,0.099900840687083,2.84785655907302e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ULBP2,UL16-binding protein 2,42016,0.0693109205576438,0.00398120132941276,0.0615077659519948,0.0771140751632929,3.81358640340391e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSS,Cathepsin S,39358,0.0425728349830315,0.00244943758139611,0.0377719373234951,0.0473737326425679,9.40046404639907e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,0.0655035902166147,0.00379189344831871,0.05807147905791,0.0729357013753194,3.74158841361803e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,0.11120424989638,0.00645790841861566,0.0985467493958931,0.123861750396866,1.28436990223497e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA14,Carbonic anhydrase 14,42262,-0.0638331884560748,0.00371679015544406,-0.0711180971607452,-0.0565482797514045,2.00902295125043e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNCA,Alpha-synuclein,39736,0.205656953947644,0.01198422790808,0.182167867247807,0.22914604064748,3.5924755532392e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD27,CD27 antigen,42181,0.0740716042408818,0.00432258190298437,0.0655993437110324,0.0825438647707311,3.86696138356465e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO3,Beta-enolase,39638,0.109633473101202,0.00639950798462246,0.097090437451342,0.122176508751062,5.94815554623135e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBKS,Ribokinase,41830,0.0855473398567234,0.0050084448514524,0.0757307879478767,0.0953638917655701,1.02077472145444e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,0.193482024443968,0.0113294595455075,0.171276283734774,0.215687765153163,1.06888625098752e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,0.103236280086358,0.00605842823056919,0.0913617607544427,0.115110799418274,1.95684083288717e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300LG,CMRF35-like molecule 9,42137,-0.0641608736708335,0.00377430315373537,-0.0715585078521549,-0.0567632394895122,3.83624361030783e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0891459577580062,0.00524956121835834,0.0788568177700239,0.0994350977459886,7.226322913047e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,0.0618594081167383,0.00364926546757337,0.0547068478002945,0.0690119684331821,8.57144427246183e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100P,Protein S100-P,41900,0.0918773337899218,0.0054217414446966,0.0812507205583165,0.102503947021527,9.58273822095015e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA5,Integrin alpha-5,42137,0.0426088932330708,0.00251543073543621,0.0376786489916158,0.0475391374745258,1.05002473367499e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UMOD,Uromodulin,42274,-0.092147189238617,0.00545038378190471,-0.10282994145115,-0.0814644370260838,1.77483673369122e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORT1,Sortilin,42129,0.0652526379755057,0.00386449075241683,0.0576782361007687,0.0728270398502427,2.57066217738867e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP7,Matrilysin,41881,0.088572219303436,0.00525323525769886,0.0782758781983462,0.0988685604085258,3.97750775432349e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0500142673282159,0.00296792980633291,0.0441971249078033,0.0558314097486284,4.63416402728607e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18,Interleukin-18,42069,0.0753575886948336,0.00448471252696545,0.0665675521419813,0.0841476252476859,1.00509685134134e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300C,CMRF35-like molecule 6,42249,0.0599221927656683,0.0035676675957699,0.0529295642779593,0.0669148212533773,1.11267308274718e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADA2,Adenosine deaminase 2,42096,0.0747140778507207,0.00444853858303527,0.0659949422279716,0.0834332134734698,1.14407867931106e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL20,C-C motif chemokine 20,42296,0.147153069537463,0.00877208179051898,0.129959789228046,0.16434634984688,1.55926118877694e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELOA,Elongin-A,42070,0.0914394814440167,0.00545247302426504,0.0807526343164573,0.102126328571576,1.73062106046272e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.0734080701218446,0.00437876774984197,0.0648256853321543,0.0819904549115349,1.87267163183391e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPO,Erythropoietin,42119,0.123840366132361,0.00738776230178681,0.109360352020859,0.138320380243864,1.94401699840458e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN4,CCN family member 4,42262,0.0663109162622671,0.00396267520399038,0.0585440728624459,0.0740777596620882,3.08912543188017e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD302,CD302 antigen,42070,0.0527175029975872,0.00315754189139033,0.0465287208904622,0.0589062851047123,5.89801178536239e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE1,Ribonuclease pancreatic,39990,0.041971164753881,0.00251581958631987,0.037040158364694,0.0469021711430679,9.41246269399768e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0636073580384083,0.0038173843371097,0.0561252847376733,0.0710894313391433,1.03344786963804e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.0651389423622516,0.0039102615186804,0.057474829785638,0.0728030549388652,1.0794030441261e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPIND1,Heparin cofactor 2,39959,0.049337977814828,0.00296218527203871,0.0435320946816321,0.0551438609480239,1.46846782164667e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0431343152430348,0.00258994680634888,0.0380580195025909,0.0482106109834786,1.50314088750622e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUSB,Beta-glucuronidase,42211,0.102880820790853,0.00618557807893256,0.0907570877561447,0.11500455382556,1.64214690085172e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B2M,Beta-2-microglobulin,39979,0.0513070954277055,0.00308982979801852,0.0452510290235892,0.0573631618318218,3.34960363929826e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPB1,Carboxypeptidase B,42310,0.104261788723992,0.00628568711465321,0.091941841979272,0.116581735468713,3.40270870210202e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.0644845133931257,0.00388862786455648,0.056862802778595,0.0721062240076564,3.66118393815714e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.0520542406243304,0.003138190358255,0.0459033875221506,0.0582050937265102,4.50698107079006e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDUA,Alpha-L-iduronidase,42262,0.0790960358660682,0.00477568644368736,0.069735690436441,0.0884563812956954,5.13472903332803e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,0.110624342053889,0.00668523634364708,0.0975212788203404,0.123727405287437,6.61467448359101e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,0.114006534954002,0.00689094935929808,0.100500274209778,0.127512795698226,6.87553238278302e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSME2,Proteasome activator complex subunit 2,41955,0.0589964850518276,0.00357243160104328,0.0519945191137828,0.0659984509898724,1.15358114131266e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA6,Carbonic anhydrase 6,42103,-0.104609681568527,0.0063386388520037,-0.117033413718454,-0.0921859494185994,1.35620210169682e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCXR,L-xylulose reductase,42181,0.0905354129446202,0.00549316368510339,0.0797688121218176,0.101302013767423,1.92385249340725e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.0868671615875202,0.00527410677339421,0.0765299123116676,0.0972044108633729,2.28324889349899e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0334344340363609,0.00203072418062813,0.0294542146423297,0.037414653430392,2.56596633549766e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EEF1D,Elongation factor 1-delta,39958,0.152914416492453,0.00928059693559057,0.134724446498695,0.17110438648621,2.6916189388031e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,0.21055860998332,0.0127953022314354,0.185479817609706,0.235637402356933,2.94207175180001e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0700910255395022,0.00426299514507501,0.0617355550551552,0.0784464960238492,3.7656089510986e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PENK,Proenkephalin-A,39736,0.0518157732779334,0.0031544087080678,0.0456331322101206,0.0579984143457463,6.2523230422076e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.115844871268693,0.00705262448005987,0.102021727287776,0.12966801524961,6.39352319026612e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEL1L,Protein sel-1 homolog 1,39638,0.0525583937865064,0.00320009533475521,0.0462862069303862,0.0588305806426267,6.5967838718429e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,0.0471346777928411,0.00287701593484925,0.0414957265605366,0.0527736290251456,9.3694956217797e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,0.078324319518163,0.00479074624827163,0.0689344568715506,0.0877141821647754,1.62257383112175e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGR1,Prostaglandin reductase 1,39958,0.139305716465449,0.00851340440448343,0.122619443832661,0.155991989098236,1.67809754350166e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0583258080269897,0.00356845314594316,0.0513316398609411,0.0653199761930383,1.75440761050576e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTYMK,Thymidylate kinase,39958,0.111828575337768,0.00684675009821678,0.0984089451452633,0.125248205530273,2.71514813523335e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G15,Phospholipase A2 group XV,42181,0.0453967427649919,0.002784667848161,0.0399387937825963,0.0508546917473875,3.45867430602046e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERMAP,Erythroid membrane-associated protein,39657,0.0741526603733338,0.00454385862457635,0.0652466974691641,0.0830586232775034,3.5285079875051e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.06443223150774,0.00395950298803341,0.0566716056511945,0.0721928573642855,5.55600141170912e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THOP1,Thimet oligopeptidase,42081,0.0516516168718584,0.00317778519631691,0.0454231578870773,0.0578800758566396,7.58593273455312e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,0.0603605875218674,0.00372582068358989,0.0530579789820313,0.0676631960617036,1.74972765915851e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THY1,Thy-1 membrane glycoprotein,42249,0.047912196048329,0.00296192921968806,0.0421068147777404,0.0537175773189176,2.59331584254829e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.0446147223275928,0.00276094770567636,0.0392032648244671,0.0500261798307184,3.40860807759171e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFA,Vascular endothelial growth factor A,42253,0.0925549580348493,0.00574381004048824,0.0812970903554924,0.103812825714206,6.96509538292572e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,0.142478654038883,0.00884464867194354,0.125143142641874,0.159814165435892,9.98786793263632e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0473316890631039,0.00294497930725887,0.0415595296208765,0.0531038485053313,1.77314363332893e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDK,Midkine,42129,0.0830406552628447,0.00518630748444738,0.0728754925933278,0.0932058179323616,3.55655772258986e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,0.100474071509848,0.00627574007939694,0.0881736209542303,0.112774522065466,3.65079263149389e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNCG,Gamma-synuclein,42016,0.108146506634716,0.00676731806922463,0.0948825632190355,0.121410450050396,5.83807506771772e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0359131020157336,0.00224566582968417,0.0315115969895526,0.0403146070419146,6.22284285723e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDCP1,CUB domain-containing protein 1,42016,0.0906021621590836,0.00567350530182589,0.0794820917675049,0.101722232550662,6.98084163794867e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BST2,Bone marrow stromal antigen 2,42249,0.082485467204643,0.00516805225815044,0.0723560847786681,0.0926148496306178,7.84320527729664e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0638761016716477,0.00400474887220604,0.0560267938821239,0.0717254094611715,9.31086381385354e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C19orf12,Protein C19orf12,41839,0.107776326845334,0.00675714890254285,0.0945323149963503,0.121020338694318,9.6180411642883e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0642722568501873,0.00403187532923645,0.0563697812048839,0.0721747324954907,1.06210325047898e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0455293404254731,0.00285740197870409,0.039928832547213,0.0511298483037331,1.21419774477755e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSL,Cathepsin L1,42145,0.039528531961041,0.00248390648863622,0.034660075243314,0.044396988678768,1.65021566695731e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,0.0737258295708808,0.00463329272770977,0.0646445758245696,0.082807083317192,1.67234968429909e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0485892609836718,0.00305969136216892,0.0425922659138207,0.0545862560535229,3.4886867255488e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.091441526977615,0.00576224374446124,-0.102735524716759,-0.080147529238471,4.31838164535955e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK4,Dickkopf-related protein 4,41992,0.0740582803795473,0.00467218609453503,0.0649007956342587,0.083215765124836,4.48046601308594e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR2,TGF-beta receptor type-2,42181,0.0549331770631515,0.00347271077703909,0.0481266639401549,0.0617396901861482,7.30552482665845e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF2,Trefoil factor 2,42166,0.0936862325938454,0.00592643151229917,0.082070426829739,0.105302038357952,8.59222502795706e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,0.0640790836339941,0.00405202309628357,0.0561371183652783,0.0720210489027099,9.79389571572978e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN8,Septin-8,39906,0.0522936876731112,0.00331568715379597,0.0457949408516711,0.0587924344945513,1.89989973702111e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0796966688063995,0.00505202796182226,0.0697946940012279,0.0895986436115711,1.9112157092161e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PVR,Poliovirus receptor,42249,0.0597113801396091,0.00379058771837947,0.0522818282115853,0.0671409320676328,2.02888598283411e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,0.0758648914453202,0.00481763867666175,0.0664223196390631,0.0853074632515772,2.27625308582425e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.0446408449160466,0.00283625468246948,0.0390817857384064,0.0501999040936868,2.48018796216214e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH17,Protocadherin-17,42145,0.0598150346354772,0.00380363570237934,0.0523599086588137,0.0672701606121407,3.10087365205854e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.060605785146012,0.00385124555178917,0.0530573438645053,0.0681542264275188,3.3690214261196e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA7A,Semaphorin-7A,42272,0.0455014907898308,0.00289601982671483,0.0398252919294697,0.0511776896501919,3.81405100622075e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HJV,Hemojuvelin,39934,0.0674536747823292,0.00429182733148951,0.0590416932126098,0.0758656563520486,4.4219887510495e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,0.128690172104522,0.00820501385812623,0.112608344942594,0.144771999266449,7.53696690824699e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.0435205374979339,0.0027790414287084,0.0380736162976655,0.0489674586982024,8.51758342732541e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,-0.0462289731441996,0.00295323135810439,-0.0520173066060842,-0.040440639682315,9.414614814978e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBS,Cystathionine beta-synthase,39638,0.0825438813714233,0.00527196268820076,0.0722108345025498,0.0928769282402967,1.14799887655699e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTSS1,Protein MTSS 1,39930,0.177601665739631,0.0113616636748077,0.155332804937008,0.199870526542254,1.64131782645519e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSTB,Cystatin-B,41959,0.0686996772184236,0.00440053247702045,0.0600746335634635,0.0773247208733837,1.83467559646101e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG2,Desmoglein-2,42137,-0.0427041532708276,0.00274080950172692,-0.0480761398942124,-0.0373321666474428,2.90545208106873e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0472673969141751,0.00303203292275013,0.0413246123855848,0.0532101814427654,3.13204992491926e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARA5,Scavenger receptor class A member 5,42249,0.047947062706151,0.00309417391082344,0.041882481840937,0.0540116435713649,1.05905803891575e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.054307082569162,0.00351402294825463,0.0474195975905829,0.0611945675477411,2.02430454779179e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.131253656388775,0.00849797187672611,0.114597631510392,0.147909681267158,2.32547112836808e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD48,CD48 antigen,42166,0.0481652773577688,0.00311959264330997,0.0420508757768812,0.0542796789386563,2.51739605749765e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD274,Programmed cell death 1 ligand 1,42016,0.05274163148357,0.00342140997138883,0.0460356679396479,0.0594475950274921,3.69369978531137e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0716521996391541,0.00464540983990025,0.0625471963529496,0.0807572029253586,3.90192649511103e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,-0.101147351690891,0.00656863482570692,-0.114021875949276,-0.0882728274325051,4.72712893825701e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD5,Programmed cell death protein 5,42249,0.0893333422858723,0.00580638420586682,0.0779528292423733,0.100713855329371,5.70900210988468e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.152050886306207,0.00988441565970598,0.132677431613183,0.171424340999231,7.52402353565632e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0731811818991505,0.00475848519045034,0.0638545509258678,0.0825078128724331,7.96886650192904e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BSG,Basigin,42284,0.0325550977532919,0.00212112049348181,0.0283977015860676,0.0367124939205162,1.00268367077505e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,0.0572748283612246,0.00373156685710712,0.0499609573212946,0.0645886994011545,1.00846937498554e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA2,Ephrin type-A receptor 2,41614,0.0505110395514494,0.00329128557780475,0.0440601198189521,0.0569619592839467,1.07434913837988e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.0819616939861675,0.00534263587644956,0.0714901276683264,0.0924332603040087,1.1529721777621e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFC1,Cryptic protein,41843,0.0745603306937297,0.00486659275022275,0.0650218089032931,0.0840988524841663,1.5648074962903e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,0.142065347158641,0.00928031768462888,0.123875924496768,0.160254769820513,1.8456743008526e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,0.0968137968420022,0.00632075684956578,0.0844251134168533,0.109202480267151,1.97891683337394e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.0991860133249253,0.0064809182036629,0.0864834136457461,0.111888613004105,2.00889134690781e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17RB,Interleukin-17 receptor B,41934,-0.0838429750680837,0.00547900183393684,-0.0945818186625999,-0.0731041314735675,2.04728630608297e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAB2,Stabilin-2,39966,0.0437819984165491,0.00286000390090938,0.0381763907707668,0.0493876060623315,2.23600780594276e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,0.0766285255422463,0.00501511658370032,0.0667988970381937,0.0864581540462989,2.86104890164075e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUMB,Protein numb homolog,39657,0.130781613784865,0.0085630594112215,0.113998017338871,0.14756521023086,3.9479158722852e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRDL1,Chordin-like protein 1,42166,0.0506110916265792,0.00332003205893226,0.0441038287910719,0.0571183544620864,4.85711496115317e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL7,C-C motif chemokine 7,42119,0.086883965294232,0.00570226238684424,0.0757075310160173,0.0980603995724467,5.44809944447457e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMOT,Angiomotin,39736,0.059504893038004,0.00390524951573633,0.0518506039871608,0.0671591820888473,6.67943967410922e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC1,Sialoadhesin,42185,0.0642514650703765,0.00422132895532857,0.0559776603179326,0.0725252698228205,6.90539326847734e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0779582194397025,0.00512679236848493,0.067909706397472,0.0880067324819329,8.63744753683602e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,0.0736410677488643,0.00484444281929728,0.0641459598230417,0.083136175674687,9.31607693720718e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDT,D-dopachrome decarboxylase,39966,0.0629663416872695,0.0041407769114096,0.0548504189409067,0.0710822644336323,1.03361102595225e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCA,Calcitonin,41997,0.106901075730729,0.00703981738463799,0.0931030336568384,0.120699117804619,1.19209132405218e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BECN1,Beclin-1,39638,0.0922213723242215,0.00606821477383933,0.0803276713674964,0.104115073280947,1.2230650137485e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRD1,Natural killer cells antigen CD94,42296,0.072542512252203,0.00479152292743012,0.06315112731444,0.0819338971899661,2.30469230713235e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.0955248044314012,0.00630470171343286,0.0831675890730728,0.10788201978973,2.36118239941409e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL11,C-X-C motif chemokine 11,42249,0.119469153383812,0.00791950156763797,0.103946930311242,0.134991376456383,5.20258081166637e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL11,Eotaxin,42296,0.057204569459625,0.00379582940676789,0.0497647438223599,0.0646443950968901,6.49053855054038e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,-0.0759972338410291,0.00504488585041001,-0.0858852101078327,-0.0661092575742254,8.61832983548003e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,0.0585912876347373,0.0038941847087209,0.0509586856056444,0.0662238896638303,9.47897967010781e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAMR1,Inactive serine protease PAMR1,42137,0.0401817993947292,0.00267997871652645,0.0349290411103373,0.045434557679121,2.06020587443714e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YES1,Tyrosine-protein kinase Yes,42070,0.173690415624278,0.0115937258600101,0.150966712938658,0.196414118309898,2.46891578765276e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FMNL1,Formin-like protein 1,41839,0.0957822256618142,0.00640443777623276,0.083229527620398,0.10833492370323,3.67479588907389e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOE,Apolipoprotein E,39979,0.106178511681757,0.0071041734001357,0.0922543318174906,0.120102691546023,4.93311680847642e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHMP6,Charged multivesicular body protein 6,39958,0.0872992858758536,0.00584335693093881,0.0758463062912135,0.0987522654604936,5.40053076074732e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,0.0733754487279672,0.00491260117425263,0.063746750426432,0.0830041470295023,5.72264464571177e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,0.129667964198937,0.00869728356581052,0.112621288409949,0.146714639987926,7.26814361675063e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.0520501997672823,0.00349837752338459,0.0451933798214485,0.058907019713116,1.12878137819182e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMNB2,Lamin-B2,39929,0.0434786352367909,0.00292069232519613,0.0377540782794065,0.0492031921941753,1.18855837089261e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUS,RNA-binding protein FUS,41831,0.0600286320898409,0.00403997874194551,0.0521102737556278,0.0679469904240541,1.53298635651003e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0950814526405125,0.00639643681794631,0.0825444364773377,0.107618468803687,1.67888389449493e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP1,Guanylate-binding protein 1,39911,0.0978366623634227,0.00658445024428823,0.0849311398846178,0.110742184842228,1.78581124672265e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HYAL1,Hyaluronidase-1,42077,0.0347301929008179,0.00234032708851685,0.0301431518073249,0.0393172339943109,1.98569758023482e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFM,Afamin,39979,0.0305234364104564,0.00205802879452861,0.0264896999731803,0.0345571728477325,2.647540737356e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAYN,Layilin,41997,0.0537827689433257,0.00362925267397235,0.0466694337023399,0.0608961041843115,2.70170850076112e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,0.0899653576644281,0.00607628882028072,0.0780558315766779,0.101874883752178,3.25487157807532e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLL1,Delta-like protein 1,42181,0.0460294151164468,0.00311509139370609,0.0399238359847828,0.0521349942481107,5.00546738308495e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.0863990037949633,0.00584902748162315,0.0749349099309819,0.0978630976589447,5.35303782171416e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,0.0768416046837753,0.00521229785618112,0.0666255008856603,0.0870577084818904,8.21801807026087e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0495670972162213,0.00336668622232453,0.0429683922204652,0.0561658022119774,1.08929518121647e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.0690985437053889,0.00468964753406538,0.0599068345386208,0.078290252872157,1.11412322303906e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.0453797484647161,0.00308291950312364,0.0393372262385938,0.0514222706908385,1.13836508373948e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXLNA,Alpha-taxilin,42016,0.131116353816818,0.00893015160728331,0.113613256666543,0.148619450967094,1.98357825939682e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,0.085904127523507,0.00586811457636338,0.0744026229538347,0.0974056320931792,3.68579703129761e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP5,Fatty acid-binding protein 5,42218,0.0986103239776856,0.00675343545214255,0.0853735904914862,0.111847057463885,6.32288634497666e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0496349052648532,0.00339965732917112,-0.0562982336300286,-0.0429715768996778,6.42869908114474e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGN,Mimecan,42137,0.064049748605284,0.00438727068508801,0.0554506980625115,0.0726487991480565,6.58862448135104e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRN,Progranulin,42077,0.037110129955685,0.00254736077768163,0.032117302831429,0.042102957079941,1.03306374192256e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,0.0902652003540818,0.00619769437177605,0.0781177193854007,0.102412681322763,1.31553084936939e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0761258656123032,0.00523057005904247,0.06587394829658,0.0863777829280265,1.52125924726019e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP20,Centrosomal protein 20,41843,0.111149436922032,0.00765281932197563,0.0961499110509599,0.126148962793104,1.97633790157624e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300A,CMRF35-like molecule 8,39736,0.0453234073037226,0.00311840024100121,0.0392113428313602,0.051435471776085,1.99754378464951e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF1,Trefoil factor 1,42084,0.118415097125688,0.00816386555807175,0.102413920631867,0.134416273619509,2.56541422594892e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHR,Growth hormone receptor,39736,0.0418734632877127,0.00288488450923805,0.0362190896496061,0.0475278369258193,2.63750667044765e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIAE,Sialate O-acetylesterase,42147,0.0682982357420579,0.00471512899914397,0.0590565829037358,0.0775398885803801,3.39834109014076e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,0.042915608611198,0.00296132515511394,0.0371114113071747,0.0487198059152213,3.59464312788166e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.0459972728724685,0.00317726343159012,0.0397698365465518,0.0522247091983851,3.80988703171209e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSZ,Cathepsin Z,42168,0.0474334249397937,0.00327756104938616,0.0410094052829968,0.0538574445965906,4.07383129095511e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0492334825018645,0.00340527234948802,0.042559148696868,0.055907816306861,4.96148303680755e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.131892094300032,0.00913266675319151,0.113992067463777,0.149792121136288,6.35696332575664e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSNL1,Visinin-like protein 1,39929,0.056984052057538,0.0039516782371903,0.049238762712645,0.064729341402431,1.00017736185772e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSC2,Desmocollin-2,41984,0.0513909330947096,0.0035677092961113,0.0443982228743314,0.0583836433150877,1.08347854515915e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL25,C-C motif chemokine 25,42296,0.0718757866976019,0.0049926351346956,0.0620902218335985,0.0816613515616052,1.19422051114772e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0496656778135889,0.00345443794427582,0.0428949794428083,0.0564363761843695,1.57573459545551e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0349507246759627,0.00243562530647768,0.0301768990752664,0.039724550276659,2.33736475669226e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFH,Complement factor H,39418,0.0343928126705244,0.00239665406088621,0.0296953707111874,0.0390902546298614,2.81659908431307e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,0.029100789700663,0.00203201748273501,0.0251180354345023,0.0330835439668236,3.51783499554289e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG1B,Lithostathine-1-beta,42310,0.0826199862781308,0.00579547825885183,0.0712608488907812,0.0939791236654804,8.74359610416353e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0669162851561467,0.00469627177044725,0.0577115924860701,0.0761209778262234,9.76147883510695e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA1,Carboxypeptidase A1,42310,0.093569310315858,0.00657173333201685,0.080688712985105,0.106449907646611,1.12382008337779e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.0342442081753493,0.00240601483698045,0.0295284190948676,0.038959997255831,1.21668859695875e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTDH,Protein LYRIC,39657,0.138599476422201,0.00974012435226859,0.119508832691754,0.157690120152647,1.51048109435867e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,0.0538731082873001,0.00378944605067178,0.0464457940279834,0.0613004225466168,1.56215645216917e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.0827828338330693,0.00582999816624866,0.071356037427222,0.0942096302389167,2.29127318436323e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,0.0550289196971317,0.00388317061173305,0.0474179052981349,0.0626399340961285,2.96058372736405e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAST,Gastrin,39929,0.189149777928985,0.0133406355689737,0.163002132213797,0.215297423644174,3.03307403067361e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD160,CD160 antigen,42296,0.0696617041925512,0.0049261001718717,0.0600065478556826,0.0793168605294197,4.38325555197865e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0582094479532823,0.00412076472371635,0.0501327490947982,0.0662861468117663,5.45253614938e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.11463746726893,0.00811442800440858,0.0987331883802889,0.130541746157571,6.17892391561897e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTNB,Dystrobrevin beta,39900,0.0655431205856267,0.00463989263702566,0.0564489310170564,0.074637310154197,6.32848407652831e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.116904285714408,0.00828311567034277,0.100669379000537,0.13313919242828,6.47890006825938e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.122400082202728,0.00866602836668887,0.105414666604018,0.139385497801438,6.63129078513712e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.102362214899491,0.00725309682673482,0.0881461451190906,0.116578284679891,7.58588034672686e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,0.0438015416751776,0.00311159369479512,0.0377028180333792,0.049900265316976,1.25144413787012e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.139739511354772,0.00993932488672096,0.120258434576799,0.159220588132746,1.37970628751728e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB6A,Ras-related protein Rab-6A,42119,-0.063385183560895,0.00450986239718282,-0.0722245138593733,-0.0545458532624166,1.48180311194226e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO1,Roundabout homolog 1,42144,0.0341665354167753,0.00243310321575597,0.0293976531138936,0.038935417719657,1.75914199219799e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,0.0494956360415664,0.00352860408460801,0.0425795720357347,0.0564117000473981,2.17903619357129e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.064593857407838,0.00461105512734891,0.0555561893582341,0.0736315254574418,2.82813656278532e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTBDN,Retbindin,42070,0.0426677008840756,0.0030475999862388,0.0366944049110475,0.0486409968571036,3.16227301411697e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNA1,Ephrin-A1,42113,0.0417885744688614,0.00298731083230965,0.0359334452375345,0.0476437037001883,3.71256897686917e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0394952257937317,0.00282780678668767,0.0339527244918238,0.0450377270956395,5.03044280560202e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0739594808072177,0.00530449660777408,0.0635626674559805,0.0843562941584549,6.98787841412984e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL14,C-C motif chemokine 14,42152,0.0572432680547306,0.00410997988832324,0.049187707473617,0.0652988286358442,8.59259524994521e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS1,Galectin-1,42145,0.0495615497726143,0.00356046086684992,0.0425830464735884,0.0565400530716401,9.58409591426077e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.0607762419588893,0.00436733714800513,0.0522162611487993,0.0693362227689794,1.01799742541346e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.0380378531660969,0.00273368796977642,0.0326798247453351,0.0433958815868587,1.0377726935811e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GH1,Somatotropin,42129,-0.251183216817217,0.0180662259438728,-0.286593019667208,-0.215773413967227,1.20438162289002e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,0.119937607070878,0.00862630699137191,0.103030045367789,0.136845168773967,1.21865118284029e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN1,Dynactin subunit 1,42262,0.0901070643467765,0.00649176712193954,0.077383200787775,0.102830927905778,1.64806971509497e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.119416163277634,0.00861268727026601,0.102535296227913,0.136297030327356,2.03691078724148e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD63,CD63 antigen,41992,0.0708935155993569,0.00512205080705012,0.0608542960175386,0.0809327351811751,2.86849916727323e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0694107048974243,0.00502636005271171,0.0595590391941094,0.0792623706007393,4.45067281529176e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.110522540917172,0.0080002199401903,0.0948421098343988,0.126202971999945,4.63115306414747e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN8,Tetraspanin-8,39930,0.134430636108299,0.00974123150492865,0.115337822358639,0.153523449857959,5.65717931633448e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN5,CCN family member 5,42137,0.053109669419934,0.00385416658434272,0.0455555029146222,0.0606638359252457,6.56720407985047e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAT,Linker for activation of T-cells family member 1,42296,0.106088975927546,0.00770836002768672,0.0909805902732804,0.121197361581812,8.21524681809326e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0464633095171644,0.00337863205221194,0.039841190694829,0.0530854283394998,9.52219601184424e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.0746636034542051,0.00544248158132999,0.0639963395547983,0.0853308673536119,1.53030341065765e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRPK2,SRSF protein kinase 2,42119,0.118692262897552,0.00865291455063709,0.101732550378303,0.135651975416801,1.54659263091682e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFC,Platelet-derived growth factor C,41843,0.0389581735850887,0.00284571632580352,0.0333805695865138,0.0445357775836636,2.25960216598445e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0286876120384009,0.00209747089512619,0.0245765690839536,0.0327986549928483,2.70532622493873e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.0442225939553361,0.00323279316276755,0.0378863193563117,0.0505588685543605,2.97891925008764e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDC1,Syndecan-1,42145,0.0562530028673155,0.00411894214447291,0.0481798762641486,0.0643261294704824,3.48150540779648e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NIT2,Omega-amidase NIT2,39903,0.101798094345941,0.00745842630124006,0.0871795787955106,0.116416609896372,4.42479333651521e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLSCR3,Phospholipid scramblase 3,39911,0.0802918434325645,0.00588350424110572,0.0687601751199973,0.0918235117451317,4.53081555998533e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COCH,Cochlin,39958,0.0640012642931905,0.00469022679771211,0.0548084197696748,0.0731941088167063,4.59516287060733e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RLN2,Prorelaxin H2,39709,0.0716577638666838,0.00525991101710979,0.0613483382731486,0.0819671894602189,6.31143178838873e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.135195533267731,0.00993981251269181,0.115713500742855,0.154677565792607,7.42051186422631e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFX1,Transcriptional repressor NF-X1,39575,0.093894245117062,0.00689962804190191,0.0803709741549343,0.10741751607919,7.77360476190261e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOC1,Apolipoprotein C-I,39959,-0.0534524482229521,0.00393181808381916,-0.0611588116672376,-0.0457460847786665,9.11263229759619e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0852325162921836,0.00627538043763836,0.0729327706344124,0.0975322619499548,9.70586768148388e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.0867912146680179,0.00639459192785499,0.0742578144894221,0.0993246148466137,1.22886870416854e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPON1,Spondin-1,42144,0.0449270254659861,0.00331474976788531,0.0384301159209309,0.0514239350110413,1.4066704080935e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,-0.0441212349936179,0.00325644122674777,-0.0505038597980435,-0.0377386101891923,1.49462901968725e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,0.0686460090334155,0.00506839342967471,0.0587119579112531,0.078580060155578,1.60373633187453e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTSS2,Protein MTSS 2,39919,0.139092855333055,0.0102667488130309,0.118970027659514,0.159215683006595,1.71598609759648e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH9,Myosin-9,39966,0.156911147538888,0.0115880940507308,0.134198483199456,0.179623811878321,1.88345937420426e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,0.11614399713953,0.00857888917346862,0.0993293743595316,0.132958619919529,1.99404820970629e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD59,CD59 glycoprotein,41638,0.0324800218518549,0.00240194641328028,0.0277722068818256,0.0371878368218843,2.1929966425854e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3GLB2,Endophilin-B2,39929,0.0907704921338011,0.00671123655049661,0.0776164684948277,0.103924515772774,2.32557155001747e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YAP1,Transcriptional coactivator YAP1,39929,0.0380632413137525,0.00281487165991661,0.0325460928603159,0.0435803897671891,2.41944596402357e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,0.0554934049299471,0.00410846955828582,0.0474408045957069,0.0635460052641873,2.60973067222472e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SARG,Specifically androgen-regulated gene protein,39915,0.151679850212239,0.0112367295236316,0.129655860345921,0.173703840078557,3.32066815642507e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0565645078154035,0.00419165957762515,0.0483488550432583,0.0647801605875488,3.54576990599191e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.0941986728271701,0.00698935909295313,0.0804995290049819,0.107897816649358,3.89094158502321e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,-0.0370495820422802,0.00274899267056247,-0.0424376076765827,-0.0316615564079778,3.90518553930355e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,0.032407906442311,0.00240498294591941,0.027694139868309,0.0371216730163131,4.51474396530467e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.0858370430598854,0.006384993561972,0.0733224556784203,0.0983516304413505,6.14568667159851e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSM,Oncostatin-M,42051,0.0944014166321535,0.00702341427156507,0.0806355246598859,0.108167308604421,6.38936250330084e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG1A,Lithostathine-1-alpha,42105,0.0681971798733195,0.00507522089464153,0.0582497469198221,0.0781446128268169,6.69411486801198e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QDPR,Dihydropteridine reductase,42081,0.0575404641578016,0.00428689539555668,0.0491381491825105,0.0659427791330927,8.17020386384604e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,0.0663787224328477,0.00494572766088988,0.0566850962175036,0.0760723486481919,8.34538886469241e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.0877241054084074,0.00653242171816335,0.0749205588408073,0.100527651976008,8.38019119513905e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.0350763789831236,0.00261608033026767,0.029948861535799,0.0402038964304483,9.93821298172422e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,0.0583911209757184,0.00435541561717934,0.0498545063660469,0.0669277355853899,1.00728408291468e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0354447730051472,0.00264660175015856,0.0302574335748364,0.040632112435458,1.21715387545586e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MATN2,Matrilin-2,42144,0.0403347942326123,0.00301201938163212,0.0344312362446134,0.0462383522206113,1.23278375586068e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6,Interleukin-6,42070,0.101771475684545,0.00760051760192186,0.0868744611847783,0.116668490184312,1.2567979094491e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,0.0533453039913998,0.00398596899349655,0.0455328047641466,0.0611578032186531,1.39575367660278e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FYB1,FYN-binding protein 1,42115,0.125580779843532,0.00939288134775114,0.10717073240194,0.143990827285124,1.64212950185279e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLO1,Lactoylglutathione lyase,41900,0.0767206193053868,0.0057456083010297,0.0654592270353686,0.0879820115754051,2.0732229377118e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,0.0389600038865626,0.00292406454131656,0.0332288373855821,0.0446911703875431,3.01081760696371e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPL14,60S ribosomal protein L14,39638,0.0531442602622506,0.0039940122287167,0.0453159962939659,0.0609725242305353,4.34762764584728e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTN,Pleiotrophin,41900,0.06734163109459,0.0050652221363128,0.0574137957074169,0.0772694664817631,4.46439617907417e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JAM2,Junctional adhesion molecule B,42249,0.036894315698306,0.00277690390877022,0.0314515840371164,0.0423370473594956,4.93771268883164e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.0509213014472917,0.00384887770589905,0.0433775011437295,0.0584651017508538,1.03702610204677e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD46,Membrane cofactor protein,42107,0.0385634597787047,0.002915750221938,0.0328485893437063,0.0442783302137032,1.09717856746151e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLIN1,Perilipin-1,41839,0.0455047077865483,0.00344387706012379,0.0387547087487056,0.0522547068243909,1.31085602413375e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R9B,Neurabin-2,42296,0.127385075963347,0.00964332302400112,0.108484162836304,0.146285989090389,1.34745845994598e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL4,C-C motif chemokine 4,42148,0.0834572541810311,0.00632776352639453,0.0710548376692978,0.0958596706927644,1.77590739649889e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA2,Annexin A2,39492,0.0952022189136004,0.00721459390126271,0.0810616148671255,0.109342822960075,1.86197451702279e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.112370167001598,0.00852643297630824,0.0956583583680342,0.129081975635162,2.25645429341857e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.0924720940772363,0.00702126110543681,0.0787104223105802,0.106233765843892,2.57328321190005e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.0448424432146235,0.00340807989007485,0.0381626066300768,0.0515222797991702,2.66480322763291e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.0695247661688586,0.00528535427673555,0.0591654717864569,0.0798840605512603,2.78542551867053e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0344258732882952,0.00261659431934724,0.0292973484223746,0.0395543981542158,3.07029732231322e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,0.0519563646471471,0.00395271379025914,0.0442090456182392,0.059703683676055,3.22135805852431e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,0.0537318740889888,0.00408812871151103,0.0457191418144271,0.0617446063635504,3.63210047561998e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,0.0914132980728731,0.00695780788151094,0.0777759946251117,0.105050601520635,3.84067741783688e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARF6,ADP-ribosylation factor 6,39930,0.145911046210455,0.0111091970460599,0.124137020000178,0.167685072420733,4.04438607820673e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,0.0414005257316646,0.00316149791986136,0.0352039898087363,0.0475970616545928,6.004909904521e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.13926086372868,0.0106314225013959,0.118423275625944,0.160098451831416,6.39585352663465e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD244,Natural killer cell receptor 2B4,42296,0.0365949309098776,0.00280137008121998,0.0311042455506864,0.0420856162690687,9.10537653531719e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6AP2,Renin receptor,41843,0.0523991931527523,0.00401093680108996,0.044537757022616,0.0602606292828887,9.16964186308877e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TALDO1,Transaldolase,39948,0.0589054890619501,0.00451054739341784,0.0500648161708511,0.0677461619530491,1.06586294642445e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAG1,Dystroglycan,42185,0.0628845602513922,0.00482857616498465,0.0534205509680223,0.0723485695347621,1.53174023679793e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS3,Galectin-3,42196,0.0390856978016331,0.00300901788274705,0.0331880227514489,0.0449833728518173,2.37259288838854e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.0875544249642438,0.00674800658236689,0.0743283320628047,0.100780517865683,2.90690432477698e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.0807536512535797,0.00622389035650265,0.0685548261548345,0.0929524763523249,2.90955556524286e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.102235727722335,0.00787933863360249,0.0867922240004742,0.117679231444196,3.16193925236952e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,0.0860259019503857,0.0066374567391077,0.0730164867417347,0.0990353171590368,3.48908976885539e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.0967250505151135,0.00746610075452426,0.0820914930362459,0.111358607993981,3.74227138917097e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.0355471459085999,0.00274685804906962,0.0301633041324234,0.0409309876847764,4.43598509757221e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMN,Protein amnionless,41913,0.0620859260683179,0.00480752462909508,0.0526631777952915,0.0715086743413442,6.31260728642592e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINH1,Serpin H1,39757,0.170421767403512,0.0131932819033245,0.144562934872996,0.196280599934028,6.71649636437271e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0678753008525167,0.00525996920037842,0.057565761219775,0.0781848404852584,7.87678639548425e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,0.111361969668942,0.00863826170673251,0.0944309767237461,0.128292962614138,8.38467878254205e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP43,Centrosomal protein 43,41797,0.0923017524372941,0.00716270199871152,0.0782628565198195,0.106340648354769,9.06489253945636e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOST,Sclerostin,42129,0.0507038470040404,0.00394277538283895,0.0429760072536761,0.0584316867544048,1.25627276336434e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.0253079588315903,0.00196880144138955,0.0214491080064668,0.0291668096567139,1.34892499073139e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2,Complement C2,42199,0.0295444920651392,0.00229953693140723,0.025037399679581,0.0340515844506974,1.45913393362395e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD209,CD209 antigen,42171,-0.0509919365534976,0.00397167701569318,-0.0587764235042562,-0.043207449602739,1.64108086615079e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK1,Dickkopf-related protein 1,42249,0.0767582152483186,0.00599214642615685,0.0650136082530512,0.088502822243586,2.37106744622693e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0255685420774388,0.00199624760813251,0.0216558967654991,0.0294811873893785,2.41482659441195e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MARCO,Macrophage receptor MARCO,42145,0.0336823383316937,0.00263132941772658,0.0285249326729496,0.0388397439904378,2.67913337089307e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD1,Programmed cell death protein 1,42232,0.0546168987164022,0.00426746357894416,0.0462526701016716,0.0629811273311327,2.7415337008653e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POSTN,Periostin,39966,-0.0494142388573274,0.0038626332527249,-0.0569850000326682,-0.0418434776819866,3.24332397070418e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.0533746718717667,0.00417410021431592,0.0451934354517075,0.0615559082918259,3.48578966329908e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0639592837341872,0.00500617521008431,0.0541471803224219,0.0737713871459524,4.02047630110282e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0410989538447035,0.00322366243573032,0.034780575470672,0.0474173322187349,5.20026811051785e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,0.0790127917020611,0.00621308990441339,0.0668351354894109,0.0911904479147114,7.79666837275902e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0301288448828901,0.00236856227709712,0.0254864628197797,0.0347712269460004,8.12496964648271e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.0697885117829966,0.00548780847338632,0.0590324071751594,0.0805446163908338,8.48407292449698e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.0678691259745434,0.00534205448690559,0.0573986991802085,0.0783395527688784,9.06882181592443e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.0860261126180814,0.00677368801207383,0.0727496841144167,0.0993025411217461,9.67763887024003e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.0561803845079874,0.00442566283684857,0.0475060853477642,0.0648546836682106,1.12874199370588e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0691360866658303,0.00546349004925135,0.0584276461692977,0.079844527162363,1.71054599189042e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,P4HB,Protein disulfide-isomerase,42073,0.0496391115611178,0.0039258180185134,0.0419445082448315,0.057333714877404,1.93780831107801e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,0.0752732537052781,0.00596277752041276,0.063586209765269,0.0869602976452871,2.52524194767766e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRB1,Chymotrypsinogen B,42137,0.0748317500403115,0.00593669236669385,0.0631958330015915,0.0864676670790314,3.16745977732294e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,0.0850341397220079,0.00675737379895324,0.0717896870760596,0.0982785923679563,4.09930151257317e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRC1,Macrophage mannose receptor 1,39990,0.0365627535873465,0.00290708427015055,0.0308648684178515,0.0422606387568416,4.89505259214373e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MET,Hepatocyte growth factor receptor,42158,-0.0245728929821915,0.00195569700331434,-0.0284060591086876,-0.0207397268556954,5.23395805118813e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,0.0317816549889686,0.0025319305632907,0.0268190710849188,0.0367442388930184,6.10794079070585e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.121156048085287,0.00965312802203605,0.102235917162096,0.140076179008477,6.21478225759041e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.128098346133704,0.010209264799836,0.108088187126025,0.148108505141383,7.12181465830179e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.090372948145881,0.00721752399089452,0.0762266011237278,0.104519295168034,9.07605023132465e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0566614894047399,0.00452790868567946,0.0477867883808082,0.0655361904286717,1.07962636342183e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS22,Brain-specific serine protease 4,39657,0.0442481958166727,0.00354512716991894,0.0372997465636316,0.0511966450697138,1.63541435546932e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WDR46,WD repeat-containing protein 46,39919,0.046666701705441,0.00374570785124686,0.0393251143169972,0.0540082890938849,2.13883974374493e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,0.0677053710233768,0.00543650452567535,0.0570498221530532,0.0783609198937005,2.31672811157399e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.106500053299434,0.00856110335756453,0.0897202907186071,0.12327981588026,2.50348098658181e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0465674856529633,0.00374780108123927,0.0392217955337343,0.0539131757721922,2.97270308845412e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR1,Folate receptor alpha,42110,0.0372991551099794,0.00300236116181027,0.0314145272328312,0.0431837829871275,3.04344749993065e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,0.0615941062967886,0.00495807326791304,0.0518762826916791,0.0713119299018982,3.05316474253907e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLF4,Krueppel-like factor 4,39586,0.0516478313554831,0.00415505919757357,0.0435039153282388,0.0597917473827273,3.09436624090602e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.0546331733252599,0.004413412271795,0.0459828852725417,0.0632834613779781,5.25667558557897e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FEN1,Flap endonuclease 1,41843,0.0811726949864155,0.00655998206430724,0.0683151301403733,0.0940302598324577,5.64424001064442e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBIN,Erbin,42070,0.128961098783626,0.0104352782834845,0.108507953347996,0.149414244219255,6.79940830029177e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.113281806581946,0.00917088478207478,0.0953068724090798,0.131256740754813,7.92633774714417e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUCA2A,Guanylin,42083,0.0441581933374124,0.00357814967388396,0.0371450199765998,0.0511713666982249,8.38780124860272e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD207,C-type lectin domain family 4 member K,41832,0.0490165398069029,0.00397390332503655,0.0412276892898312,0.0568053903239745,9.15448238100331e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCN1,Ficolin-1,39978,0.0704005811467524,0.0057063377382965,0.0592161591796912,0.0815850031138135,9.51388029200495e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,0.051710838268482,0.00419557531434683,0.0434875106523622,0.0599341658846018,1.11652249456732e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA9,Serpin A9,42025,0.0905900319427354,0.00736172419610168,0.0761610525183761,0.105019011367095,1.29918417879932e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NADK,NAD kinase,42145,0.0684831332011183,0.00556892362053444,0.0575680429048708,0.0793982234973659,1.43050363138609e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A4,Protein S100-A4,42181,0.0699934434406848,0.00569862166135365,0.0588241449844316,0.0811627418969379,1.71362295079022e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGFR,Opioid growth factor receptor,42070,0.0401263504069021,0.00326984670643743,0.0337174508622847,0.0465352499515194,1.96433519805778e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RETN,Resistin,42105,0.0534855571938338,0.00436558730384651,0.0449290060782946,0.0620421083093729,2.50478742999003e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.0874829597263538,0.00713699386729913,0.0734944517464475,0.10147146770626,2.52052649763332e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0450861472510018,0.00367987832819304,0.0378735857277435,0.0522987087742602,2.74180378562506e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA4,Kallistatin,39802,0.0293045443430047,0.00239206604359482,0.0246160948975588,0.0339929937884505,2.7585140780807e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNMBP,Dynamin-binding protein,42016,0.0754905722024252,0.00616673247748463,0.0634037765465554,0.0875773678582951,2.83893867157026e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,0.0982768448395511,0.0080356374799207,0.0825269953789066,0.114026694300196,3.28241302446974e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD14,Monocyte differentiation antigen CD14,41932,0.0511470860086828,0.00420078303242389,0.042913551265132,0.0593806207522336,6.34652272826889e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSN,Gelsolin,39943,-0.0235991063443237,0.00193772850215321,-0.027397054208544,-0.0198011584801034,6.56653787354783e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASS1,Argininosuccinate synthase,39575,0.0962804752925105,0.00790830701082472,0.080780193551294,0.111780757033727,7.01701287036696e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,0.0821811361220196,0.00676415896376156,0.068923384553047,0.0954388876909923,9.43548770126962e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.11767720074669,0.00969237053877023,0.0986801544907006,0.13667424700268,9.63269929899942e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH15,Cadherin-15,42230,0.0853387448841362,0.00703461996934017,0.0715508897442295,0.0991266000240429,1.07592836951769e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5E,5'-nucleotidase,42181,0.0663171139094424,0.00547147263075591,0.0555930275531609,0.077041200265724,1.22650822415786e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB8,Serpin B8,42296,0.0721308247209945,0.00595460361145246,0.0604598016425476,0.0838018477994413,1.33128845233713e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL5,C-C motif chemokine 5,42217,0.124226169188328,0.0102687659446754,0.104099387936765,0.144352950439892,1.61780237035329e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDN1,Endothelin-1,39638,0.0364018357863741,0.00300780041123625,0.0305065469803511,0.0422971245923971,1.66967436337984e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,0.0294068386095539,0.00243558911315594,0.0246330839477683,0.0341805932713396,2.16373464138602e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD6,T-cell differentiation antigen CD6,42284,0.0640650270227315,0.00530675214229312,0.053663792823837,0.0744662612216261,2.18475852969269e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BACH1,Transcription regulator protein BACH1,42119,0.0919245074421181,0.0076352252718727,0.0769594659092476,0.106889548974989,3.25606576517847e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP1,Interstitial collagenase,41693,0.11052807608501,0.00918083784146289,0.092533633915743,0.128522518254278,3.31852447560322e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF8,SLAM family member 8,41843,0.0661590338387829,0.00549674789748004,0.055385407959722,0.0769326597178437,3.42301483724322e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.135686969302051,0.0112704774927732,0.113596833416215,0.157777105187886,3.52876718597848e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH17,Cadherin-17,42145,0.0836437616576179,0.00695244382705748,0.0700169717565852,0.0972705515586505,3.61067252687345e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD248,Endosialin,39966,-0.0497501770162046,0.00413600004028463,-0.0578567370951625,-0.0416436169372467,3.9950077308849e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.0949399984551527,0.00790103909646374,0.0794539618260838,0.110426035084222,4.31516886662775e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.0919372000018733,0.00764901202685016,0.076945136429247,0.1069292635745,4.52653272430276e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NSFL1C,NSFL1 cofactor p47,42249,0.0768192696236013,0.00639569004708747,0.0642837171313098,0.0893548221158927,4.56037215502011e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,0.0578128337633339,0.00481736710310305,0.0483707942412519,0.0672548732854159,5.17892528493464e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASSF2,Ras association domain-containing protein 2,41843,0.0697553675935463,0.00582419050522678,0.0583399542033018,0.0811707809837908,6.94781427340185e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0600758497589926,0.00501434263718639,0.0502477381901072,0.0699039613278779,7.16085597316428e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300LF,CMRF35-like molecule 1,42262,0.0730296889446207,0.00611418179139919,0.0610458926334783,0.0850134852557631,1.01162613434896e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH3,Cadherin-3,42249,0.0447023827766393,0.00374850640337052,0.0373553102260331,0.0520494553272455,1.2674482180862e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.132690308772962,0.0111338667589013,0.110867929925515,0.154512687620408,1.49727199330079e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,0.0666752478727449,0.00560542279026624,0.0556886192038231,0.0776618765416667,1.84352524539812e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCR,Breakpoint cluster region protein,42119,0.111823408525771,0.00940210738767954,0.0933952780459194,0.130251539005623,1.8583220741711e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,0.0938012044820567,0.00788932661812704,0.0783381243105277,0.109264284653586,2.08778863217438e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0668377569218691,0.00563147292312632,0.0558000699925415,0.0778754438511967,2.48167952157737e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,0.0625298108454833,0.00528027604636674,0.0521804697946045,0.0728791518963621,3.42923860669748e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FETUB,Fetuin-B,42199,0.0387474223117811,0.00327624898048263,0.0323259743100351,0.045168870313527,4.0783280845161e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMB1,Laminin subunit beta-1,39638,0.038008969092724,0.00321498318317985,0.0317076020536915,0.0443103361317566,4.66368773057851e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCHE,Cholinesterase,39806,0.0325165717974849,0.0027525692229054,0.0271215361205903,0.0379116074743795,5.16665479443157e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISM1,Isthmin-1,42119,0.0473078500275186,0.00402174728550313,0.0394252253479324,0.0551904747071047,8.6487029905795e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0406441131244311,0.00345355650351659,0.0338751423775386,0.0474130838713236,8.65702397474184e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.0427968466850852,0.0036393062350238,0.0356638064644386,0.0499298869057319,8.99541079527693e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.0813089184563958,0.00691451662916032,0.0677564658632416,0.0948613710495501,9.05373122710258e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEFTY2,Left-right determination factor 2,42247,0.0616740261780364,0.00524618043153166,0.0513915125322344,0.0719565398238385,9.3597929007372e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,0.152923171878638,0.0130094894662645,0.127424572524759,0.178421771232516,9.5126740488271e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP2,Methionine aminopeptidase 2,42247,0.0666897093388011,0.00567504796242415,0.0555666153324497,0.0778128033451524,9.87763887079969e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGRN,Neugrin,39929,0.0269434474063073,0.00229214835585578,0.02245083662883,0.0314360581837847,1.02101468102129e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS8,Galectin-8,42249,0.0726680942157916,0.00619294806712461,0.0605299160042274,0.0848062724273558,1.21068032270348e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.0337541925706417,0.00287882229396379,0.0281117008744727,0.0393966842668107,1.34526813604431e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHB4,Ephrin type-B receptor 4,42310,0.0302650566051148,0.00258276496551934,0.0252028372726969,0.0353272759375327,1.45618310095311e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,0.0331034736057481,0.00282555043717192,0.0275653947488911,0.0386415524626051,1.50045310549135e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELP,P-selectin,42217,0.06654482294333,0.00568191490894362,0.0554082697218005,0.0776813761648595,1.57281205156026e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.0355560311616367,0.003039355457313,0.0295988944653033,0.0415131678579702,1.85155788156785e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0449705332563569,0.00384451468607689,0.0374352844716462,0.0525057820410676,1.87458553590111e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEMIP2,Cell surface hyaluronidase,39657,0.0388554684769716,0.00332009865270499,0.0323480751176698,0.0453628618362734,1.88281774651562e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPO,Myeloperoxidase,42137,0.0534288795755656,0.00457584707022088,0.0444602193179327,0.0623975398331986,2.38161751510062e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.0727019692540922,0.00624708866944495,0.0604576754619801,0.0849462630462043,3.72967002643547e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,0.148403732036327,0.0127687611537697,0.123376960174939,0.173430503897716,4.44812627291888e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.136022226037315,0.0116989725820604,0.113092239776476,0.158952212298153,4.5454546849449e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLK1,Protein delta homolog 1,42310,0.0683919020295965,0.00588998215845037,0.0568475369990338,0.0799362670601592,5.02819880050161e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.0288694952203111,0.00248720353968761,0.0239945762825234,0.0337444141580989,5.31550432804892e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,0.0669577356615953,0.00577182237158955,0.0556449638132798,0.0782705075099109,5.76255670432558e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TJAP1,Tight junction-associated protein 1,42181,0.0980819044459786,0.00845765161382174,0.081504907282888,0.114658901609069,5.98230714603605e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRG1,Scrapie-responsive protein 1,39958,0.0324602321343855,0.00279781441308216,0.0269765158847445,0.0379439483840266,6.01511404715669e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.125573055418857,0.0108327701979949,0.104340825830787,0.146805285006927,6.33808724941237e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,0.161931800702059,0.0139701797821689,0.134550248329008,0.18931335307511,6.39846179605589e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL19,C-C motif chemokine 19,42249,0.133197053308818,0.0114939278169116,0.110668954787672,0.155725151829965,6.57808065770367e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASAH2,Neutral ceramidase,42016,0.0626704647838414,0.00541292913971181,0.0520611236700063,0.0732798058976766,7.47360264343553e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,0.0430842750744454,0.00371993970505914,0.0357931932525295,0.0503753568963613,7.58433664355332e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,0.0859209634319843,0.00743364460101751,0.07135102001399,0.100490906849979,9.38988966832019e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,0.047906013183077,0.00414589983438854,0.0397800495076755,0.0560319768584786,9.72593145876828e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMSB10,Thymosin beta-10,42137,0.0892502352878832,0.00773097159943037,0.0740975309529997,0.104402939622767,1.09545726079658e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFR,Epidermal growth factor receptor,42310,-0.01875680225933,0.00162595123672444,-0.0219436666833099,-0.0155699378353501,1.20460773561505e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.165674530118543,0.0143630294553135,0.137522992386128,0.193826067850957,1.30567853491644e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.0259103589335877,0.00225244845242669,-0.030325157900344,-0.0214955599668314,1.77151428455629e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0631980220315497,0.00549895470563499,0.0524200708085052,0.0739759732545943,1.98661102289177e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,0.101262401119499,0.00882806249551003,0.0839593986282995,0.118565403610699,2.72643099596931e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,0.144671330495286,0.0126141306225805,0.119947634475028,0.169395026515544,2.80133535582171e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0419521021751632,0.00365857764850607,0.0347812899840913,0.0491229143662351,2.86416706509215e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,0.0637838236978155,0.00556624690467093,0.0528739797646605,0.0746936676309705,3.10525856328229e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWC2,Brorin,41973,0.0475956063018409,0.00416448505853882,0.0394332155871048,0.055757997016577,4.13555860685918e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.0817824169588644,0.00715678260986962,0.06775512304352,0.0958097108742089,4.19630862416491e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.0702735374934503,0.00615388301158015,-0.0823351481961475,-0.0582119267907532,4.57759872764177e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.0283641566640745,0.00248519229812158,0.0234931797597562,0.0332351335683928,4.91983943879614e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0684695930514767,0.00600341635029457,0.0567028970048993,0.0802362890980541,5.44439675707723e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0516770168525911,0.00454959226565746,0.0427598160119025,0.0605942176932797,9.82051508540015e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0376104602005339,0.00331458858715846,0.0311138665697033,0.0441070538313645,1.04192450917983e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAX1BP1,Tax1-binding protein 1,39929,0.07206371472057,0.0063497352229593,0.0596182336835698,0.0845091957575703,1.08380264040687e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.109503340440732,0.00965652655385695,0.0905765483951722,0.128430132486291,1.13691642100724e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,0.0517937607100942,0.00457130875068756,0.0428339955587466,0.0607535258614419,1.26134674911184e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN3,CCN family member 3,42299,0.0391099353876448,0.00345882064115161,0.0323306469309876,0.0458892238443019,1.63166837739002e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,0.0878706471657935,0.00778339590879314,0.072615191184559,0.103126103147028,2.00205603227063e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLIT2,Slit homolog 2 protein,41839,0.0592519548040463,0.00525377674234256,0.0489545523890549,0.0695493572190377,2.29466617475979e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.0597485417746453,0.00530420864241562,-0.0701447907137799,-0.0493522928355107,2.65641736364685e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.0832920325091726,0.00739311185404698,0.0688015332752405,0.0977825317431046,2.75971163748888e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.066077012152818,0.00587493342637969,0.0545621426371138,0.0775918816685222,3.22738502770958e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTR,Transthyretin,39862,0.0285538030650897,0.0025380057810525,0.0235793117342268,0.0335282943959526,3.29643322723431e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,0.0475241875482057,0.00422840644166064,0.0392365109225508,0.0558118641738605,3.51216748494095e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP8,Neutrophil collagenase,42224,0.0819513998837862,0.00729309509406624,0.0676569334994163,0.096245866268156,3.61175457817049e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPE,Carboxypeptidase E,42134,-0.0446895012304419,0.00398130779317103,-0.0524928645050571,-0.0368861379558267,4.14092512542082e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGMN,Legumain,42185,0.0415204130502846,0.00370067279640477,0.0342670943693312,0.0487737317312379,4.38142404324687e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,0.0727652100680892,0.00649882578151159,0.0600275115363265,0.0855029085998519,5.67900256515567e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL8,Interleukin-8,42035,0.0773824390775168,0.00691124437114734,0.0638364001100681,0.0909284780449656,5.6921208953201e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AXIN1,Axin-1,42119,0.110054462498748,0.00983363167713934,0.0907805444115547,0.129328380585941,6.00569839480901e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0644077413730932,0.00578183713761674,0.0530753405833644,0.0757401421628221,1.07855789923853e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.0427247077900302,0.00383564789661894,0.035206837912657,0.0502425776674033,1.08704300847716e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN2,CCN family member 2,42146,0.0639713215492695,0.00575331317430216,0.0526948277276373,0.0752478153709017,1.34768602018398e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RSPO3,R-spondin-3,42262,0.0318222164476137,0.00286309353865582,0.0262105531118483,0.0374338797833791,1.41198403736229e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.0634990661570594,0.00571642406154037,0.0522948749964403,0.0747032573176786,1.52452936310244e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTBS,Di-N-acetylchitobiase,39860,0.0313632406729651,0.00282240762960656,0.0258313217189362,0.0368951596269939,1.53925662080014e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0821887367594858,0.00740397753762753,0.0676769407857359,0.0967005327332358,1.65787808451958e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSTL1,Follistatin-related protein 1,39638,0.0264166062537329,0.00238228483394053,0.0217473279792095,0.0310858845282564,2.00916713135542e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAL,Galanin peptides,42185,-0.0752166932581134,0.00678727531333842,-0.0885197528722567,-0.0619136336439701,2.0301828338091e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EHBP1,EH domain-binding protein 1,39958,0.0849868356504936,0.00767522003366002,0.0699434043845199,0.100030266916467,2.37160944375324e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.0827614599271915,0.00747601182353461,0.0681084767530637,0.0974144431013194,2.46468815244651e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALCAM,CD166 antigen,42310,0.0221786242529365,0.00200528356035878,0.0182482684746333,0.0261089800312397,2.58071627770032e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IKBKG,NF-kappa-B essential modulator,42119,0.102961161137796,0.0093114365269724,0.0847107455449299,0.121211576730662,2.66619284424993e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.117076467316253,0.0106022228920402,0.0962961104478539,0.137856824184651,3.14151744265599e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCF2,Neutrophil cytosol factor 2,42097,0.0932709129333664,0.00846553150727843,0.0766784711791007,0.109863354687632,4.13561381829702e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,0.0974208134258161,0.00885742983415923,0.0800602509508641,0.114781375900768,5.08959802745902e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,0.106894105397926,0.00972337101688918,0.0878362982048235,0.125951912591029,5.3803804438008e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.062381304732291,0.00567621245194093,0.0512559283264868,0.0735066811380953,5.60804498060357e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NBN,Nibrin,41913,0.0608206724405927,0.00554083327705779,0.0499606392175594,0.0716807056636259,6.50764266699093e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXO1,Forkhead box protein O1,42119,0.0968726061814374,0.00882998679864354,0.079565832056096,0.114179380306779,6.91696051267885e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,0.0348078078075362,0.00317366282907076,0.0285874286625575,0.0410281869525149,7.14244127064888e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,0.0337844982064147,0.00307992481288831,0.0277478455731536,0.0398211508396758,7.43498507331324e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRR3,Small proline-rich protein 3,39929,0.0706730756091428,0.00644460418288218,0.0580416514106937,0.0833044998075918,7.66426438024615e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.0931448606076562,0.00849416780295096,0.0764962917138723,0.10979342950144,7.74887686053037e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0272331888376043,0.00248493119405197,0.0223627236972625,0.0321036539779462,7.85638304303632e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADA,Adenosine deaminase,42296,0.0396735391207459,0.00362069050070801,0.0325769857393582,0.0467700925021336,7.98448164299679e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSE,Cathepsin E,39736,0.0594892330606362,0.00543363408300166,0.0488393102579529,0.0701391558633194,9.37293008269786e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD7,T-cell antigen CD7,39636,0.0502201672328344,0.00458978492311257,0.0412241887835338,0.0592161456821351,1.01034746434398e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD164,Sialomucin core protein 24,42137,0.0300548620014644,0.00274925880123599,0.0246663147510419,0.0354434092518869,1.05816901145705e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPL,Periplakin,39657,0.0361727318409496,0.00331023666732757,0.0296846679729875,0.0426607957089116,1.1787240978058e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS3BP,Galectin-3-binding protein,39979,0.0348690667128313,0.00319166509299765,0.0286134031305559,0.0411247302951067,1.20022633876387e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3D,Protein FAM3D,39930,0.097759266724567,0.00896325001358205,0.0801912966979462,0.115327236751188,1.46795009240009e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL18,C-C motif chemokine 18,42020,0.0779717903831059,0.00715501596361958,0.0639479590944115,0.0919956216718003,1.5450131373837e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD22,B-cell receptor CD22,42296,0.0473608214593761,0.00434883917272214,0.0388370966808407,0.0558845462379115,1.65943362533588e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,0.0814245589946433,0.0074840631340131,0.0667557952519777,0.096093322737309,1.96736368921738e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.0858937032670444,0.00789815648692741,0.0704133165526666,0.101374089981422,1.97709358469315e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLIN3,Perilipin-3,42145,0.0475001745937274,0.00436971421946317,0.0389355347235795,0.0560648144638752,2.07163835966658e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEXIM1,Protein HEXIM1,42119,0.0893769968096089,0.00822541663836644,0.0732551801984107,0.105498813420807,2.17326072305734e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP2B1,AP-2 complex subunit beta,39649,0.0541273399660491,0.00498310469590812,0.0443604547620692,0.063894225170029,2.39905054690536e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0746424157464252,0.00688480345126125,0.0611482009819531,0.0881366305108972,2.98964148869347e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,0.0354353778913426,0.00327002406830986,0.0290261307174553,0.0418446250652299,2.99268890848623e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS7_LGALS7B,Galectin-7,42076,0.0485452710427792,0.0044832860153663,0.0397580304526613,0.0573325116328972,3.2804599205322e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,0.0262273894719169,0.00242768871549636,0.021469119589544,0.0309856593542897,4.27786160127027e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.0323659251780855,0.00299879331497047,0.0264882902807433,0.0382435600754276,4.78823756084072e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,0.0460725023135158,0.00427181294323607,0.0376997489447731,0.0544452556822585,5.19371540045433e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0684611673165799,0.00634461323200866,0.0560257253818429,0.0808966092513169,5.20838209013119e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.0704097128239083,0.00652988007735555,0.0576111478722914,0.0832082777755252,5.61664390850572e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.0406796926270381,0.00377604283905819,0.033278648662484,0.0480807365915921,6.22137463794311e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPPK1,Epiplakin,39638,0.0817743107925943,0.00759386656178036,0.0668903323315048,0.0966582892536838,6.59708098280342e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIT,Citron Rho-interacting kinase,39649,0.05045007773844,0.00469208220032953,0.0412535966257941,0.0596465588510859,7.85636727964856e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPR,Nucleoprotein TPR,39575,0.0537090539863103,0.00500235322892523,0.0439044416576169,0.0635136663150038,9.28748710892853e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSF,Cathepsin F,42181,0.0440240454144569,0.00410641410890895,0.0359754737609954,0.0520726170679185,1.03971268069878e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.092595906856562,0.0086462543104529,0.0756492484080743,0.10954256530505,1.23332434322507e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USO1,General vesicular transport factor p115,42070,0.0971042948499345,0.00907943530603323,0.0793086016501094,0.11489998804976,1.37376735814962e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,0.0945300793586687,0.00884560894655596,0.077192685823419,0.111867472893918,1.49998550733374e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL5,Insulin-like peptide INSL5,39930,0.112181040164263,0.0104933546622198,0.0916140650263121,0.132748015302214,1.50609445201859e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES3,Carboxylesterase 3,42070,0.0774330026599817,0.00724615718371966,0.0632305345798911,0.0916354707400722,1.51079080121391e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2,Microtubule-associated protein 2,39929,0.0512035385374477,0.00479381972602321,0.0418076518744422,0.0605994252004532,1.66713629740587e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPB6,Heat shock protein beta-6,42262,0.0442629922793374,0.00414592658700468,0.0361369761688083,0.0523890083898666,1.67213897964204e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0753822734244768,0.00706135881588511,0.0615420101453419,0.0892225367036116,1.69476314313075e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,0.0345251332209154,0.00323443751455128,0.0281856356923949,0.0408646307494359,1.71460439387082e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0348705545950071,0.00327189233840526,0.0284576456117328,0.0412834635782814,2.15870991786739e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,0.0330123120926788,0.00310286609632272,0.0269306945438863,0.0390939296414713,2.49309632620436e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.122469018949114,0.0115213121896755,0.0998872470573504,0.145050790840878,2.75087276022132e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN3,Ataxin-3,39929,0.0664432704237449,0.00624947435123409,0.0541943006953261,0.0786922401521637,2.81841793337088e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0520229297513899,0.00489700880101526,0.0424247925014,0.0616210670013798,3.08143429962052e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.0469182410330842,0.00442213171950552,0.0382508628628534,0.055585619203315,3.41130549124748e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GET3,ATPase GET3,39958,0.0587642412755617,0.00553879047232344,0.0479082119498077,0.0696202706013156,3.56564082690296e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASAH1,Acid ceramidase,39876,0.0512643882373931,0.00484370424802142,0.0417707279112711,0.0607580485635151,4.69797072657447e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMD,Osteomodulin,42185,-0.0442590684117947,0.00418488995504703,-0.0524614527236869,-0.0360566840999025,4.86508708712803e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.0543702063046624,0.00514336356408612,0.0442892137190536,0.0644511988902712,5.36956127261935e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APLP1,Amyloid-like protein 1,42145,-0.0547544129030128,0.00518580078998996,-0.0649185824513931,-0.0445902433546325,5.85147464523297e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.0782387103267053,0.0074173495143478,0.0637007052785836,0.092776715374827,6.53756343711967e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPACT,Protein IMPACT,39929,0.0585659316705646,0.00555013478244196,0.0476876674969784,0.0694441958441508,6.54636917506593e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,0.0258141611925457,0.00244761900273422,0.0210168279471867,0.0306114944379048,6.63673090308842e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.0295109437368573,0.00280114250718868,0.0240207044227675,0.0350011830509471,7.4543659748708e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0694976527181087,0.00659824498467043,0.0565650925481547,0.0824302128880628,7.66729544357214e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,0.0365357212837238,0.0034700001543343,0.0297345209812285,0.043336921586219,8.40872310475442e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,0.0307642053511802,0.00292714158794183,0.0250270078388142,0.0365014028635462,9.75458549849855e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.0461761420727359,0.00439458246514092,0.0375627604410597,0.0547895237044121,1.05203109546451e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POF1B,Protein POF1B,39657,0.0489313626630074,0.00466048806412444,0.0397968060573235,0.0580659192686913,1.15028269053588e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,0.0679993372884905,0.00648165192097569,0.0552952995233781,0.0807033750536028,1.24439239862725e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0770670318834453,0.00735896887152244,0.0626434528952613,0.0914906108716292,1.45198772125471e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,0.0895264203564582,0.0085548285381295,0.0727589564217243,0.106293884291192,1.63448544769116e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STC2,Stanniocalcin-2,42113,0.0255811663038979,0.00244603857584251,0.0207869306952466,0.0303754019125492,1.68144404264427e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNPEP,Aspartyl aminopeptidase,39929,0.060940350216515,0.00582551667137783,0.0495223375406144,0.0723583628924155,1.70578779238298e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARF1,Scavenger receptor class F member 1,42310,0.0451761006176512,0.00432990340926943,0.0366894899354831,0.0536627112998193,2.16977676070127e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHPS,Deoxyhypusine synthase,39919,0.0430928430466358,0.00412930544811927,0.0349994043683221,0.0511862817249496,2.21690522743174e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CR2,Complement receptor type 2,42217,0.0496140027324547,0.00475814817185183,0.0402880323156251,0.0589399731492843,2.32186289614443e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0440725415483902,0.00422522963837707,0.0357910914571711,0.0523539916396093,2.33631559731238e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PI3,Elafin,41966,0.0597006257678208,0.00572991525874908,0.0484699918606727,0.070931259674969,2.53580167785515e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0647505093411946,0.00621824706068228,0.0525627451022573,0.0769382735801319,2.69630360513665e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLA2,Src-like-adapter 2,39934,0.113938673665139,0.0109441791116637,0.0924880826062785,0.135389264724,2.87439077068497e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL19,Interleukin-19,41756,0.0779734294487584,0.00749280279723875,0.0632875359661705,0.0926593229313464,2.9039423318157e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CILP,Cartilage intermediate layer protein 1,39966,0.0588206240833729,0.00565279227399604,0.0477411512263407,0.0699000969404052,3.03526813199463e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.0538049449663982,0.00517124592191791,0.0436693029594391,0.0639405869733573,3.06789401771784e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.0844102557281335,0.00811492205748265,0.0685050084954675,0.100315502960799,3.18055637817737e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL16,C-X-C motif chemokine 16,42295,0.0246795797656834,0.00237661951566389,0.0200214055149822,0.0293377540163846,3.62363741916938e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.105874828677581,0.0101978494797955,0.0858870436971816,0.12586261365798,3.71961172651914e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMPR,GMP reductase 1,42296,0.0503257796356242,0.00485672196580097,0.0408066045826543,0.0598449546885941,4.56483197925358e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNM3,Dynamin-3,39934,0.0584147188958488,0.00565220293877481,0.0473364011358502,0.0694930366558475,6.32332307170324e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCK2,Cytoplasmic protein NCK2,42185,0.112465653754348,0.0108951772322872,0.0911111063790654,0.133820201129631,6.8888059439671e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SBSN,Suprabasin,39954,-0.0375152770981332,0.00363545332742634,-0.0446407656198888,-0.0303897885763775,7.42316636140058e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEK,Angiopoietin-1 receptor,42181,0.0232653310418633,0.00225572965635972,0.0188441009153982,0.0276865611683283,7.53210221726669e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNGR2,Interferon gamma receptor 2,42016,0.0554500952413571,0.00537790164327015,0.0449094080205476,0.0659907824621666,7.80140579089499e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOLGA3,Golgin subfamily A member 3,39934,0.0821409887052764,0.00796556569479248,0.0665284799434832,0.0977534974670697,8.00513828119865e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0471089983260837,0.00457158210879572,0.0381486973928441,0.0560692992593233,8.32136837816867e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR2,Folate receptor beta,42249,0.0305052497870565,0.00296050061473794,0.0247026685821701,0.0363078309919429,8.32512674459681e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMOX2,Heme oxygenase 2,41839,0.0500536089509913,0.00486381283187467,0.040520535800517,0.0595866821014657,9.5869165770039e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,0.0279570477542232,0.00271734133657418,0.0226310587345378,0.0332830367739086,9.81360957476483e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0316586753774706,0.00307828373416101,0.025625239258515,0.0376921114964262,1.02029745386468e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.0958303052741833,0.00932019222628574,0.0775627285106633,0.114097882037703,1.0970154017194e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,0.0631037972097744,0.0061520901600085,0.0510457004961577,0.0751618939233911,1.40522859462096e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.073659054905014,0.00718503393262659,0.0595763883970659,0.0877417214129621,1.49712246924293e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBI,Acyl-CoA-binding protein,42085,0.0811941106826999,0.00792349851441518,0.0656640535944462,0.0967241677709537,1.49786382072407e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0569860592622664,0.00556340502735192,0.0460817854086566,0.0678903331158761,1.63511478073363e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP10,Caspase-10,41839,0.0742867372360752,0.00725611001092007,0.0600647616146719,0.0885087128574785,1.65642678562693e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,0.0802769333757324,0.00784179952986311,0.0649070062972007,0.0956468604542641,1.66784205222284e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKB,Creatine kinase B-type,39966,-0.0601843931740568,0.00587724545895721,-0.071703794273613,-0.0486649920745007,1.67251266175289e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF19,Fibroblast growth factor 19,42185,0.0810651528468428,0.00792221933145745,0.0655376029571862,0.0965927027364994,1.73760762685845e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0397841054541485,0.00388864896347569,0.0321623534857361,0.0474058574225608,1.77113923626013e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESYT2,Extended synaptotagmin-2,39929,0.0873552620141473,0.00853812810977842,0.0706205309189816,0.104089993109313,1.83617834116485e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0645024048406987,0.00630895427462879,0.0521368544624263,0.0768679552189712,1.97631156067388e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX15,Sorting nexin-15,39736,0.0564799281317735,0.00552963543848165,0.0456418426723494,0.0673180135911975,2.19737948934954e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAB2,Disabled homolog 2,42262,0.115343574575313,0.0113000424795412,0.0931954913154117,0.137491657835213,2.24816150427248e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0619001810987877,0.00606917999065222,0.0500045883171094,0.0737957738804661,2.45896858090336e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,0.062053524417343,0.00608699168314692,0.0501230207183751,0.073984028116311,2.57863334277098e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0552461225907823,0.00541954540643107,0.0446238135941775,0.0658684315873872,2.58524137499179e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RILP,Rab-interacting lysosomal protein,42224,0.0607616028433715,0.00597655340785975,0.0490475581639664,0.0724756475227766,3.40753101979368e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0464783194847474,0.00457099506615718,-0.0554374698144155,-0.0375191691550794,3.49499899209856e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPSE,Heparanase,39866,0.0993410983161688,0.00977229829302679,0.0801873936618363,0.118494802970501,3.59067933894265e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.0566795718236516,0.00558101952607849,0.0457407735525378,0.0676183700947655,3.96176240590111e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.0754090207168763,0.00743609962562245,0.0608342654506563,0.0899837759830963,4.42691885321759e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0586355572645812,0.0057845489939119,0.0472978412365139,0.0699732732926485,4.63346295517989e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0544030478299883,0.0053704018162405,0.0438770602701569,0.0649290353898197,5.15851869609889e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CMIP,C-Maf-inducing protein,39919,0.0870797855062567,0.00860173243025177,0.0702203899429632,0.10393918106955,5.49665298387276e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ING1,Inhibitor of growth protein 1,41820,0.0490610486882206,0.00484851362055768,0.0395579619919275,0.0585641353845136,5.57631344660871e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL17,C-C motif chemokine 17,42107,0.094238413008172,0.00931773744201515,0.0759756476218223,0.112501178394522,5.83590512441092e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,0.0815193120995547,0.00806963536148323,0.0657028267910476,0.0973357974080619,6.87250169321848e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0467663693859988,0.00463489865684646,0.0376819680185797,0.0558507707534178,7.43207592668774e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.0747721743970922,0.00741150536720016,0.0602456238773799,0.0892987249168046,7.53108439877717e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0756562400523976,0.00751119601513931,0.0609342958627245,0.0903781842420706,8.86684879714432e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL32,Interleukin-32,42119,-0.0456430712682552,0.0045327983438184,-0.0545273560221393,-0.0367587865143712,9.13814858113901e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.0718099683091731,0.00713522534368659,0.0578249266355474,0.0857950099827988,9.67494376585623e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.0304030356813764,0.00302640414869965,0.0244712835499251,0.0363347878128277,1.1599809982828e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSAP,Prosaposin,39886,0.0292868337148227,0.00292073632978938,0.0235621905084355,0.0350114769212098,1.45240415803887e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.0506761102071864,0.00506472209639293,0.0407492548982562,0.0606029655161165,1.74328481857468e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.0809247931353747,0.00810239966169496,0.0650440897984525,0.0968054964722968,2.08677936878811e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX8,Syntaxin-8,42119,0.0487094576823561,0.00487878946109526,0.0391470303386094,0.0582718850261028,2.1598436582954e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAMBP,STAM-binding protein,41997,0.06400365326685,0.00641560301322214,0.0514290713609346,0.0765782351727654,2.33612804963471e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH9,Protocadherin-9,39930,0.0346088800967604,0.00347131206564078,0.0278051084481045,0.0414126517454163,2.57333992392434e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNRD2,Protein ZNRD2,39930,0.0712807642818046,0.00715527145282435,0.0572564322342689,0.0853050963293403,2.78653468841867e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,0.0309988682262918,0.00311340676226685,0.0248965909722488,0.0371011454803349,2.94120104707305e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNST,Consortin,42145,0.110596244251464,0.0111135845095208,0.0888136186128032,0.132378869890125,2.9868108919958e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST13,Hsc70-interacting protein,39736,0.055462848803602,0.00557259299074999,0.044540566541732,0.0663851310654719,3.06590156661171e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY6D,Lymphocyte antigen 6D,42041,0.0403210931110732,0.00405644520776212,0.0323704605038594,0.0482717257182869,3.35243737041821e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0356527526619048,0.00358918933187098,0.0286179415714377,0.0426875637523719,3.56933338664925e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,0.0336000366030909,0.00338276829804994,0.026969810738913,0.0402302624672688,3.74438911687674e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0540690251134703,0.00544771252151258,0.0433915085713056,0.0647465416556349,3.90001469461676e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,0.0783987275217212,0.00789685903554728,0.0629208838120486,0.0938765712313939,3.93002061045566e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CETN2,Centrin-2,41839,0.0687322303658716,0.0069290395638983,0.0551513128206309,0.0823131479111122,4.12539108055045e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.0770892949746046,0.00777088028615102,0.0618583696137486,0.0923202203354606,4.22062704529146e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN4,Nectin-4,42181,0.0339803976090275,0.00342670125046627,0.0272640631581136,0.0406967320599414,4.23426566830918e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BID,BH3-interacting domain death agonist,42119,0.0669250410315118,0.00675435189511184,0.0536865113170926,0.080163570745931,4.58508570106901e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0271400794082515,0.00273999557679844,0.0217696880777266,0.0325104707387765,4.73717041536634e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,0.0896117895802584,0.00905077178000785,0.0718722768914431,0.107351302269074,5.11002278992136e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KAZN,Kazrin,39930,0.106398314232566,0.0107552391995419,0.0853180454014633,0.127478583063668,5.54881778800066e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,0.0862980114992322,0.00874017285303738,0.0691672727072789,0.103428750291185,6.46400847795712e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.0633999869179682,0.00642629762163921,0.0508044435795554,0.0759955302563811,7.29645633682293e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0581608778026877,0.00590026681625171,0.0465963548428344,0.0697254007625411,7.90098807536792e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK10,Kallikrein-10,42138,0.0410538680088775,0.00416791542063052,0.0328847537844417,0.0492229822333134,8.17993732503877e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JAM3,Junctional adhesion molecule C,39736,0.0513748852536015,0.00521375642018449,0.0411559226700399,0.0615938478371631,8.18772374127124e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.115223592572754,0.0117051479596167,0.0922815025719052,0.138165682573603,8.99462319986261e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNA4,Plexin-A4,42119,0.0807256736851071,0.00820561100031252,0.0646426761244945,0.0968086712457196,9.22139507920927e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATG4A,Cysteine protease ATG4A,41843,0.0584879670696364,0.00594760403316469,0.0468306631646336,0.0701452709746392,9.62682034200586e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.0749127373945372,0.00761867133825534,0.0599801415715568,0.0898453332175177,1.00832830444395e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0544752276645765,0.00554258770644978,0.043611755759935,0.0653386995692181,1.04953349736238e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,0.0247316754772909,0.00251849784625372,0.0197954196986336,0.0296679312559482,1.09711423224533e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,0.0582278029948578,0.0059305760699091,0.046603873897836,0.0698517320918797,1.12044846529929e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RFC4,Replication factor C subunit 4,39919,0.0223199717505276,0.00227321403252666,0.0178644722467753,0.0267754712542798,1.15227011552171e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0668515028683617,0.00681534619280183,0.0534934243304701,0.0802095814062533,1.26614522574767e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NID1,Nidogen-1,42189,0.03598013800408,0.00367658569637194,0.028774030039191,0.043186245968969,1.53053539380719e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKD1,Polycystin-1,39958,0.0272968106772007,0.00278883629509672,0.0218306915388111,0.0327629298155902,1.55811098647521e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.0631602467810901,0.00645949050359383,0.0504996453940462,0.075820848168134,1.66931360503213e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.04780333175426,0.00489006365640139,0.0382188069877133,0.0573878565208067,1.75811857197281e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0530063171764385,0.00543089970429367,0.0423617537560229,0.0636508805968541,1.98680055645133e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,0.0727241441104125,0.00745970903532738,0.0581031144011708,0.0873451738196541,2.28133775694926e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPON2,Spondin-2,42070,0.0347018474198416,0.00356153012709895,0.0277212483707277,0.0416824464689556,2.33050986466014e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.0975153031896902,0.0100124014483583,0.077890996350908,0.117139610028472,2.42359665218022e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.021662790301391,0.00222437107336771,0.0173030229975903,0.0260225576051917,2.51601130147092e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,0.0227321748111461,0.00233567135091448,0.0181542589633538,0.0273100906589385,2.58509601543566e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARSA,Arylsulfatase A,42137,0.0447290086898786,0.00459623670449873,0.0357203847490611,0.0537376326306961,2.61469745610423e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0544191605337368,0.00559182115476519,0.043459191070397,0.0653791299970766,2.61538825835383e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.0780215246984899,0.0080267776144293,0.0622890405742085,0.0937540088227714,3.02163174018374e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0625698851358887,0.00643879102615841,0.0499498547246182,0.0751899155471591,3.09979613798807e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EREG,Proepiregulin,41997,0.0793526992793683,0.00817097201970784,0.0633375941207409,0.0953678044379957,3.18725154268921e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.0444095361092646,0.00457270653054348,0.0354470313093994,0.0533720409091298,3.29173369101705e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX4,Syntaxin-4,42070,0.058386121323827,0.00602172353198652,0.0465835432011334,0.0701886994465206,3.70748612212652e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,0.0213707487796993,0.00220503081419664,0.0170488883838738,0.0256926091755247,3.98092632634637e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL1,Fc receptor-like protein 1,42145,0.0452619115580984,0.00467739833445303,0.0360942108225705,0.0544296122936264,4.46352012661133e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH2B3,SH2B adapter protein 3,41843,0.0974895142446019,0.0100748675745511,0.0777427737984818,0.117236254690722,4.48989796656716e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.0340271820594912,0.00351699910901349,0.0271338638058248,0.0409205003131577,4.54590243401951e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,0.0323268842398915,0.0033464115694689,0.0257679175637324,0.0388858509160505,5.24650303455913e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCTN3,Tectonic-3,39958,0.0301083491457848,0.00311820247666511,0.0239966722915212,0.0362200260000484,5.64858221129969e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOK2,Docking protein 2,42145,0.120873841638779,0.0125403509303911,0.0962947538152126,0.145452929462346,6.44706205620176e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL2,Fc receptor-like protein 2,42229,0.0491741818062122,0.00510824082170814,0.0391620297956643,0.0591863338167602,7.25757718553786e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LARP1,La-related protein 1,39919,0.0614837328013652,0.00638722442096052,0.0489647729362825,0.0740026926664478,7.52590890228376e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYDGF,Myeloid-derived growth factor,39958,0.0981739300500623,0.0102059150191182,0.0781703366125905,0.118177523487534,8.02552611841662e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIMAP8,GTPase IMAP family member 8,39560,0.0494464086558853,0.00514007401859262,0.0393718635794437,0.0595209537323268,8.04479617006454e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0497618305469565,0.00517886135485335,0.039611262291444,0.0599123988024691,8.61614392810153e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0632180061603556,0.00658376951465585,0.0503138179116301,0.076122194409081,9.47802736173195e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,0.0372117332569421,0.00388050355514563,0.0296059462888566,0.0448175202250275,1.03841553161897e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNLR1,Interferon lambda receptor 1,42119,0.0355854878189429,0.00371302546452502,0.0283079579084739,0.042863017729412,1.09454377728356e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,0.0337897957933782,0.00352697822506704,0.0268769184722468,0.0407026731145096,1.13119226553591e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0301884167769649,0.00315461220651751,0.0240053768521905,0.0363714567017392,1.3050382312718e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SWAP70,Switch-associated protein 70,39930,0.0359686961407795,0.00375987572945826,0.0285993397110413,0.0433380525705177,1.33487942893342e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.0368518343111675,0.00385472220734386,0.0292965787847735,0.0444070898375614,1.42629404283888e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.0932800754776816,0.00976953075560786,0.0741317951966902,0.112428355758673,1.54510134836531e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF6,SLAM family member 6,41843,0.0377279615435575,0.00395249588501165,0.0299810696089346,0.0454748534781803,1.59090248604172e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADD1,Alpha-adducin,39736,0.0682355766025458,0.00715057622700169,0.0542204471976225,0.0822507060074691,1.68198244330061e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA2,Apolipoprotein A-II,39990,-0.04835398686193,0.00506863670096594,-0.0582885147958232,-0.0384194589280367,1.72086630325033e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.0297322173707824,0.0031195300871906,0.0236179383998888,0.035846496341676,1.81703785793492e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN3,Calsyntenin-3,39929,0.0295263770995327,0.00309878041673497,0.0234527674827321,0.0355999867163332,1.92191525152233e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAL,Integrin alpha-L,39657,0.0427420692985672,0.00448810502164509,0.0339453834561428,0.0515387551409915,2.02457783412565e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPT,Dermatopontin,42310,0.0246353548451406,0.00258980139933401,0.0195593441024459,0.0297113655878352,2.16779074369212e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0332613928692067,0.00349819889675204,0.0264049230315727,0.0401178627068407,2.2638538597484e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPG,Macrophage-capping protein,42015,0.0570629077609556,0.00600971916307487,0.0452838582013288,0.0688419573205823,2.5665300993414e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0554488424368357,0.00584247775084894,0.0439975860451718,0.0669000988284997,2.76837260794905e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,0.0480852772443442,0.00506925119525816,0.0381495449016382,0.0580210095870502,2.88781041864376e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK11,Kallikrein-11,42062,0.0311575233636923,0.0032894212048985,0.0247102578020913,0.0376047889252934,3.19528722914273e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,0.0222366743226665,0.00234870176721814,0.0176332188589189,0.026840129786414,3.33405799887345e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEFL,Neurofilament light polypeptide,41797,0.0456587675506622,0.00482480592319496,0.0362021479412001,0.0551153871601244,3.48138417013329e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.0836920165759337,0.00884416663478427,0.0663574499717565,0.101026583180111,3.58410884127121e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,-0.025035855810093,0.00265240768060972,-0.030234574864088,-0.019837136756098,4.3749479837854e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,0.0221986035836795,0.00235214533177001,0.0175883987334103,0.0268088084339487,4.55609397413457e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAN,Brevican core protein,42016,-0.0331824346641914,0.0035187706718252,-0.0400792251809688,-0.026285644147414,4.75904410697239e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.0784479595968258,0.00832092455322487,0.062138947472505,0.0947569717211465,5.00019076482289e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0361583128790216,0.00384005520358023,0.0286318046800044,0.0436848210780389,5.43158401950757e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,0.0641874653555257,0.00681831934667899,0.0508235594360349,0.0775513712750165,5.52809459545807e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,0.0489035561516818,0.00519781026644968,0.0387158480294404,0.0590912642739232,6.0268305479145e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,0.0737336828649615,0.00784017817721501,0.0583669336376201,0.0891004320923029,6.2253925394679e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,0.0845426428352312,0.00899711406721045,0.0669082992634987,0.102176986406964,6.71223153704805e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRELP,Prolargin,42123,0.0223927521113374,0.00238733844523405,0.0177135687586786,0.0270719354639961,7.64675581990417e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,0.0452981265978045,0.00483162784826291,0.0358281360152092,0.0547681171803998,7.9968437608138e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0469671086279536,0.00501824716163581,0.0371313441911474,0.0568028730647598,9.54036303175413e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.100212067550316,0.0107155072023746,0.0792096734336616,0.12121446166697,9.93853198725624e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL6,Fc receptor-like protein 6,42119,0.0653193388905471,0.00700269127156312,0.0515940639982834,0.0790446137828108,1.24717459089046e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.0904787116819178,0.00970560027868643,0.0714557351356924,0.109501688228143,1.31530764320861e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXO3,Forkhead box protein O3,41843,0.0914423325418966,0.00982510856181079,0.0721851197607474,0.110699545323046,1.51894394584486e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EBI3_IL27,Interleukin-27,42247,0.0290649751192274,0.00312446193334167,0.0229410297298778,0.0351889205085771,1.57913616274616e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATRN,"Attractin, Isoform 2",39979,0.0158654515140311,0.00170547545646336,0.0125227196193629,0.0192081834086993,1.61954062580604e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,-0.0498248780938757,0.00535939916440831,-0.060329300456116,-0.0393204557316355,1.66718790006994e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRIB,Protein scribble homolog,39638,0.0835797058555457,0.00899336856007658,0.0659527034777956,0.101206708233296,1.77338097962308e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEC31A,Protein transport protein Sec31A,39638,0.0739162901807439,0.00795385859337056,0.0583267273377376,0.0895058530237502,1.77910566113337e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.103564512000521,0.0111514680811651,0.0817076345614375,0.125421389439605,1.82322248752134e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0589323812851778,0.00634651078213826,0.0464932201521868,0.0713715424181688,1.84372213102458e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.0387107884521365,0.00417247363111686,0.0305327401351474,0.0468888367691256,2.04611543265527e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAC1,Cartilage acidic protein 1,42310,-0.0292719969046939,0.00315878646548152,-0.0354632183770377,-0.0230807754323501,2.19881163871901e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR5,Cadherin-related family member 5,42145,0.0366122599335871,0.00395260455573448,0.0288651550043475,0.0443593648628267,2.28668834495123e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.105486998624623,0.0113887111908048,0.0831651246906457,0.1278088725586,2.29874382344063e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.034616784872641,0.00373660071167657,0.027293047477755,0.0419405222675271,2.31819070228735e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0624637560017689,0.00674867627902903,0.049236350494872,0.0756911615086658,2.50953591069511e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREML2,Trem-like transcript 2 protein,42137,0.0324990118667797,0.00351277102537049,0.0256139806570536,0.0393840430765059,2.53673711458765e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.138632903175667,0.0149826952322204,0.109266820520515,0.167998985830819,2.57669718626798e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF2,TNF receptor-associated factor 2,42119,0.0653787917195374,0.00707849906868748,0.0515049335449099,0.0792526498941648,2.92811369177531e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.0345571310662558,0.00374392254578983,0.0272190428765078,0.0418952192560039,3.19271685146448e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRLB,Fc receptor-like B,41843,0.0581570422519477,0.0063046624594148,0.0457999038314947,0.0705141806724007,3.27617447994853e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGMB,RGM domain family member B,42249,0.026361406844098,0.00285912491217295,0.020757522016239,0.031965291671957,3.39705844624597e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,-0.104844503267407,0.0113819479792226,-0.127153121306683,-0.082535885228131,3.81886881438721e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53,Cellular tumor antigen p53,41843,0.0418659420102551,0.0045484796483791,0.0329509218994321,0.0507809621210781,3.9453247573506e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.0972040177884497,0.0105585152341202,0.0765093279295741,0.117898707647325,3.98678936217738e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASHC3,WASH complex subunit 3,39929,0.0716469094379616,0.00778480896514654,0.0563886838662744,0.0869051350096488,4.07382075266974e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.0267541053564912,0.00291248724973134,0.0210456303470178,0.0324625803659646,4.7824136879896e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0532061994416086,0.00579437216257556,0.0418492300029605,0.0645631688802567,4.83425032609059e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,0.0591986869592673,0.00645601500795164,0.0465448975436821,0.0718524763748525,5.41764610587742e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALB2,Calretinin,41839,0.0274686127168473,0.00299694252534193,0.0215946053671771,0.0333426200665175,5.64702776832253e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHB6,Ephrin type-B receptor 6,41997,0.0305803991045735,0.00334009438603756,0.0240338141079399,0.0371269841012071,6.18169443555362e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,0.0745166889546424,0.00814462186716668,0.0585532300949957,0.0904801478142891,6.74163134449402e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,0.0278321746663717,0.0030425736967443,0.0218687302207528,0.0337956191119905,6.8150829841586e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,0.0419682316882987,0.00459290927195728,0.0329661295152624,0.050970333861335,7.48594616198433e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREH,Trehalase,39966,0.070459432105081,0.00771224776794958,0.0553434264798999,0.0855754377302622,7.57251081056223e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG6,Large proline-rich protein BAG6,41900,0.0343941526196324,0.00376867201203665,0.0270075554760406,0.0417807497632243,8.09359340470746e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP7,Retinoid-binding protein 7,39930,0.0584720236853404,0.00640649347717267,0.0459152964700819,0.0710287509005988,8.23191235713625e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBXN1,UBX domain-containing protein 1,39736,0.0644229498032086,0.00706276381080515,0.0505799327340306,0.0782659668723867,8.68088272832086e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,0.0199437943615657,0.00218925791700618,0.0156528488442336,0.0242347398788979,9.39889090202848e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPO,Lactoperoxidase,41647,0.0572029653096403,0.00627927114523652,0.0448955938649767,0.0695103367543039,9.44134662951885e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0564980872108439,0.00620345530423377,0.0443393148145458,0.0686568596071421,9.59087053448549e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,0.0820573088939299,0.00901383536222153,0.0643901915839757,0.0997244262038841,1.02503930858805e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNG,Interferon gamma,41913,0.105887940829514,0.011659447611718,0.083035423510547,0.128740458148482,1.21734712247017e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,0.0232220519562498,0.00255763278172349,0.0182090917040717,0.0282350122084278,1.23909142492859e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPHN1,Oligophrenin-1,39929,0.100982152247487,0.0111189317181061,0.0791890460799989,0.122775258414975,1.24221404928113e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,0.0252434356500883,0.00278119497239876,0.0197922935041867,0.0306945777959898,1.27352343227015e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.0962923171833137,0.0106119866854869,0.0754928232797594,0.117091811086868,1.30391494259166e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.0705070156018247,0.00777217648148188,0.0552735496981202,0.0857404815055292,1.36975284764768e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKD2,Polycystin-2,39575,0.0543943580997643,0.00600181247582136,0.0426308056471544,0.0661579105523742,1.4844536914564e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGKA,Diacylglycerol kinase alpha,39657,0.0515430420592911,0.00568918380352187,0.0403922418043882,0.0626938423141939,1.52597427523271e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGH,Gamma-glutamyl hydrolase,41933,0.0313639999371759,0.0034666496268353,0.0245693666685787,0.0381586332057731,1.66506004260386e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.0669446718149652,0.00740354528830597,0.0524337230498855,0.0814556205800449,1.78858653767529e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AZI2,5-azacytidine-induced protein 2,39934,0.0516120899916188,0.00571028382011167,0.0404199337041999,0.0628042462790377,1.8464716541476e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0364031327303213,0.00402800326457316,0.0285082463317579,0.0442980191288847,1.86178047198271e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH7,Protocadherin-7,39930,0.0323205167938536,0.00358030328934241,0.0253031223467425,0.0393379112409648,2.04289834524372e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOLA1,BolA-like protein 1,39586,0.0505613118297693,0.00560064795786204,0.0395840418323597,0.0615385818271789,2.0440987806909e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLRX,Glutaredoxin-1,42057,0.0511265024240198,0.00567653188331936,0.0400004999327138,0.0622525049153258,2.40685905397883e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYAP1,Synapse-associated protein 1,39736,0.0541069418005218,0.00600918680605544,0.0423289356606531,0.0658849479403904,2.52890073174262e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA10,Annexin A10,41839,0.0749314346608882,0.00833251285660854,0.0585997094619354,0.0912631598598409,2.73733724901004e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFC,Vascular endothelial growth factor C,42181,0.0507890503189728,0.00564839867023849,0.0397181889253054,0.0618599117126403,2.75092332733963e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0424714911594028,0.00472403564417147,0.0332123812968267,0.0517306010219789,2.78052630026057e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.0799126820222836,0.00889100427380947,0.062486313645617,0.0973390503989501,2.84800227659662e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA2,Carbonic anhydrase 2,42103,0.0607457629176064,0.00675886910933988,0.0474983794633002,0.0739931463719126,2.85939021234003e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMPR2,GMP reductase 2,39736,0.0612722552809192,0.00681692027947022,0.0479110915331575,0.0746334190286808,2.91651906051408e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARK7,Parkinson disease protein 7,42137,0.0463411180581462,0.00515981080544888,0.0362278888794664,0.056454347236826,3.02866988376695e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.0736569026695361,0.0082051971977526,0.057574716161941,0.0897390891771312,3.14944949163788e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGA,Protein O-GlcNAcase,39930,0.0656787329607553,0.00732813867530864,0.0513155811571503,0.0800418847643602,3.66874087435648e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,0.0535614594382874,0.00598793547813484,0.0418251059011431,0.0652978129754317,4.20510809217005e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.0522328600881261,0.00584480559497821,0.0407770411219688,0.0636886790542834,4.53458493402197e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINI2,Serpin I2,39930,0.0529674328560247,0.00592998787568351,0.041344656619685,0.0645902090923644,4.82255364761312e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARSB,Arylsulfatase B,42070,0.0506083999068965,0.00567088303319387,0.0394934691618365,0.0617233306519564,5.06019993506449e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.0689723410126922,0.00772917423724004,0.0538231595077017,0.0841215225176826,5.08937639328396e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTA,Lymphotoxin-alpha,42119,0.0363129430329655,0.00408611011498292,0.028304167207599,0.044321718858332,7.06788119678896e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFB,Vascular endothelial growth factor B,39657,0.0269526810200868,0.0030331422228871,0.0210077222632281,0.0328976397769455,7.31097283752304e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.0715082388775795,0.00805095691940954,0.0557283633155368,0.0872881144396222,7.39552771828119e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,0.0578132429421105,0.00650933880338234,0.0450549388874811,0.0705715469967399,7.41559635931969e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNLY,Granulysin,42137,0.0488482936139825,0.0055002666600891,0.0380677709602078,0.0596288162677571,7.44593746716192e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACYP1,Acylphosphatase-1,39701,0.0592943021861918,0.00667722433267149,0.0462069424941556,0.0723816618782279,7.70737484190472e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,A1BG,Alpha-1B-glycoprotein,39979,0.0150079625417658,0.00169261475891413,0.0116904376142941,0.0183254874692375,8.65211885612383e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLMP,CXADR-like membrane protein,42262,0.0199942955688192,0.00225884398758039,0.0155669613531617,0.0244216297844768,9.6797161959131e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIF1,Allograft inflammatory factor 1,41843,0.047260903925268,0.00534558962484816,0.0367835482605656,0.0577382595899704,1.06629556554336e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0589805303806301,0.00667173844562057,0.0459039230272138,0.0720571377340464,1.07341704408542e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLTA,Clathrin light chain A,41900,0.0421969340886647,0.00477736455001823,0.0328332995706289,0.0515605686067004,1.14866454797462e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,0.0425911842839512,0.00482816276913594,0.0331279852564447,0.0520543833114576,1.29552683712558e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,0.0534223976842678,0.00607607718994826,0.0415132863919692,0.0653315089765664,1.63878493866312e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACAN,Aggrecan core protein,41994,-0.0245634325603542,0.00279396069438074,-0.0300395955213405,-0.019087269599368,1.65214263898546e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCN2,Ficolin-2,42116,0.0364017508893224,0.00414196148420586,0.0282835063802789,0.0445199953983659,1.69617293012487e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,0.0722549051444356,0.00822765383053189,0.0561287036365931,0.0883811066522781,1.797273340098e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NIT1,Deaminated glutathione amidase,39638,0.040054304962029,0.00456221829592967,0.0311123571020069,0.0489962528220512,1.88275114548704e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.0924580184491668,0.0105368211812108,0.0718058489339937,0.11311018796434,1.95756738890037e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.0582561166403399,0.00664368502689859,0.0452344939876187,0.0712777392930611,2.07295918865393e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP6,Bone morphogenetic protein 6,41886,0.0358366720696674,0.00408866825670469,0.0278228822865262,0.0438504618528086,2.09453657483875e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,0.06091571948042,0.00695670300886737,0.04728058158304,0.0745508573778,2.30660110409839e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASC3,Protein CASC3,39649,0.0387397310038886,0.00443038127061247,0.0300561837134882,0.0474232782942891,2.57299327122222e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,0.0209059058616045,0.00239239598630549,0.0162168097284457,0.0255950019947633,2.63903895143963e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM13A,Protein FAM13A,39930,0.0609534822995531,0.00697412524185536,0.0472841968255166,0.0746227677735896,2.66000491908179e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATOX1,Copper transport protein ATOX1,42181,0.0633064036500315,0.00724799689579322,0.0491003297342767,0.0775124775657862,2.73470844940364e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C3,Complement C3,39445,0.0412421128550504,0.00472408674059466,0.0319829028434849,0.050501322866616,2.915403337467e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WNT9A,Protein Wnt-9a,41913,0.0259716344879045,0.00297632607175545,0.0201380353872638,0.0318052335885452,2.94713547123473e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.0325379208306512,0.00373334973640549,0.0252205553472964,0.0398552863140059,3.23180181644337e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RALY,RNA-binding protein Raly,39919,0.0430233150238223,0.0049362978437776,0.0333481712500182,0.0526984587976264,3.2913875456519e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST7,Cystatin-F,42148,0.0839452613243274,0.00963732102894584,0.0650561121075935,0.102834410541061,3.37437566292685e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRAP,BRCA1-associated protein,39813,0.0983272241864734,0.0112921859298211,0.0761945397640241,0.120459908608923,3.53970687969926e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0498241155476195,0.00572411071476318,0.0386048585466836,0.0610433725485553,3.55950110931437e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17C,Interleukin-17C,41913,0.0629959986343262,0.00723954955755412,0.0488064815015201,0.0771855157671323,3.65166940540402e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C7,Complement component C7,39722,0.029586967380779,0.0034122360633285,0.0228989846966552,0.0362749500649029,4.88395824493168e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROC,Vitamin K-dependent protein C,42199,0.0227078396974848,0.00262040695547085,0.017571842064762,0.0278438373302077,4.98641938004482e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUB1,NEDD8 ultimate buster 1,42119,0.0743879600577921,0.00858770867142039,0.0575560510618081,0.0912198690537761,5.14994458843839e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP9,Matrix metalloproteinase-9,42125,0.0528240119132165,0.00610059228148525,0.0408668510415054,0.0647811727849276,5.30056784948958e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,0.0518612602289027,0.00599200791563759,0.040116924714253,0.0636055957435524,5.59031784508051e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSC22D1,TSC22 domain family protein 1,39934,0.0586731065817191,0.00677983308081028,0.045384633743331,0.0719615794201073,5.63963585167231e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RWDD1,RWD domain-containing protein 1,42249,0.0549054424345522,0.00635190708880309,0.0424557045404982,0.0673551803286063,6.03002063774142e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,-0.0350790856376081,0.00406003884526791,-0.0430367617743332,-0.027121409500883,6.24063939604941e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,0.0596438431019034,0.00690514598500104,0.0461097569713014,0.0731779292325054,6.37712742905185e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.108959657397957,0.0126354899990785,0.0841940969997632,0.133725217796151,7.24481119999016e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.0383520884107867,0.00444839384077376,0.0296332364828701,0.0470709403387033,7.34856644851154e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA9,Carbonic anhydrase 9,42262,0.0409768636718777,0.00476608204798259,0.0316353428578319,0.0503183844859236,9.01697514532391e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBP1,Z-DNA-binding protein 1,39657,0.036516819739976,0.00424781056809789,0.0281911110265041,0.0448425284534478,9.31444507233824e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,0.025193006590671,0.00293331497904287,0.019443709231747,0.030942303949595,9.77502584276931e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPI,Glucose-6-phosphate isomerase,39990,0.0421619491203002,0.00491195932987616,0.0325345088337429,0.0517893894068575,1.03926827204411e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBD,Thrombomodulin,42145,0.0259065062755535,0.00301992518308213,0.0199874529167126,0.0318255596343945,1.06446630463435e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.085040150616275,0.00991325525877333,0.0656101703090792,0.104470130923471,1.06656351525335e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MINK1,Misshapen-like kinase 1,39929,0.0817451508816584,0.0095547902351927,0.0630177620206807,0.100472539742636,1.32546511251803e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGL1,Fibrinogen-like protein 1,39990,0.0569373564230557,0.00665615439197793,0.043891293814779,0.0699834190313325,1.33973836744632e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY96,Lymphocyte antigen 96,42016,0.0318698340926475,0.00372801594354881,0.0245629228432918,0.0391767453420031,1.37784910078646e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,0.0851699345386881,0.00996745145042716,0.0656337296958508,0.104706139381525,1.45644949034297e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA3G,Semaphorin-3G,39736,0.0399110520298492,0.00467096293229656,0.0307559646825479,0.0490661393771504,1.45898689659401e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.0235590019285363,0.00275827572753872,0.0181527815025604,0.0289652223545122,1.50252219938723e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.0433246280787911,0.00507607477423946,0.0333755215212818,0.0532737346363005,1.54829813422983e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAT,Catalase,39827,0.0458159238397755,0.00536811882929982,0.0352944109343478,0.0563374367452031,1.58408291577496e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0423310221035998,0.0049640297629371,0.0326015237682431,0.0520605204389565,1.68378649167065e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMPD3,AMP deaminase 3,39929,0.0601876373214658,0.00706165264391799,0.0463467981393866,0.0740284765035451,1.7489247845591e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0580741358054972,0.00681382799238435,0.0447190329404239,0.0714292386705705,1.75839654883582e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGN,Secretagogin,41913,0.0386291592386325,0.00453714197810452,0.0297363609615476,0.0475219575157173,1.85918563586257e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AAMDC,Mth938 domain-containing protein,39638,0.0463332900430391,0.00544410639470712,0.0356628415094131,0.057003738576665,1.95191817486031e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0234268141402283,0.00275288799046637,0.0180311536789142,0.0288224746015423,1.95899081742949e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0307246510679559,0.00361150328356024,0.0236461046321778,0.0378031975037339,1.96415742589724e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TADA3,Transcriptional adapter 3,39919,0.0352899804475172,0.00415357602726053,0.0271489714340865,0.0434309894609478,2.20213625429365e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRDL2,Chordin-like protein 2,42145,0.0396583041286924,0.00467026323065192,0.0305045881966146,0.0488120200607701,2.24733745261727e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROK1,Prokineticin-1,42119,0.0429822122971768,0.00507562276887592,0.03303399167018,0.0529304329241736,2.74325744749276e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,0.0794274602951237,0.00938044584183063,0.0610417864451357,0.0978131341451118,2.81872870130904e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YJU2,Splicing factor YJU2,39919,0.0287174173694024,0.00339574372833467,0.0220617596618665,0.0353730750769384,3.08273963974675e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,0.0173790161255375,0.00205538469118468,0.0133504621308155,0.0214075701202595,3.12299032954996e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX9,Sorting nexin-9,42145,0.0586540196475067,0.00694335577242281,0.045045042333558,0.0722629969614554,3.27673224987571e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.0939094386850024,0.0111151055903687,0.0721238317278797,0.115695045642125,3.30174192885354e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0324401708782294,0.00383947538598555,0.0249147991216977,0.0399655426347611,3.30256072756534e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.0573475146467967,0.00679659816815268,0.0440261822372174,0.0706688470563759,3.62950472480275e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0450124861564247,0.00533719314603348,0.0345515875901991,0.0554733847226503,3.69205062462965e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL5,C-X-C motif chemokine 5,42101,0.0968009994540771,0.0114966370067727,0.0742675909208027,0.119334407987352,4.1435865747775e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0525585341519219,0.00624128547498177,0.0403256146209576,0.0647914536828862,4.19342630241739e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0256754429442394,0.00304991557345587,0.0196976084202659,0.0316532774682129,4.27357317422113e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0359303049184033,0.00427163527896703,0.0275578997716279,0.0443027100651787,4.55324500325893e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACHE,Acetylcholinesterase,39736,0.0295531528215637,0.00351478604905247,0.0226641721654208,0.0364421334777065,4.66891538632705e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRY2,Protein sprouty homolog 2,41913,0.0796966221254047,0.00948453781596189,0.0611069280061194,0.09828631624469,4.79865704308693e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGCC,Regulator of cell cycle RGCC,39934,0.0660437761902732,0.00786588616606416,0.0506266393047875,0.081460913075759,5.15817402610809e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0459749836116828,0.0054795530765906,0.0352350595815652,0.0567149076418003,5.32918287815751e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBPL,FK506-binding protein-like,39930,0.0511131080777463,0.006093679215549,0.0391694968152703,0.0630567193402224,5.53521585994162e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,0.0150333726698271,0.00179348194162293,0.0115181480642462,0.0185485972754081,5.70185841522081e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,0.0476680285755793,0.00568787415053865,0.0365197952405235,0.058816261910635,5.88541673147493e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,-0.0346236820726942,0.00413284420646958,-0.0427240567173745,-0.0265233074280138,5.93441856916693e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0352366049974518,0.00420695961687451,0.0269909641483778,0.0434822458465259,6.02177557004381e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MITD1,MIT domain-containing protein 1,42016,0.0824625912645098,0.00985465740255353,0.0631474627555049,0.101777719773515,6.44224011731064e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.0189777340871118,0.00226884150413772,0.0145308047390019,0.0234246634352217,6.62338536787981e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY75,Lymphocyte antigen 75,42119,0.0330359380034138,0.00394995950170408,0.0252940173800739,0.0407778586267538,6.67361096059492e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX1,Peroxiredoxin-1,41742,-0.0782733180010296,0.0093589309451655,-0.096616822653554,-0.0599298133485052,6.69839314176352e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GM2A,Ganglioside GM2 activator,39733,0.0330139392151605,0.00394805099414576,0.0252757592666348,0.0407521191636862,6.89528727509514e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLVRB,Flavin reductase,42137,0.054173062805693,0.00649736110100128,0.0414382350477305,0.0669078905636555,8.30049885351548e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0302798771507343,0.0036324300573531,0.0231603142383222,0.0373994400631464,8.57295059701467e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRKL,Crk-like protein,42143,0.0896173468551231,0.0107634954258014,0.0685208958205523,0.110713797889694,9.15465007617818e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMT,Catechol O-methyltransferase,41740,0.0709248158552723,0.00852294494864133,0.0542198437559353,0.0876297879546093,9.52662358067463e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INHBB,Inhibin beta B chain,39736,0.0445477014669405,0.00535974903233051,0.0340425933635727,0.0550528095703083,1.05439059245596e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.072504783042114,0.00873382821008037,0.0553864797503564,0.0896230863338715,1.14682438109362e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,0.078623192192463,0.00947984074543679,0.0600427043314069,0.0972036800535191,1.20235809602022e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPLAH,5-oxoprolinase,39638,0.059177737722805,0.00713445042113322,0.0451942148973838,0.0731612605482261,1.21555514260841e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRAS,Ras-related protein R-Ras,39649,0.111874593832126,0.0135046177664047,0.0854055430099729,0.138343644654279,1.32655554625599e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMH,Granzyme H,41900,0.0665344691375517,0.00803839638183555,0.050779212229154,0.0822897260459494,1.38183328117434e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.0857178805564621,0.0103909632932101,0.0653515925017703,0.106084168611154,1.7399491578446e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.104371835288401,0.012662367561255,0.079553594868341,0.129190075708461,1.83795644106885e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN2L,Ataxin-2-like protein,39934,0.0407137285346129,0.0049418671375724,0.031027668944971,0.0503997881242548,1.93478558705695e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,0.0274695689886201,0.00334595404467241,0.0209114990610622,0.0340276389161781,2.41514280331e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,0.0488343438703753,0.00594989483675985,0.037172549990326,0.0604961377504246,2.50084723425455e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,0.0309370215259274,0.00377260740987434,0.0235427110025737,0.0383313320492812,2.60878891609921e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAA4,Serum amyloid A-4 protein,39979,0.027680627264088,0.00337527993459557,0.0210650785922807,0.0342961759358953,2.64001760707982e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0508787629370463,0.00621857332123568,0.0386903592274244,0.0630671666466682,3.05142645759687e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0633814295593994,0.00775470614677516,0.0481822055117201,0.0785806536070787,3.31996691602772e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNL1,Interferon lambda-1,41839,0.0378787742692341,0.00463577083459212,0.0287926634334336,0.0469648851050347,3.33505785051774e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0443116821993685,0.00542253400546117,0.0336835155486646,0.0549398488500724,3.37075496773022e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.0869446300408401,0.0106468647690367,0.0660767750935281,0.107812484988152,3.46232403770915e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCC,Tubulin-specific chaperone C,42016,0.0669473791275955,0.00820188352232645,0.0508716874238357,0.0830230708313553,3.57418669473068e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL15,Interleukin-15,42119,0.0274324110880246,0.00336318655452644,0.0208405654411528,0.0340242567348965,3.7456812879104e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.0433032242444389,0.00531083699016034,0.0328939837437247,0.0537124647451532,3.84367684836532e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A12,Protein S100-A12,41910,0.061057120791163,0.00750688282094817,0.0463436304621045,0.0757706111202214,4.53849738068682e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,0.0340705911241912,0.00418900124316587,0.0258601486875861,0.0422810335607963,4.53855823283883e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.0556464680520772,0.00684168788528063,0.0422367597969271,0.0690561763072272,4.60715928062462e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,-0.0211728375189463,0.00260748390507355,-0.0262835059728904,-0.0160621690650021,5.05653043082784e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSB,Cathepsin B,42153,-0.0420425118027054,0.00517910438937696,-0.0521935564058843,-0.0318914671995266,5.15752525681041e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.0292926693439588,0.00360966934503639,0.0222177174276875,0.0363676212602302,5.3571357985723e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.0372613836473242,0.00459556381435722,0.0282540785711841,0.0462686887234644,5.58228504211588e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.056404602154268,0.00695969741609832,0.0427635952187152,0.0700456090898207,5.76022196268262e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,0.073226478298232,0.00904742290575023,0.0554935294029616,0.0909594271935025,6.39768170630095e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.0325416597197788,0.00402331280783586,0.0246559666164205,0.0404273528231371,6.66731033545656e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.0681349068466719,0.00844363419247542,0.0515853838294201,0.0846844298639237,7.65812676281296e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APRT,Adenine phosphoribosyltransferase,42002,0.0387299740603377,0.0048023758501321,0.0293173173940788,0.0481426307265966,7.95804825632687e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRSF1,G-rich sequence factor 1,39486,0.0688097911672346,0.00853806181437279,0.052075190011064,0.0855443923234053,8.48381120264018e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IST1,IST1 homolog,39850,0.0813855856416696,0.0101066490002565,0.0615765536011668,0.101194617682172,8.91584319209492e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,0.0390840363361157,0.00485958359813534,0.0295592524837705,0.048608820188461,9.51681337871924e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L15,Bcl-2-like protein 15,39657,0.0467859176866096,0.00581837296462945,0.0353819066759359,0.0581899286972833,9.81378985164973e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB27B,Ras-related protein Rab-27B,39958,0.0681058160458995,0.00847370391534925,0.051497356371815,0.0847142757199841,1.00912366076685e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0350000847030747,0.00435652987379266,0.0264612861504411,0.0435388832557083,1.03996893033067e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0436919207151847,0.00543995110591468,0.0330296165475919,0.0543542248827774,1.05657965786447e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.0225557279387883,0.00280958175115409,0.0170489477065262,0.0280625081710503,1.08973452894002e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,0.0284342305571734,0.00354571486713348,0.0214846294175918,0.035383831696755,1.15163768330584e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAX,Protein max,41839,0.086746230738901,0.0108199468424035,0.0655391349277901,0.107953326550012,1.17164298924747e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.0764837471925079,0.00954752204859142,0.0577706039772687,0.0951968904077471,1.23268609835419e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FIS1,Mitochondrial fission 1 protein,42125,0.0626775946362251,0.00783126730858497,0.0473283107113985,0.0780268785610516,1.30729351507255e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XG,Glycoprotein Xg,42261,0.0282678447012617,0.00353265033181611,0.0213438500509022,0.0351918393516213,1.32356857318417e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,0.103054270606464,0.0128829217130995,0.0778037440487893,0.128304797164139,1.37618139991706e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,0.0326462776367709,0.0040829828968002,0.0246436311590426,0.0406489241144993,1.41544563002691e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,0.0386337076718366,0.00483348317439687,0.0291600806500187,0.0481073346936545,1.42435328834065e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DRAXIN,Draxin,42016,0.034675462482213,0.00433931265359875,0.0261704096811594,0.0431805152832665,1.44717308215775e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGES2,Prostaglandin E synthase 2,39579,0.045746275575159,0.0057317539530223,0.0345120378272353,0.0569805133230827,1.5934548301096e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFB,Complement factor B,39794,0.0267819089524358,0.00335758182529415,0.0202010485748593,0.0333627693300124,1.65131009300332e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXJ3,Forkhead box protein J3,39657,0.0370468090721119,0.00465487625233583,0.0279232516175337,0.0461703665266902,1.90824570390875e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,0.02929753961694,0.00368352408199616,0.0220778324162275,0.0365172468176525,1.98262666656785e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,0.0271131022643572,0.00341563178177411,0.0204184639720799,0.0338077405566344,2.21677167065065e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDA,Cytidine deaminase,39946,0.0388084222073629,0.00489282248868121,0.0292184901295477,0.048398354285178,2.36428171074264e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,0.024654977523592,0.0031094304396855,0.0185604938618085,0.0307494611853756,2.37993460484352e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTF2,Transcription termination factor 2,39649,0.0405365728201148,0.005112284142128,0.030516495901544,0.0505566497386857,2.41702686859425e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA1,Carbonic anhydrase 1,41890,0.0455588142212471,0.00576174563257475,0.0342657927814005,0.0568518356610936,2.84107386486011e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL8,C-C motif chemokine 8,42239,0.0489076118651646,0.00618818614412981,0.0367787670226702,0.0610364567076591,2.92153099129798e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMMD1,COMM domain-containing protein 1,39638,0.0494099720873561,0.00627301271235445,0.0371148671711414,0.0617050770035708,3.67974988122363e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL13,C-C motif chemokine 13,42275,0.0547327673970572,0.00695801945951279,0.0410950492564121,0.0683704855377023,3.93060618696524e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.0448118166836172,0.00569819211851789,0.0336433601313222,0.0559802732359123,4.05957500733357e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,0.0306767838509852,0.00390369830402083,0.0230255351751044,0.038328032526866,4.19030257255358e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0452771871562131,0.00576132077008873,0.0339849984468392,0.056569375865587,4.23227993167979e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.0539165308503184,0.00686343394696541,0.0404642003142662,0.0673688613863706,4.27638301256483e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DMD,Dystrophin,39638,0.0414616904733809,0.00528799012881257,0.0310972298209083,0.0518261511258535,4.89168384739685e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LUZP2,Leucine zipper protein 2,39919,0.0361769711963866,0.0046141820859621,0.0271331743079009,0.0452207680848723,4.89424834561444e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,0.0573684070964258,0.00733502200149655,0.0429917639734925,0.071745050219359,5.61455970340338e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,0.0428327755061855,0.00548057853651254,0.032090841574621,0.0535747094377501,5.96431798114882e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAS2,Growth arrest-specific protein 2,39757,0.0419142631288903,0.00536343242289052,0.0314019355800249,0.0524265906777557,5.99831119802242e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL4,Myosin light chain 4,39638,0.0413604996566746,0.00529757392426843,0.0309772547651085,0.0517437445482408,6.36385462804316e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERI1,3'-5' exoribonuclease 1,39757,0.0275879557549851,0.00353397671541734,0.0206613613927671,0.0345145501172031,6.40588533221156e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.0610525124046681,0.00783460383696119,0.0456966888842242,0.0764083359251121,7.03713020289378e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A11,Protein S100-A11,42027,0.0368465332187742,0.00472930831362076,0.0275770889240775,0.0461159775134709,7.12880851341076e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNB3,Plexin-B3,42099,0.038138175188018,0.00491056675550281,0.0285134643472325,0.0477628860288035,8.6446706599865e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,0.0259614342873914,0.00334300909908434,0.0194091364531861,0.0325137321215967,8.68067852062203e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCA,Tubulin-specific chaperone A,39736,0.0669222695589228,0.00862856928625387,0.0500102737578653,0.0838342653599804,9.53737185538282e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.0711738918828686,0.00920033946673292,0.0531412265280721,0.0892065572376651,1.11261461224638e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,0.0209897686937135,0.00271575993525686,0.01566687922061,0.0263126581668169,1.1761383968749e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.01272948508621,0.00164754196828306,0.00950030282837522,0.0159586673440448,1.1833797581027e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0223391259136949,0.00289138797732237,0.016672005478143,0.0280062463492467,1.20565133175058e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.0401765885101575,0.00520218344807195,0.0299803089519364,0.0503728680683785,1.21703804132711e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBNL,Drebrin-like protein,42185,0.0731151475254405,0.00946765729045123,0.0545585392361561,0.0916717558147249,1.21910141370889e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,0.0276376660758666,0.0035790412631785,0.0206227452000368,0.0346525869516965,1.24393752288014e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMA4,Laminin subunit alpha-4,42185,0.0269623819147429,0.00349436338639633,0.0201134296774061,0.0338113341520797,1.28418525925274e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK24,Serine/threonine-protein kinase 24,41839,0.0488448729836254,0.00633814866429665,0.0364221016016039,0.0612676443656468,1.38513491022209e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAP3,Cytosol aminopeptidase,41913,0.0377584396228054,0.00490552248932756,0.0281436155437234,0.0473732637018874,1.48937722300411e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OLFM4,Olfactomedin-4,39347,0.0975729896880728,0.0126957574197383,0.0726893051453857,0.12245667423076,1.65712074209908e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.074524727531775,0.00969963942868585,0.0555134342515508,0.0935360208119993,1.67886206784422e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNGR1,Interferon gamma receptor 1,42185,0.0169714502260807,0.00220996607895352,0.0126399167113318,0.0213029837408296,1.70592667383614e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0564347026952304,0.00735495806755376,0.042018984882825,0.0708504205076358,1.81786514212205e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RCOR1,REST corepressor 1,41900,0.034984770476795,0.00456087898370352,0.0260454476687361,0.0439240932848539,1.83041237030944e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDC,Nuclear migration protein nudC,42296,0.0497342907870817,0.00648818513938307,0.0370174479138909,0.0624511336602725,1.90296391740214e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0392956583427776,0.00512690009904011,0.029246934148659,0.0493443825368962,1.94259515470714e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MIF,Macrophage migration inhibitory factor,42105,0.0522904176071715,0.00682622234365497,0.0389110218136078,0.0656698134007352,1.98208833249744e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MILR1,Allergin-1,41913,0.0400186089510736,0.00522693374964181,0.0297738188017757,0.0502633991003716,2.04639028315855e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0386472266654535,0.00504726428066659,0.028754588675347,0.04853986465556,2.06090647748185e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.0677004091251245,0.00884500423158112,0.0503642008312255,0.0850366174190235,2.10815046461598e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDS,Iduronate 2-sulfatase,42296,-0.00718520066280083,0.000940142288079129,-0.00902787954743592,-0.00534252177816573,2.26866587321729e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPD52L2,Tumor protein D54,39736,0.0854650299750774,0.0111798275255558,0.063552568024988,0.107377491925167,2.26869604075702e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB1A1,Uteroglobin,42165,0.041814825511099,0.00547528509840734,0.0310832667182206,0.0525463843039774,2.37164233303217e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.0844741333014988,0.0110613728213923,0.0627938425715699,0.106154424031428,2.40440203639812e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIAPIN1,Anamorsin,42181,0.0477487794069431,0.00625628924703063,0.0354864524827631,0.0600111063311232,2.46277264479307e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YWHAQ,14-3-3 protein theta,39736,0.0581056175405386,0.00761495601157329,0.0431803037578549,0.0730309313232222,2.53001870243882e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0338308629193792,0.0044344199709008,0.0251393997764136,0.0425223260623448,2.55246356061401e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTF1,Cardiotrophin-1,41900,0.0658368735741282,0.0086365034831144,0.048909326747224,0.0827644204010324,2.64420894437263e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDK2,Protein sidekick-2,39736,0.0307846360086936,0.0040401403489663,0.0228659609247197,0.0387033110926676,2.74902562696424e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSNAX,Translin-associated protein X,39575,0.0307511391060254,0.00403612610593433,0.0228403319383941,0.0386619462736567,2.76749229467464e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,0.0358474570066796,0.00470627136255744,0.026623165136067,0.0450717488772922,2.76915998157819e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,-0.0186151527305471,0.0024482257279933,-0.023413675157414,-0.0138166303036803,3.07002202736059e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XRCC4,DNA repair protein XRCC4,41839,0.0286067375884535,0.00376360150651336,0.0212300786356873,0.0359833965412197,3.13844201891156e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0448183488761001,0.00589867335046956,0.0332569491091798,0.0563797486430204,3.208090652391e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.022726038589141,0.00299527315800206,0.016855303199457,0.028596773978825,3.5237581695785e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,0.0703454181301784,0.00928089045368328,0.0521548728409592,0.0885359634193976,3.69638695849243e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.0254753409105515,0.00336175507767256,-0.0320643808627897,-0.0188863009583133,3.73699957925887e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR3,Toll-like receptor 3,42296,0.0473173499629213,0.00624792438332364,0.0350714181716069,0.0595632817542356,3.87142303768451e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0403941533217329,0.00535353496123911,0.0299012247977042,0.0508870818457615,4.85740266196432e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,-0.021030543609135,0.00279029242502098,-0.0264995167621761,-0.0155615704560939,5.17282527788478e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,0.0190235035511837,0.00252403463275294,0.014076395670988,0.0239706114313795,5.1844578753527e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0520257034568597,0.00690342145821547,0.0384949973987574,0.065556409514962,5.2187890425811e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEPR,Leptin receptor,42145,-0.0241859152988539,0.00321349580384552,-0.0304843670743911,-0.0178874635233167,5.54647491792587e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC39A14,Zinc transporter ZIP14,41839,0.0258928865623969,0.00344127521288619,0.0191479871451399,0.0326377859796538,5.64579357754054e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA12,Carbonic anhydrase 12,42070,0.0251534507330225,0.0033463566771404,0.0185945916458274,0.0317123098202177,5.97338647642473e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD101,Immunoglobulin superfamily member 2,39930,0.0333839835189749,0.00444057541096211,0.0246804557134891,0.0420875113244606,5.98430567337131e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.0784965582302576,0.0104505879221701,0.0580134059028042,0.0989797105577109,6.22278484371276e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0412926307859673,0.00549710103602928,0.0305183127553499,0.0520669488165847,6.27475155725184e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINE2,Glia-derived nexin,39958,0.0499956234778084,0.00666320495676355,0.0369357417625518,0.0630555051930649,6.69067680040367e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.0683089246406757,0.00911788043032927,0.0504378789972303,0.0861799702841211,7.30127249827655e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,0.0190273916072338,0.00254070939230339,0.0140476011983192,0.0240071820161485,7.46904717119918e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD276,CD276 antigen,42123,0.0274179002073522,0.00366713903249499,0.020230307703662,0.0346054927110424,8.09302967332447e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,0.079625528989114,0.0106544138715265,0.058742877800922,0.100508180177306,8.29146950932383e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBS4,Thrombospondin-4,42189,0.0346907677198897,0.00464459024965723,0.0255873708305616,0.0437941646092179,8.56835668933077e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A13,Protein S100-A13,39657,0.0273370533771996,0.00366109697960449,0.0201613032971748,0.0345128034572244,8.82823559633721e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN1,Tetraspanin-1,41900,0.055555727251857,0.00744326068782065,0.0409669363037285,0.0701445181999855,8.92171304124098e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS1BP3,HCLS1-binding protein 3,39638,0.0700867331293831,0.0093888955392779,0.0516844978723984,0.0884889683863678,8.9670786932878e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APP,Amyloid-beta precursor protein,42112,0.0503697501593111,0.00675065799474415,0.0371384604896125,0.0636010398290096,9.07917940629735e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,0.0478462904626156,0.00641222612601621,0.0352783272556238,0.0604142536696074,9.16401629053953e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNN,Tenascin-N,39966,0.0330706058306776,0.00443285965188187,0.0243822009129892,0.0417590107483661,9.2593440014044e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDHD2,Phospholipase DDHD2,39934,0.0508349533014549,0.00681892698917443,0.037469856402673,0.0642000502002368,9.64321082445597e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPT1,Angiopoietin-1,42085,0.0636401158594141,0.00853868769360687,0.0469042879799446,0.0803759437388836,9.66854967002828e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.0215950673402832,0.00289854442748723,-0.0272762144181582,-0.0159139202624082,9.86821000078641e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0356502981374368,0.00479027164346921,0.0262613657162372,0.0450392305586365,1.05114410482786e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,0.089956000621425,0.0121207668977011,0.0661992975019309,0.113712703740919,1.22570993371879e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGCR6,Protein DGCR6,39586,0.0319643349050776,0.00430630998429198,0.0235239673358654,0.0404047024742899,1.23265318964666e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0224178217639818,0.00302951433505295,0.016479973667278,0.0283556698606855,1.44514022509036e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10,Interleukin-10,41913,0.0581124207454239,0.00786043468583317,0.0427059687611909,0.0735188727296569,1.52088289922415e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0251831279417338,0.00340730460975145,0.0185048109066209,0.0318614449768466,1.54371567907493e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.0910578246411583,0.0123277348202417,0.0668954643934846,0.115220184888832,1.61425128493459e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CETN3,Centrin-3,39930,0.0596797595942503,0.00808219303300707,0.0438386612495564,0.0755208579389441,1.64244893970229e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSTN,Growth/differentiation factor 8,41900,0.0406999532629526,0.00551747432659486,0.0298857035828267,0.0515142029430786,1.72056535496943e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.0670987883682939,0.00910930921419349,0.0492445423084747,0.0849530344281131,1.88058483913684e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,-0.020244964850289,0.00274918381510966,-0.025633365127904,-0.0148565645726741,1.88800230680247e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0248507061007234,0.00337786639326792,0.0182300879699183,0.0314713242315286,1.99078693371982e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0329621538568102,0.00448208977653062,0.0241772578948101,0.0417470498188102,2.05680331364636e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0323017290182874,0.0043992362713187,0.0236792259265027,0.0409242321100721,2.21686186891178e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD55,Complement decay-accelerating factor,41714,0.0197819198276571,0.00269540214953241,0.0144989316145736,0.0250649080407406,2.27631816813279e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLG4,Disks large homolog 4,39929,0.0541939315907029,0.00740288471860586,0.0396842775422354,0.0687035856391704,2.6348188846913e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.0636362289214894,0.00869672905086613,0.0465906399817918,0.080681817861187,2.67350272303549e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA4D,Semaphorin-4D,42249,0.0224388968217032,0.00307085452630709,0.0164200219501413,0.0284577716932651,2.88220630956032e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLNK,B-cell linker protein,39657,0.0314077610278324,0.0043029585324665,0.0229739623041981,0.0398415597514668,3.09554806560854e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,0.02619360765068,0.00359324648139131,0.0191508445471531,0.033236370754207,3.28237352994819e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.0649593836277057,0.00891469934135536,0.0474865729186492,0.0824321943367623,3.38566052390054e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL2,C-C motif chemokine 2,41992,0.0385535934920588,0.00529358485302013,0.0281781671801393,0.0489290198039782,3.44510454617575e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRAP2,GRB2-related adapter protein 2,42145,0.0960879852277252,0.0131970061788673,0.0702218531171453,0.121954117338305,3.49511397622605e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,0.0355553901987972,0.00488267762511612,0.0259853420535696,0.0451254383440248,3.50803146579977e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPARC,SPARC,42181,0.0518243264750559,0.00713554163153493,0.0378386648772474,0.0658099880728644,3.99669225190701e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F2R,Proteinase-activated receptor 1,42166,0.0424682385132961,0.00585394407998763,0.0309945081165203,0.0539419689100718,4.24591044328103e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,0.0336062711010328,0.00463255969934646,0.0245264540903138,0.0426860881117519,4.25993715920929e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AOC3,Membrane primary amine oxidase,42217,0.0219755733210394,0.00303093943231699,0.0160349320336981,0.0279162146083807,4.3789487924287e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE3,Eosinophil cationic protein,42081,0.0806999621977804,0.0111387110133884,0.0588680886115392,0.102531835784022,4.55925786360424e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.0579994858958356,0.00802495730739277,-0.0737284022183254,-0.0422705695733458,5.18680483149228e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPART,Spartin,39736,0.0577301475992303,0.00799072488261166,0.0420683268293114,0.0733919683691491,5.35239220863601e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEXN,Nexilin,39990,0.0517955710976488,0.00717070472482576,0.0377409898369903,0.0658501523583073,5.40096254182047e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS1,"Nitric oxide synthase, brain",41839,0.0432395398521307,0.00599573628010873,0.0314878967431176,0.0549911829611439,5.82524923041091e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICA1,Islet cell autoantigen 1,41913,0.058921784584765,0.00817279423032266,0.0429031078933326,0.0749404612761975,5.91853746256848e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,0.0233079717318419,0.00323885244300749,0.0169598209435472,0.0296561225201366,6.50908581579903e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AZU1,Azurocidin,41751,0.0551782323761938,0.00769000687976517,0.0401058188918541,0.0702506458605336,7.60056028066807e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0315040553995453,0.00439455079157691,-0.040117374951036,-0.0228907358480545,7.95031292703167e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0291582094447661,0.00406912556441376,0.0211827233385151,0.037133695551017,8.22609261226946e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,0.0319283333951254,0.00445785968671018,0.0231909284091735,0.0406657383810774,8.35327454044004e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL1,Growth-regulated alpha protein,42117,0.0680293686544637,0.00950677910766731,0.0493960816034358,0.0866626557054917,8.74223139202796e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,0.0229855684015955,0.0032125207993949,0.0166890276347815,0.0292821091684095,8.8053843493908e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.0228943890530556,0.00320012691015336,0.016622140309155,0.0291666377969562,8.94779189496397e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL5,Fc receptor-like protein 5,42137,0.0431346200574819,0.00603461782866021,0.0313067691133078,0.0549624710016559,9.26541961129611e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLB1,Beta-galactosidase,42016,0.0314220710728865,0.00439983534071721,0.0227983938050808,0.0400457483406923,9.69698970990971e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPAG1,Sperm-associated antigen 1,39934,0.0428814002597646,0.00600598082002825,0.0311096778525092,0.0546531226670199,9.91963992179753e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSC,Dipeptidyl peptidase 1,42123,0.0323344370255827,0.00453082543411432,0.0234540191747186,0.0412148548764468,1.00582856068642e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,0.0383851300639283,0.00537841212486582,0.0278434422991913,0.0489268178286653,1.013050182974e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,0.0257046284658331,0.00360271837560217,0.0186433004496529,0.0327659564820134,1.01834009139266e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0490648500479213,0.0068784397087859,0.0355831082187009,0.0625465918771417,1.03204225646436e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0480557588743671,0.00673736917767558,0.034850515286123,0.0612610024626112,1.04602594325757e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFRC,Transferrin receptor protein 1,42200,0.0273087394559214,0.00383125621764555,0.0197994772693361,0.0348180016425067,1.07063795031624e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.0221490765978497,0.00311169727426937,0.0160501499402818,0.0282480032554177,1.16286780089557e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,0.0186368951923687,0.0026228230515422,0.013496162011346,0.0237776283733914,1.26912643213055e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENAH,Protein enabled homolog,41913,0.0349885329336987,0.00492545653939895,0.0253346381164767,0.0446424277509206,1.27714297519276e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.0296138036008801,0.00416998785548261,0.0214406274041342,0.037786979797626,1.30653598243117e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCN2,Transcobalamin-2,42286,0.021898438247382,0.0030887484427429,0.0158444912996059,0.0279523851951581,1.40945777867132e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA11,Annexin A11,42087,0.0479826533518652,0.00676800285087186,0.0347173677641563,0.061247938939574,1.41159117411176e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CENPF,Centromere protein F,39757,0.0393245849206816,0.0055484699603732,0.0284495837983501,0.0501995860430131,1.44834219355773e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0381764195108673,0.00539735186195018,0.0275976098614449,0.0487552291602896,1.60591905013194e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.0321807172298554,0.0045663164797005,-0.0411306975300684,-0.0232307369296424,1.91095920852992e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNPY4,Protein canopy homolog 4,42070,0.0541275344599485,0.00768294302567175,0.0390689661296319,0.0691861027902651,1.94252505449105e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TST,Thiosulfate sulfurtransferase,41809,0.0541879683940539,0.00770029962134287,0.0390953811362218,0.0692805556518859,2.05928431716114e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0499478168518811,0.00710058909132576,0.0360306622328826,0.0638649714708796,2.12157040832892e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,0.029225436364359,0.00415586396489513,0.0210799429931645,0.0373709297355534,2.12896647033582e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP6,Gastrotropin,41881,0.0407950366981477,0.00580814418432091,0.0294110740968787,0.0521789992994167,2.26483340962953e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.0652927602916776,0.00929585354356044,0.0470728873462992,0.0835126332370561,2.28186441495377e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA12,Serpin A12,41751,0.0777494463757077,0.0110789500153593,0.0560347043456035,0.0994641884058119,2.36497371789312e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,0.0307941276182995,0.00438954656024772,0.022190616360214,0.039397638876385,2.40444185461142e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0420837905966469,0.00600315212572547,0.030317612430225,0.0538499687630689,2.51698645015616e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELOB,Elongin-B,39575,0.0281604154144974,0.00402834665872715,0.0202648559633922,0.0360559748656026,2.89679670028466e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PF4,Platelet factor 4,39914,0.0697175687570786,0.00999597208639496,0.0501254634677444,0.0893096740464127,3.23925074953818e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0338599305645457,0.00485973862751611,0.0243348428546141,0.0433850182744773,3.40663228648068e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,0.0787941379436615,0.0113114005180021,0.0566237929283773,0.100964482958946,3.41362170971864e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAN,Neurocan core protein,42249,-0.0266073989562347,0.00382635452034794,-0.0341070538161167,-0.0191077440963528,3.71958072634148e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB33A,Ras-related protein Rab-33A,39575,0.0474740834339067,0.00682932297263848,0.0340886104075353,0.0608595564602781,3.819214757297e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFP,Properdin,39979,0.0168730371121365,0.00242773037953615,0.0121146855682456,0.0216313886560273,3.84902919724713e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D17,TBC1 domain family member 17,41839,0.0305208210126033,0.00439431305245689,0.0219079674297878,0.0391336745954188,3.94656958989409e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TWF2,Twinfilin-2,39966,0.0606314135577677,0.00873948031356372,0.0435020321431829,0.0777607949723526,4.20350047599323e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA4,Ephrin type-A receptor 4,39736,0.0208088631430056,0.00300088435168931,0.0149271298136945,0.0266905964723166,4.31013254325036e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LACTB2,Endoribonuclease LACTB2,42145,0.046713493950586,0.00673880792601667,0.0335054304155934,0.0599215574855787,4.33679667030995e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A14,Protein S100-A14,39934,0.0368815747435768,0.00532293082081086,0.0264486303347875,0.0473145191523661,4.47401872102695e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD36,Platelet glycoprotein 4,39657,0.0331614428095518,0.00478933392020218,0.0237743483259555,0.0425485372931481,4.63345023838711e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX7,Syntaxin-7,39657,0.0348986565303602,0.00504782798719121,0.0250049136754654,0.044792399385255,4.98550961726027e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0445587332711714,0.0064621633651952,0.0318928930753888,0.057224573466954,5.61785543818575e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,0.0161295791750555,0.0023399563048254,0.0115432648175977,0.0207158935325133,5.74846161301371e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.0581075771706778,0.00843484280288302,0.0415752852770271,0.0746398690643285,5.86694326705633e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0452497646445246,0.00656770654092659,0.0323770598243085,0.0581224694647407,5.89392460271638e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0455997813797959,0.00661881928405626,0.0326268955830457,0.0585726671765462,5.89921396930226e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,-0.024408140822182,0.00354427696412379,-0.0313549236718646,-0.0174613579724993,5.96507702832089e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D23,TBC1 domain family member 23,42070,0.0633251799203316,0.00920930389742118,0.0452749442813861,0.0813754155592771,6.41714826342123e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDHB,Succinate dehydrogenase,39930,0.0463905343345484,0.00674542975074148,0.0331694920230951,0.0596115766460017,6.41949634798121e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MGLL,Monoglyceride lipase,42166,0.0611546260091264,0.00891413674425799,0.0436829179903808,0.0786263340278721,7.16405929574104e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.074932025797886,0.0109496374524876,0.0534707363910103,0.0963933152047616,8.13611383258321e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DXO,Decapping and exoribonuclease protein,39929,0.0318316177835731,0.00465237493777901,0.0227129629055262,0.0409502726616199,8.2112839936788e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.0501348803123026,0.00733756626129555,0.0357532504401634,0.0645165101844419,8.69239555628239e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0374816332464647,0.00548503413603793,0.0267309663398303,0.048232300153099,8.72714744988189e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.0253573608120262,0.0037151243582318,0.0180757170698919,0.0326390045541605,9.22788445394067e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THTPA,Thiamine-triphosphatase,39897,0.0614938751795938,0.00901396631722998,0.043826501197823,0.0791612491613645,9.43261870120861e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHAD,Chondroadherin,39736,-0.0328704892857593,0.00481836621386352,-0.0423144870649318,-0.0234264915065868,9.4492406930437e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.0349946408987561,0.00513248401452998,0.0249349722302774,0.0450543095672349,9.61420132585994e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,0.0551951181428809,0.00809985017178765,0.0393194118061771,0.0710708244795847,9.87409548827238e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.0547423507337237,0.00804678216579404,0.0389706576887674,0.07051404377868,1.07614496656246e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST5,Cystatin-D,41846,0.039030154145613,0.00573956834447744,0.0277806001904372,0.0502797081007887,1.08962168255374e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPPB,Natriuretic peptides B,41900,0.0974422936695928,0.0143380107602544,0.0693397925794942,0.125544794759691,1.12082965417261e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.0209326615430741,0.0030811871249717,0.0148935347781296,0.0269717883080186,1.13902421298169e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,-0.0292307603537419,0.00430305801068352,-0.0376647540546816,-0.0207967666528022,1.14381618969893e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALB1,Calbindin,42070,0.0313653415404085,0.00462797174619934,0.0222945169178578,0.0404361661629592,1.27499678865753e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCB,Tubulin-folding cofactor B,42016,0.0692010651344454,0.010211209569164,0.0491870943788838,0.0892150358900069,1.27846603736879e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGA4,Pepsin A-4,39990,0.0520891637472268,0.00770657905595609,0.0369842687975529,0.0671940586969007,1.45679856174766e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CERT,Ceramide transfer protein,41839,0.0423039474266225,0.00626080692713788,0.0300327658494323,0.0545751290038128,1.46823570559696e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,0.0296231091839936,0.00438621743040219,0.0210261230204053,0.0382200953475819,1.50032228791219e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0339670781293029,0.0050380267827752,0.0240925456350635,0.0438416106235422,1.63656298872034e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0485047395203027,0.00719607135390301,0.0344004396666528,0.0626090393739526,1.6570228987636e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,0.0277645203587703,0.00412171657517539,0.0196859558714265,0.035843084846114,1.69262527159539e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,0.0833613732887474,0.0123856906437349,0.0590854196270269,0.107637326950468,1.77562037107798e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,0.0186006176647333,0.0027710065658179,0.0131694447957302,0.0240317905337364,2.00306956933598e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,0.0421209399485318,0.00628112657518635,0.0298099318611665,0.054431948035897,2.08107553820773e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.0576087940873642,0.00861515664125223,0.0407230870705098,0.0744945011042186,2.38657829803199e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NID2,Nidogen-2,42137,0.0497434296390294,0.00744132726029662,0.035158428208848,0.0643284310692108,2.40377642167975e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD5L,CD5 antigen-like,39925,0.0329160460240122,0.00492347653035977,0.023266032024507,0.0425660600235173,2.40907602624355e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.062162916861585,0.00930227406667028,0.0439304596909112,0.0803953740322587,2.46110043259793e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.0256995624925963,0.00384730455610269,0.018158845562635,0.0332402794225576,2.50605271456218e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPP,Lipoma-preferred partner,39575,0.0452735772455378,0.00678638196130311,0.0319722686013837,0.0585748858896919,2.65859171016283e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,0.0363776514358916,0.00546262016815061,0.0256709159063164,0.0470843869654668,2.85839872504675e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.014150812722985,0.00212566363927858,0.00998451198999895,0.018317113455971,2.90046605489629e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.0760134527719003,0.0114422389158171,0.0535866644968989,0.0984402410469017,3.18817301649564e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF2,Fibroblast growth factor 2,42119,0.0468038233829235,0.0070609791214912,0.0329643043048008,0.0606433424610463,3.51936372783291e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.0404953465678868,0.00610886916439736,0.028521963005668,0.0524687301301057,3.53448151044522e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0262256400545636,0.00396115512509142,0.0184617760093844,0.0339895040997428,3.74177767605555e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KEL,Kell blood group glycoprotein,41839,0.0243950074084282,0.00369380610832398,0.0171551474361132,0.0316348673807431,4.1464849801314e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.0588828855670937,0.00893722683135594,0.041365920977636,0.0763998501565513,4.6434413340687e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,0.0307793888197628,0.00467193830924493,0.0216223897336428,0.0399363879058829,4.65163447524005e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYMP,Thymidine phosphorylase,42070,0.0447150184870533,0.00680182676548806,0.0313834380266967,0.0580465989474099,5.0795206282085e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,0.0600255403201933,0.0091336059620075,0.0421236726346586,0.077927408005728,5.1486887456277e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,0.0448436576336754,0.00682677211369876,0.0314631842908258,0.058224130976525,5.29450230471817e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,-0.040224607009337,0.00612503022513478,-0.0522296662506012,-0.0282195477680728,5.31498488665171e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPXM1,Probable carboxypeptidase X1,42181,0.046105991467072,0.00702451524821878,0.0323379415805631,0.0598740413535808,5.44368706077695e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,0.025804081429885,0.00393180781160669,0.0180977381191358,0.0335104247406341,5.50770362909727e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,0.076992122348836,0.0117495465399832,0.0539630111304689,0.100021233567203,5.89263871391455e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.0238863936417162,0.00364649545702791,0.0167392625459415,0.0310335247374909,5.94517218208944e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN5,Contactin-5,42170,-0.0247450985234416,0.00378262851662051,-0.0321590504160178,-0.0173311466308654,6.29733752334445e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,0.0192751748355489,0.00294730015125272,0.0134984665390936,0.0250518831320043,6.3772193619667e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,0.0388748322919636,0.00594666332138389,0.0272193721820511,0.050530292401876,6.49171649801969e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0525857725876726,0.00804558099742133,0.0368164338327268,0.0683551113426184,6.55080355616744e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,0.0194284517159637,0.00297731884160591,0.0135929067864162,0.0252639966455113,7.0256015061905e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0385859099185831,0.00592007600441607,0.0269825609499277,0.0501892588872386,7.3893308511624e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD226,CD226 antigen,39657,0.0285386512707851,0.00438231485077132,0.0199493141632733,0.0371279883782969,7.72534738232063e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYO9B,Unconventional myosin-IXb,41913,0.0438539995548264,0.00674152917703695,0.0306406023678339,0.0570673967418188,8.04429090100095e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMS1,PMS1 protein homolog 1,39649,0.0330190121016887,0.00507900392980334,0.0230641643992741,0.0429738598041032,8.31828518045193e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.0261473726677876,0.00402411476704318,0.0182601077243829,0.0340346376111922,8.44418102431523e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR1,Toll-like receptor 1,39657,0.0178893030903359,0.00275294146396339,0.0124935378209676,0.0232850683597041,8.47536402954867e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,0.0408694235132024,0.00629155530044782,0.0285379751243247,0.0532008719020801,8.54118445481546e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.0272067626921253,0.00418976404814687,0.0189948251577575,0.0354187002264932,8.673390024883e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH1,Protocadherin-1,42264,0.0136721860025268,0.00210651498231779,0.00954341663718394,0.0178009553678697,8.8545827296977e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0495471367513954,0.00764027579581133,0.0345721961916052,0.0645220773111856,9.24859524006565e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,0.0248013508654758,0.00382482634620343,0.0173046912269171,0.0322980105040346,9.29058260187243e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,0.0553701753481935,0.00854394469231836,0.0386240437512495,0.0721163069451375,9.44906182976316e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CR1,Complement receptor type 1,39970,0.0236241728199212,0.00364755764339861,0.0164749598388599,0.0307733858009825,9.76107033886526e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFLAM,Pikachurin,39930,0.0205556278598643,0.00317681636634491,0.0143290677818283,0.0267821879379003,1.01699122098398e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.0267226015537,0.00413038727392081,0.0186270424968152,0.0348181606105847,1.0219646412564e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PREB,Prolactin regulatory element-binding protein,41913,0.0187391367730871,0.00289966106417232,0.0130558010873094,0.0244224724588649,1.06555396499686e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB6,Serpin B6,42216,0.0386379343498836,0.00597980859613504,0.0269175095014589,0.0503583591983083,1.07267939303377e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARF2,Scavenger receptor class F member 2,42249,0.0187665053384567,0.00290515800271114,0.0130723956531429,0.0244606150237706,1.0845345993659e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIF,Leukemia inhibitory factor,41839,0.0329541542188583,0.00511005820200057,0.0229384401429372,0.0429698682947794,1.16593262195056e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFD,Complement factor D,39979,0.0133884643443611,0.00207623227668029,0.00931904908206774,0.0174578796066545,1.17582242453072e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,0.0405148949170919,0.00628974719532369,0.0281869904142574,0.0528427994199263,1.23140395340452e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN6,Dynactin subunit 6,41839,0.04738226884175,0.00736783235985088,0.0329413174164423,0.0618232202670578,1.31152501930608e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0608838908292872,0.00946929243296783,0.0423240776606703,0.0794437039979042,1.3321100999981e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAGED1,Melanoma-associated antigen D1,41843,0.0317692952735052,0.00494251544922681,0.0220819649930207,0.0414566255539898,1.3393779192504e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0453050573238214,0.00704761096144424,0.0314917398393907,0.0591183748082521,1.34192522893579e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF7,SLAM family member 7,42119,0.0391902691656218,0.00610047916612341,0.0272333300000199,0.0511472083312237,1.37067629842541e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACE,Angiotensin-converting enzyme,39990,0.0178497390404665,0.00277824290426267,0.0124043829481116,0.0232950951328213,1.37280791895261e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR4,Complement factor H-related protein 4,39945,-0.0481623901593165,0.00749664160286747,-0.0628558077009367,-0.0334689726176963,1.37573354187244e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACYBP,Calcyclin-binding protein,39713,0.068475969844912,0.0106656144014925,0.0475713656179868,0.0893805740718372,1.41592322206515e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0259661943664413,0.00404587009319583,0.0180362889837775,0.0338960997491051,1.43635098844265e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,0.0133586645203175,0.0020831387148526,0.00927571263920636,0.0174416164014286,1.47639208195939e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPBP,Platelet basic protein,39908,0.0563413271489129,0.00879134032669997,0.0391103001085809,0.0735723541892448,1.52572277085189e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.0238958176288747,0.00373170421697663,0.0165816773636005,0.0312099578941489,1.57915893203112e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BGN,Biglycan,41820,-0.0773823215872175,0.0120956479692829,-0.101089791607012,-0.0536748515674231,1.6322723465519e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYBB1,Beta-crystallin B1,39958,0.0434274377445713,0.0067992318433684,0.0301009433315692,0.0567539321575734,1.75654139351443e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0149050208293802,0.00233563807450494,0.0103271702033505,0.0194828714554098,1.80990237203713e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.0283471922243688,0.00444319360036714,0.0196385327676492,0.0370558516810884,1.84281216855683e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0314110778009033,0.00492570246388758,0.0217567009716836,0.041065454630123,1.87646877276258e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP1,Caspase-1,41839,0.0447853492124725,0.00703265274803886,0.0310013498263163,0.0585693485986286,1.97576960953141e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.043879913002464,0.00689030835482872,0.0303749086269997,0.0573849173779283,1.9865586447111e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPI,Mannose-6-phosphate isomerase,42070,0.0554176815131562,0.00870710997589929,0.0383517459603936,0.0724836170659188,2.02080223087868e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,0.0255273918207691,0.00401750324434041,0.0176530854618619,0.0334016981796763,2.16438313445884e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.0759172371009189,0.011949478809652,0.052496258634001,0.0993382155678369,2.17686663108339e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA2,GDNF family receptor alpha-2,42070,0.0135574407825965,0.00213558414835982,0.00937169585181128,0.0177431857133818,2.24611871957405e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0576556641097283,0.0090855553147905,0.039847975692739,0.0754633525267177,2.2962730394109e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0235920693283568,0.00372375834910339,0.0162935029641142,0.0308906356925995,2.45697051642455e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.0546749212271831,0.00863184498836151,0.0377565050499945,0.0715933374043716,2.46458812007924e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0263283268901966,0.00416295034875337,0.0181689442066399,0.0344877095737532,2.62336499339878e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAM,Integrin alpha-M,42137,-0.0203884685522754,0.00322410673023555,-0.0267077177435371,-0.0140692193610137,2.63299042617845e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,-0.019374869011714,0.00306502938497504,-0.0253823266062651,-0.0133674114171629,2.67533963579589e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,0.0213270360564789,0.0033741511336772,0.0147136998344716,0.0279403722784862,2.70405464986846e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD69,Early activation antigen CD69,42082,0.0566095962558553,0.00895830983835601,0.0390513089726775,0.0741678835390331,2.71144149513404e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL34,Interleukin-34,41814,0.0235613695673298,0.00372894396713488,0.0162526393917454,0.0308700997429142,2.72572585558231e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,-0.0222127257039,0.00352004588447273,-0.0291120156374666,-0.0153134357703335,2.87043171024858e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPB1,Heat shock protein beta-1,41949,0.0451970326129071,0.00716283103271295,0.0311578837887897,0.0592361814370245,2.87962788107511e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN9,Septin-9,42070,0.0185573569859099,0.00294169818185267,0.0127916285494786,0.0243230854223411,2.90785096607289e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP7,Caspase-7,39929,0.0547690203704347,0.00868078707847015,0.0377546776966332,0.0717833630442362,2.90900158414972e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH12,Protocadherin-12,39934,0.0165287907013688,0.00262161641414424,0.0113904225296461,0.0216671588730915,2.99277456886408e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RP2,Protein XRP2,42070,0.0274536320375929,0.00435636253878369,0.0189151614615769,0.0359921026136089,3.03055282930982e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0362860840290918,0.00576087685497887,0.0249947653933332,0.0475774026648504,3.11383719464792e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAX,Apoptosis regulator BAX,41814,0.0589440175491253,0.00936494443548478,0.0405887264555752,0.0772993086426755,3.18933306016839e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN4B,Sodium channel subunit beta-4,39638,0.0281516607002839,0.00447657912451158,0.0193775656162412,0.0369257557843266,3.3233484831293e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAMDC2,MAM domain-containing protein 2,39958,0.0229896416337061,0.00365599670126385,0.015823888099229,0.0301553951681833,3.32956917790103e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.0127973285003591,0.00203853644512328,0.00880179706791745,0.0167928599328007,3.5414962386408e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMS,Spermine synthase,39586,0.0414204630937625,0.00661395160844594,0.0284571179412085,0.0543838082463166,3.9278443809269e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,0.0763390060179915,0.0122072822404389,0.0524127328267311,0.100265279209252,4.15633331405226e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFPI,Tissue factor pathway inhibitor,42152,-0.0198859174928219,0.00318572294411327,-0.0261299344632839,-0.0136419005223599,4.44322886241086e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMBS,Porphobilinogen deaminase,42262,0.0256376906802289,0.00410904854631221,0.017583955529457,0.0336914258310008,4.5243236154536e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F10,Coagulation factor X,39990,0.0185658801394002,0.00298145207017561,0.012722234081856,0.0244095261969444,4.91796720301942e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRND,Prion-like protein doppel,39929,0.0312372681123546,0.00501755291117959,0.0214028644064426,0.0410716718182665,4.96692131322997e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17A,Interleukin-17A,41877,0.0273139930834704,0.00438808988004648,0.0187133369185793,0.0359146492483615,4.97397170045207e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0463504797132489,0.00746700163933112,0.0317151565001599,0.0609858029263379,5.57558635621738e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.0668213935415852,0.0107684961698049,0.0457151410487676,0.0879276460344029,5.65443681483032e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EHD3,EH domain-containing protein 3,39638,0.0753785244475763,0.0121534338328832,0.0515577941351253,0.0991992547600274,5.76566805785357e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0565292696919847,0.00912103609188092,0.0386520389518981,0.0744065004320713,5.93421388968745e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,0.076251455912402,0.0123097149794376,0.0521244145527043,0.1003784972721,6.05671031381285e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHGB,Secretogranin-1,42210,0.0267151819928338,0.00431625324001743,0.0182553256423996,0.035175038343268,6.21120734515489e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSHB,Thyrotropin subunit beta,42145,0.0431023148782003,0.00696576982166553,0.0294494060277359,0.0567552237286648,6.27945318871284e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS27,Serine protease 27,42107,0.0254077799110173,0.00410959055286115,0.0173529824274095,0.0334625773946252,6.48875601404103e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0311968566586833,0.00504758822829844,0.0213035837312184,0.0410901295861483,6.5711780504833e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0255256172718939,0.00413067137236769,0.0174295013820533,0.0336217331617346,6.64998498012478e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMOTL2,Angiomotin-like protein 2,39882,0.0310017296714306,0.00501987536488251,0.0211627739562609,0.0408406853866003,6.80959137509179e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,0.0399017833531134,0.00647133553717632,0.0272179657002478,0.052585601005979,7.25353253804262e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDGF,Hepatoma-derived growth factor,42243,0.0574828210911975,0.00933425160338707,0.0391876879485588,0.0757779542338361,7.56090136495903e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17D,Interleukin-17D,41913,0.0214678337990783,0.00348629154803518,0.0146347023649293,0.0283009652332273,7.58911051498591e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP4,Guanylate-binding protein 4,41839,0.030787724615681,0.00500616358777682,0.0209756439836385,0.0405998052477236,7.97310445940718e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.0460467596280622,0.00749396100573187,0.0313585960568278,0.0607349231992967,8.29708364467463e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,-0.0157847295599471,0.00256974156766513,-0.0208214230325708,-0.0107480360873234,8.34596343781704e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0305475505752828,0.0049737241400673,0.0207990512607509,0.0402960498898148,8.43365617014683e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSPN,Persephin,42119,0.0541891871051939,0.00883594818429723,0.0368707286639713,0.0715076455464164,8.87465064930093e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0414330533685967,0.00676746632401512,0.0281688193735271,0.0546972873636664,9.52338131994385e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSNK1D,Casein kinase I isoform delta,39657,0.040535954681017,0.00662150960896989,0.027557795847436,0.0535141135145979,9.56266205767975e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0449618971112091,0.00735504595128209,0.0305460070466962,0.059377787175722,1.00480184307141e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0333969621907885,0.00548001037224225,0.0226561418611937,0.0441377825203833,1.12856130150742e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.0569098448179339,0.00934421854071883,0.038595176478125,0.0752245131577428,1.16393033704934e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOL1,Apolipoprotein L1,39990,-0.0333942934060803,0.00549308280331253,-0.0441607357005729,-0.0226278511115878,1.24545781651092e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.0614588015782027,0.010129093602763,0.0416057781167873,0.0813118250396181,1.34013144190043e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,0.0539528108690537,0.00889522601114892,0.0365181678872019,0.0713874538509056,1.35850825191084e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTD,Biotinidase,39979,0.0127582412457783,0.00210467802514435,0.00863307231649537,0.0168834101750612,1.38829256935505e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STXBP3,Syntaxin-binding protein 3,41843,0.0269461885666705,0.00445295552748334,0.0182183957328032,0.0356739814005379,1.47555654998932e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,0.0294200273390016,0.00487114097362728,0.0198725910306921,0.038967463647311,1.59415353268227e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX16,Syntaxin-16,41843,0.0352868199606117,0.00584658486888353,0.0238275136175999,0.0467461263036234,1.62746189069034e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL22,Interleukin-22,39919,0.0436516172341852,0.0072354064266201,0.0294702206380098,0.0578330138303606,1.65916872004465e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0368704915789776,0.00611786873439679,0.0248794688595599,0.0488615142983953,1.72544851812024e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,0.0209998719207856,0.00348524531833218,0.0141687910968545,0.0278309527447166,1.7318738481968e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0413889204617054,0.00687262710437791,0.0279185713371247,0.0548592695862861,1.77388718196771e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA3,Annexin A3,42224,0.0427528587368197,0.00710104135860854,0.0288348176739469,0.0566708997996924,1.78187697152675e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,0.0163393730571843,0.00271467167974514,0.0110186165648838,0.0216601295494848,1.80996679195336e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA3,Carbonic anhydrase 3,42287,0.0361544119146146,0.00600778947976961,0.0243791445342662,0.0479296792949631,1.81181987611745e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGF,Pro-epidermal growth factor,42081,0.0640140346345743,0.0106418781643958,0.0431559534323585,0.0848721158367901,1.84208583244605e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,0.0596336044272568,0.00991688790070247,0.0401965041418799,0.0790707047126336,1.87344255702702e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MESD,LRP chaperone MESD,42137,0.0747792573438186,0.0124395969004125,0.05039764741901,0.0991608672686271,1.88670667430241e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.0460669721245992,0.00769399709217927,0.0309867378239278,0.0611472064252706,2.19679981217125e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17RA,Interleukin-17 receptor A,42137,0.0270657972170939,0.0045306340870551,0.0181857544064659,0.0359458400277219,2.37382300323144e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,0.0171594109439275,0.00287628545406235,0.0115218914539653,0.0227969304338897,2.50658275367237e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,0.0178635084482657,0.0029944876668246,0.0119943126212894,0.0237327042752419,2.51224414346252e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0252481240025261,0.00424089755378249,0.0169359647971124,0.0335602832079397,2.69135974362343e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,0.0438873032162902,0.00737454255800656,0.0294331998025973,0.058341406629983,2.74201034347491e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIFBP,KIF-binding protein,42070,0.0501829985926702,0.00844489576662051,0.033631002890094,0.0667349942952464,2.87805399242686e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,0.0421493936381094,0.00709325310631649,0.0282466175497291,0.0560521697264898,2.89528605535122e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0389500918936644,0.00657000747048444,0.0260728772515149,0.0518273065358139,3.13384288372694e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAFB2,Scaffold attachment factor B2,39934,0.0166058464424602,0.00280218504174661,0.0111135637606368,0.0220981291242835,3.1936452157984e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIMAP7,GTPase IMAP family member 7,39736,-0.0195546000347705,0.00330776813572288,-0.0260378255807873,-0.0130713744887537,3.48483902998432e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKLR,Pyruvate kinase PKLR,42143,0.0374565580159191,0.0063689418197061,0.0249734320492952,0.0499396839825431,4.17089875901435e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MBL2,Mannose-binding protein C,39826,-0.0664823267050644,0.0113127234549905,-0.0886552646768458,-0.0443093887332829,4.30227206044057e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMVK,Phosphomevalonate kinase,41832,0.0651463326542341,0.0110905508984206,0.0434088528933298,0.0868838124151384,4.3552043638122e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WIF1,Wnt inhibitory factor 1,42262,-0.0201490079164486,0.00344009969237441,-0.0268916033135025,-0.0134064125193948,4.81852600578959e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.0393869708785295,0.00672881199134781,-0.0525754423815712,-0.0261984993754878,4.92517192201502e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0340101674808374,0.00581037289999506,0.0226218365968471,0.0453984983648277,4.92969460568801e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASPN,Asporin,39958,-0.016741709745873,0.00286086569075522,-0.0223490064997532,-0.0111344129919927,4.99193500176537e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,0.0219169297008813,0.00375031122730527,0.0145663196953629,0.0292675397063996,5.21270122493976e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0345414819566607,0.00591582258851926,0.022946469683163,0.0461364942301585,5.37748278525455e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,0.0118050960987423,0.00202236337236331,0.00784126388891023,0.0157689283085744,5.45119912231783e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,-0.0220356394736424,0.00378579265028549,-0.029455793068202,-0.0146154858790829,6.02214847478138e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,0.0172259719332337,0.00296126119557692,0.011421899989903,0.0230300438765645,6.12231187374312e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,0.0230981180283149,0.00397063389768326,0.0153156755888557,0.030880560467774,6.14468794352847e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.0590650940418276,0.0101639086370481,0.0391438331132134,0.0789863549704419,6.36758326218873e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX6,Syntaxin-6,41843,0.0390265964632935,0.00672116067308477,0.0258531215440474,0.0522000713825397,6.52453047284961e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.0349482238347033,0.00602161131171954,0.023145865663733,0.0467505820056736,6.62822586811484e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,0.045086065945614,0.00778869033139248,0.0298202328960847,0.0603518989951432,7.28929656819462e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F12,Coagulation factor XII,39979,0.0244444268635053,0.0042327136829024,0.0161483080450166,0.032740545681994,7.89112420044775e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,0.0435512869526341,0.00758353003526914,0.0286875680835065,0.0584150058217616,9.55119651296522e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.0351479536049962,0.00612151735457744,0.0231497795900244,0.0471461276199679,9.61780830091518e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,0.0743518821910049,0.0129840135489335,0.0489032156350953,0.0998005487469146,1.05227634574763e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARD3,Partitioning defective 3 homolog,39757,0.04374664785014,0.00764291241314623,0.0287665395203734,0.0587267561799067,1.06840696673527e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXN,Thioredoxin,39854,0.0253214991506918,0.00442432301769854,0.0166498260360027,0.033993172265381,1.07175907069915e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L1,Bcl-2-like protein 1,39929,0.0584994867648374,0.0102381260617594,0.0384327596837891,0.0785662138458857,1.13208769690191e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.0559403046300944,0.00979217499725777,0.0367476416354691,0.0751329676247196,1.13497477216408e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0204965863412833,0.0036023364198625,0.0134360069583528,0.0275571657242138,1.29789578619829e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TK1,"Thymidine kinase, cytosolic",39757,0.0275608466806215,0.00485925456393876,0.0180367077353015,0.0370849856259415,1.44797184725156e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.013221455542124,0.00233561246639507,0.00864365510798962,0.0177992559762583,1.53681495170842e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNXB,Tenascin-X,42137,-0.0151000442743622,0.00266966323808164,-0.0203325842210022,-0.0098675043277222,1.57929589798376e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FN1,Fibronectin,39979,0.0158072228864327,0.00279626679629015,0.010326539965704,0.0212879058071614,1.61490092220171e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,0.018169646314259,0.0032155885251893,0.0118670928048879,0.02447219982363,1.63275880253455e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GTPBP2,GTP-binding protein 2,39649,0.0477092645442299,0.00844621303752821,0.0311546869906746,0.0642638420977852,1.65759204699335e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSLN,Mesothelin,42048,0.0335891287489939,0.00595038754442764,0.0219263691619157,0.045251888336072,1.68653728682615e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,0.0619639149950537,0.0110019283226702,0.0404001354826201,0.0835276945074874,1.82273811170375e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL3,Fc receptor-like protein 3,41913,0.0308458251987782,0.00547784414093494,0.0201092506825458,0.0415823997150107,1.82775302610436e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0586785479316144,0.0104297767581343,0.0382361854856712,0.0791209103775576,1.88063131765351e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,0.0675410130426028,0.0120054487040315,0.0440103335827009,0.0910716925025046,1.88288608130902e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.0492529094321439,0.00876473426236057,0.0320740302779172,0.0664317885863707,1.96097621137356e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,0.0295340111220698,0.00526139593265689,0.0192216750940623,0.0398463471500773,2.02425505214104e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,0.0297819849512442,0.00530654695451431,0.0193811529203961,0.0401828169820922,2.04459333824645e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,-0.0187540725687164,0.00334474948908106,-0.0253097815673153,-0.0121983635701175,2.1077974314872e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPEP1,Dipeptidase 1,41997,-0.0262599543944772,0.00468977994829376,-0.0354519230931329,-0.0170679856958214,2.1932365954146e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTG,Protogenin,42262,0.0140506043014776,0.00251171650044356,0.00912763996060824,0.018973568642347,2.26125890507886e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.0436108231855254,0.00779959119297528,0.0283236244472939,0.058898021923757,2.29669337155529e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,0.012790501026759,0.00228837474653478,0.00830528652355085,0.0172757155299672,2.32309437295862e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.0569530212500259,0.0101926877538657,0.0369753532524492,0.0769306892476026,2.35665633285433e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STXBP1,Syntaxin-binding protein 1,39934,0.0447592707754992,0.00802399608248309,0.0290322384538324,0.0604863030971661,2.48625281970129e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UROS,Uroporphyrinogen-III synthase,39649,0.037875633587995,0.00679604610085946,0.0245553832303105,0.0511958839456795,2.55985218437354e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.023059400248153,0.00414013151928364,0.0149447424703571,0.031174058025949,2.60966994493906e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX6,Peroxiredoxin-6,42262,-0.0341804987452669,0.00613854779971435,-0.0462120524327071,-0.0221489450578268,2.6227813828436e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRL,Prolactin,42249,0.0418314225112787,0.00751961891011851,0.0270929694474464,0.056569875575111,2.70207996200446e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACRBP,Acrosin-binding protein,39919,0.0228264143725367,0.00410517468714976,0.0147802719857231,0.0308725567593502,2.75259660752324e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK8,Kallikrein-8,41668,0.020774675947995,0.00374650447587247,0.013431527175285,0.0281178247207051,2.99517104583989e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.0404493647319454,0.00730355798799614,0.026134391075473,0.0547643383884178,3.12322789387793e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,0.0330190837950122,0.00596315287278584,0.021331304164352,0.0447068634256725,3.14220308288006e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DENR,Density-regulated protein,39657,0.0327552597050585,0.00591948317486254,0.021153072682328,0.0443574467277891,3.21115450590978e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROS1,Vitamin K-dependent protein S,39979,0.0144107330460998,0.00260570606725708,0.00930354915427591,0.0195179169379237,3.2645914423786e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,0.0204382825148055,0.00370270204739636,0.0131809865019087,0.0276955785277024,3.46795959101896e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPOCK1,Testican-1,42016,-0.0147015844405093,0.00266813579278895,-0.0199311305943756,-0.00947203828664294,3.65326999882439e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.039971479206236,0.00725764329505898,0.0257464983479204,0.0541964600645516,3.72028634897795e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX2,Sorting nexin-2,39919,0.0483606274035327,0.00878276475281822,0.031146408488009,0.0655748463190564,3.74428957352198e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.0379957826529197,0.00691312692669705,0.0244460538765935,0.051545511429246,3.96795215423867e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK6,Kallikrein-6,42158,0.0173375261514613,0.00315757029896239,0.0111486883654951,0.0235263639374276,4.07360374557259e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSR,Insulin receptor,39657,0.00967864956750538,0.00176384510341352,0.00622151316481489,0.0131357859701959,4.17250515099573e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,0.0230118556212285,0.0041950417231051,0.0147895738439425,0.0312341373985145,4.19681922190258e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO2,Roundabout homolog 2,42249,0.0126850730039309,0.00231278242470776,0.00815201945150373,0.0172181265563582,4.21381512145147e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAM,Basal cell adhesion molecule,42137,0.013731771792761,0.00250712853116216,0.00881779987168313,0.0186457437138388,4.40089759923794e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FXN,"Frataxin, mitochondrial",42262,0.0406896142219738,0.0074303315984132,0.026126164289084,0.0552530641548637,4.42357983743806e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0645035630402934,0.0117906741263049,0.0413938417527359,0.087613284327851,4.57718477483984e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0415983039514336,0.00760591058270209,0.0266907192093375,0.0565058886935297,4.60252819732991e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0248165967157392,0.00453824121256211,0.0159216439391175,0.0337115494923609,4.64251536776531e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.0238892534351549,0.0043714416261147,-0.0324572790223398,-0.0153212278479701,4.71546565878838e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED8,Protein TMED8,39930,0.0580444954466713,0.0106284865530717,0.0372126618026508,0.0788763290906918,4.82858048005446e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0143293809436386,0.00262451773792964,0.00918532617729646,0.0194734357099806,4.85027876414786e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0130191240924065,0.00238640644322951,0.00834176746367671,0.0176964807211364,4.96726292482655e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLGN,Calmegin,39649,0.025595922132103,0.00469633341556062,0.0163911086376042,0.0348007356266018,5.13961012416842e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0323635505123597,0.00594441948897178,0.0207124883139751,0.0440146127107444,5.29189961076424e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMTN,Smoothelin,39897,0.05178012648844,0.00951282125581636,0.0331349968270399,0.07042525614984,5.3427537187464e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.0632448566219495,0.0116235072575818,0.0404627823970892,0.0860269308468098,5.38640600420589e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGA,Fibrinogen alpha chain,39735,0.0173601356106578,0.00319209410577398,0.0111036311633408,0.0236166400579748,5.48731959501252e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RCC1,Regulator of chromosome condensation,39919,0.0291449902746233,0.00535920521115386,0.0186409480607618,0.0396490324884849,5.49080380734256e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA5,Annexin A5,41780,0.0168835174984756,0.00310511246384795,0.0107974970693336,0.0229695379276176,5.50488988658633e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX2,Peroxiredoxin-2,39819,0.0336583965944275,0.0062021637792476,0.0215021555871022,0.0458146376017528,5.8540647101435e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRADD,Death domain-containing protein CRADD,41997,0.0413222973732197,0.00762188352817149,0.0263834056580035,0.0562611890884358,6.01138163238673e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM17,Splicing factor 45,39934,0.0428826939242959,0.00791137900927979,0.0273763910661075,0.0583889967824843,6.06906103718259e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.0340921079913384,0.00629380139549588,0.0217562572561665,0.0464279587265104,6.19560761952564e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK4,Kallikrein-4,42262,0.0346382119342953,0.00639999785618094,0.0220942161361807,0.04718220773241,6.32977849842681e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.0421208672972259,0.00778281284271731,0.0268665541255,0.0573751804689519,6.33709062250349e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,0.0462640836067423,0.00854746271644342,0.0295110566825132,0.0630171105309714,6.34009932267181e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTN3,Myeloblastin,41800,0.0265277236049112,0.00492445990476772,0.0168757821915665,0.0361796650182559,7.29005685753388e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0392859438897181,0.0073049719346782,0.0249681988977489,0.0536036888816874,7.68227476713558e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOBR,Apolipoprotein B receptor,39638,-0.0237145716316569,0.00441938748149841,-0.0323765710953938,-0.01505257216792,8.21164764096025e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNC79,Protein unc-79 homolog,39560,0.0307680331068523,0.00573590737482827,0.0195256546521889,0.0420104115615157,8.30051448700116e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRN1,Secernin-1,42119,0.0303109787236737,0.00565985740587805,0.0192176582081528,0.0414042992391947,8.67495021649986e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHRL,Appetite-regulating hormone,42145,0.0454297527783398,0.00850085466910555,0.0287680776268929,0.0620914279297866,9.23195422971354e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRG,Histidine-rich glycoprotein,39925,0.0170641005714541,0.00319386434092039,0.0108041264632501,0.023324074679658,9.33083538380438e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MICALL2,MICAL-like protein 2,39649,0.0376362232267331,0.00704661618194324,0.0238248555101243,0.0514475909433418,9.42516626871907e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP2,Caspase-2,42119,0.0372843642785165,0.00698671560178128,0.0235904016990252,0.0509783268580078,9.63060357144997e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0451150163213908,0.00846186324569418,0.0285297643598302,0.0617002682829514,9.89334366665145e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF22,Kinesin-like protein KIF22,39575,0.0679876312702849,0.0127720185046533,0.0429544750011643,0.0930207875394054,1.03985278036786e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL3,C-X-C motif chemokine 3,42129,0.0518175029789803,0.00974625171286453,0.0327148496217659,0.0709201563361948,1.07369824913605e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.0306473758615068,0.00576760274999752,0.0193428744715117,0.041951877251502,1.09518551333712e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0290289869677335,0.00546504795141146,0.018317492982967,0.0397404809524999,1.10303051581078e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,0.0111272724025973,0.00210042616573559,0.00701043711775555,0.0152441076874391,1.1957165316519e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.161981408331071,0.0306045199656523,0.101996549198393,0.22196626746375,1.22388209136774e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APCS,Serum amyloid P-component,39870,0.0176887763975878,0.00334268069532912,0.0111371222347427,0.0242404305604329,1.23395256064416e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0259739141491426,0.00490945214404847,0.0163513879468076,0.0355964403514776,1.24193947976516e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX3,Syntaxin-3,39929,0.02070034054088,0.00391624583683095,0.0130244987006914,0.0283761823810687,1.2750928248609e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.017008957610107,0.00322149206625974,0.0106948331602379,0.0233230820599761,1.31333246574935e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP3,Stromelysin-1,42137,-0.0267812518544649,0.00507517352386425,-0.0367285919612388,-0.0168339117476909,1.33405155946208e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR15L,Protein GPR15L,39930,0.0338404905999387,0.0064133363850913,0.0212703512851598,0.0464106299147177,1.34045174486635e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH6,Cadherin-6,42145,0.0208970649777285,0.0039839026493854,0.0130886157849331,0.0287055141705239,1.58314208084748e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.0167243212339875,0.00318874787544886,-0.0229742670698673,-0.0104743753981078,1.59138339848288e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.0539527256562661,0.0102993840851895,0.0337659328492946,0.0741395184632376,1.64842101869096e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRUNE2,Protein prune homolog 2,39757,0.0155813535337121,0.00297477177836935,0.00975080084810815,0.021411906219316,1.65433283467751e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,-0.0368762336736817,0.00704488437680516,-0.0506842070522198,-0.0230682602951435,1.67945789174366e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTF3,Neurotrophin-3,42119,0.0184165242266024,0.00351994156085034,0.0115174387673358,0.0253156096858691,1.70142376554836e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D5,TBC1 domain family member 5,42119,0.0417007070782615,0.00797392946740294,0.0260718053221517,0.0573296088343712,1.72382983994566e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,-0.0146592025515203,0.00280360679972411,-0.0201542718789796,-0.00916413322406107,1.73763085019666e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABHD14B,Protein ABHD14B,41976,0.0298163415901615,0.00570885260415007,0.0186269904860274,0.0410056926942956,1.78857205395675e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM106A,Transmembrane protein 106A,39919,0.0384395262486947,0.00737340820603337,0.0239876461648693,0.0528914063325201,1.88816228724273e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,0.0308145110111858,0.00591219844821779,0.0192266020526789,0.0424024199696927,1.8953125018933e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBLN2,Fibulin-2,39966,0.0171918180455404,0.00329880301027271,0.0107261641454059,0.0236574719456749,1.90570085666509e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.0262250759208942,0.00503508298191047,0.0163563132763497,0.0360938385654387,1.93834100164017e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,0.0144030402312679,0.00276821338130369,0.00897734200391265,0.0198287384586231,1.98914768352515e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.0506056744687047,0.00974051561411465,0.03151426386504,0.0696970850723694,2.07855439721094e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,-0.0124499011221041,0.00240048232910611,-0.017154846487152,-0.00774495575705609,2.17432526246955e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0248274173199614,0.00481971172753036,0.0153807823340019,0.0342740523059209,2.62508138657837e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,0.0387964242884063,0.00753209245656192,0.024033523073545,0.0535593255032677,2.62955290520194e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSV,Cathepsin L2,42200,-0.0210803295623241,0.00409274824066129,-0.0291021161140203,-0.013058543010628,2.63208224157344e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0402071985177456,0.00782226234107725,0.0248755643292342,0.055538832706257,2.79325899671368e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.0514255788351246,0.0100187030888255,0.0317889207810265,0.0710622368892226,2.89264563691748e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYZL2,Lysozyme-like protein 2,39560,0.0191853371702482,0.00373929618341314,0.0118563166507584,0.0265143576897379,2.93550970120889e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,0.0146433540120501,0.0028561726949582,0.00904525552993207,0.0202414524941682,2.98557758460841e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0230442656201865,0.00450183248230264,0.0142206739548733,0.0318678572854997,3.12422771649098e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0391065721733749,0.00764899070190656,0.0241145503976381,0.0540985939491118,3.2294490158989e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR1,Cadherin-related family member 1,41839,0.0215405134872978,0.00422420740582129,0.0132610669718881,0.0298199600027076,3.45615304263792e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,0.0270909266626056,0.00532994363657464,0.0166442371349193,0.0375376161902919,3.76860505577451e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,0.0376392003222428,0.00741157583531488,0.0231125116850256,0.05216588895946,3.85642425138444e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP2,Guanylate-binding protein 2,41913,0.0314795361837836,0.00620537401614381,0.0193170031121418,0.0436420692554255,3.96973743541461e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1S,Complement C1s subcomponent,39979,0.0109742481457054,0.00216545050462404,0.00672996515664226,0.0152185311347685,4.08583042213671e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,0.0176724504412194,0.00349270221098514,0.0108267541076885,0.0245181467747502,4.25157787748816e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP3,Caspase-3,42310,0.0455038838746898,0.00899869412633653,0.0278664433870702,0.0631413243623094,4.3203274808346e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.0173747133082841,0.00344042728949861,0.0106314758208668,0.0241179507957014,4.48305455640882e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPARCL1,SPARC-like protein 1,42169,-0.0141080399351518,0.00279483654390847,-0.0195859195612124,-0.00863016030909115,4.52492905515569e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR2,Complement factor H-related protein 2,39904,0.0294934738773596,0.00585397862489635,0.0180196757725627,0.0409672719821564,4.772088790691e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JUN,Transcription factor AP-1,41913,0.0248410541020586,0.00493991634611394,0.0151588180636753,0.034523290140442,5.00401558747515e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.043899071546176,0.00873258024533668,0.0267832142653161,0.0610149288270359,5.04603451186072e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOK1,Docking protein 1,39929,0.0708845621643321,0.0141031542604551,0.0432423798138401,0.0985267445148242,5.08069454817826e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,0.0244775056930215,0.00487612984615745,0.0149202911945529,0.0340347201914901,5.23588480498087e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.0417811177789308,0.00832313598780545,0.0254677712428321,0.0580944643150295,5.2510004577919e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.014829652362616,0.00295664586110561,0.00903462647484901,0.020624678250383,5.3638933157718e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GASK1A,Golgi-associated kinase 1A,39575,0.0220500893672657,0.00439657541866657,0.0134328015466792,0.0306673771878522,5.37823578166329e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CABP2,Calcium-binding protein 2,39649,0.0337446795831024,0.00672896135780335,0.0205559153218078,0.0469334438443969,5.39011541515873e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PADI4,Protein-arginine deiminase type-4,41814,0.0373772749849957,0.00746147789338246,0.0227527783139661,0.0520017716560253,5.53148873811568e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,0.0198504229516533,0.0039637562834757,0.0120814606360409,0.0276193852672657,5.58297619084442e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLMH,Bleomycin hydrolase,42310,0.0157584055963718,0.00315948356355148,0.00956581781181092,0.0219509933809327,6.186537467184e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0165934214656748,0.0033307772823477,0.0100650979922733,0.0231217449390763,6.39074576001222e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.0162433618829295,0.0032673604248531,0.00983933545021743,0.0226473883156416,6.74740957531052e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.0610066537439128,0.0123149677503726,0.0368693169531826,0.085143990534643,7.36299641026035e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD1,Sushi domain-containing protein 1,41900,0.0246338477135664,0.00497852909976492,0.0148759306780272,0.0343917647491056,7.58904253569895e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB44,Ras-related protein Rab-44,39919,0.0228291032010915,0.00461446964215298,0.0137847427024717,0.0318734636997114,7.63372058641275e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.0304230934195324,0.00615864003640555,0.0183521589481775,0.0424940278908873,7.90835421540342e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELAVL4,ELAV-like protein 4,39586,0.041651416601412,0.00844241716139507,0.0251042789650776,0.0581985542377463,8.1915590908737e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,0.0135709478858511,0.00275099192577246,0.00817900371133708,0.0189628920603651,8.20737573203248e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,0.044533086601294,0.00904397373401314,0.0268068980826282,0.0622592751199597,8.59615653257452e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAPK2,Death-associated protein kinase 2,39657,0.0280777021548581,0.00570245351470665,0.0169008932660331,0.0392545110436831,8.61091958028181e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUGT1,Protein SGT1 homolog,41843,0.0402350727577133,0.00818590361939611,0.024190701663697,0.0562794438517297,8.97694895320008e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBN1,Drebrin,39657,0.0257980469139125,0.00525517669722655,0.0154979005873485,0.0360981932404766,9.28150045358019e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM,Paralemmin-1,39859,0.015442470097418,0.00314650062157079,0.00927532887913929,0.0216096113156968,9.33831290498933e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB10,Ras-related protein Rab-10,39958,0.0268968166599333,0.00549880529106126,0.0161191582894532,0.0376744750304133,1.01497743469242e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC51B,Organic solute transporter subunit beta,39575,0.036446734965937,0.0074589220714636,0.0218272477058683,0.0510662222260056,1.0418652863474e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,0.021878339834375,0.00449474421115085,0.0130686411805193,0.0306880384882307,1.14570516332998e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL4,Early placenta insulin-like peptide,39919,0.0240591164598729,0.00494951423511945,0.0143580685590388,0.0337601643607071,1.18419814363759e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VNN1,Pantetheinase,39990,0.0366091978485104,0.0075325827410073,0.0218453356761361,0.0513730600208847,1.18883880543269e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0239934774682418,0.00493827088209334,0.0143144665393388,0.0336724883971447,1.1952634611951e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.0261878989980165,0.00540313584526946,0.0155977527412883,0.0367780452547446,1.27131536920869e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0185598539987676,0.00383846074589571,0.011036470936812,0.0260832370607232,1.34736866067114e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.0156619167498121,0.00323920059188402,0.0093130835897194,0.0220107499099048,1.34862166367058e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,0.0435154887240244,0.00902269114284306,0.025831014084052,0.0611999633639968,1.43024231291129e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.0309357826307856,0.00641902009525036,0.0183545032440949,0.0435170620174763,1.45912041617298e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGN,Cingulin,39649,0.0185281743722687,0.00384919001350079,0.0109837619458071,0.0260725867987302,1.50255167895071e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,-0.0261165409745887,0.00543033220622465,-0.036759992098789,-0.0154730898503883,1.53012846252604e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.0283234780933492,0.00590315000330698,0.0167533040868676,0.0398936520998309,1.62311558980369e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN2,Ataxin-2,39586,0.0523782787011138,0.0109175944336702,0.0309797936111203,0.0737767637911073,1.62688307388213e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C5,Complement C5,39979,0.00739310041251606,0.00154225566257175,0.00437027931387542,0.0104159215111567,1.65811247485179e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST1,Cystatin-SN,38503,0.052609927925102,0.0109923115550727,0.0310649972771595,0.0741548585730444,1.72542594912518e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0162570178002793,0.0033998460042522,0.009593319631945,0.0229207159686136,1.75638952571689e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0231558723826125,0.00484300827312867,0.0136635761672803,0.0326481685979447,1.76413918132478e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANPEP,Aminopeptidase N,42187,0.013337960020664,0.00279133743073421,0.00786693865642499,0.0188089813849031,1.78597225713136e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.0457988685631709,0.00959795149062254,0.0269868836415507,0.0646108534847911,1.84564129245182e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRAL,GDNF family receptor alpha-like,39574,-0.0309801604247606,0.00649492789767263,-0.043710219104199,-0.0182501017453223,1.86690376536001e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,0.0274651375901772,0.00576017729176736,0.0161751900983132,0.0387550850820413,1.88338901318622e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BIN2,Bridging integrator 2,42137,0.04342864849701,0.00911446394078488,0.0255642991730716,0.0612929978209483,1.9099924280435e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN10,Ataxin-10,41839,0.0356744936160878,0.00749219579371428,0.0209897898604078,0.0503591973717678,1.94143069411407e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREG1,Protein CREG1,41960,0.019586441432703,0.00412806783097685,0.0114954284839884,0.0276774543814176,2.10978193224346e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0315400785439233,0.00666149308281315,0.0184835521016095,0.044596604986237,2.21655601487199e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0191263234878729,0.00404019696834111,0.0112075374299243,0.0270451095458215,2.22863782777826e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.0513635256645557,0.0108707514057735,0.0300568529092397,0.0726701984198718,2.3300678936458e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_A,,39934,0.015945972974272,0.00337694555806396,0.00932715968046666,0.0225647862680774,2.36324356637413e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMFG,Glia maturation factor gamma,39958,0.0348812369205077,0.00740820930530265,0.0203611466821145,0.0494013271589009,2.52552044385827e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2orf69,UPF0565 protein C2orf69,39649,0.0285552433422916,0.0060653667445853,0.0166671245229044,0.0404433621616788,2.53303986297111e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,0.027769019304992,0.00589918855590515,0.0162066097354179,0.0393314288745661,2.54121840886202e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROCR,Endothelial protein C receptor,39575,-0.0167326132885566,0.00356103506393482,-0.0237122420138689,-0.00975298456324439,2.64866438049359e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,0.0381067499393957,0.00811256681578208,0.0222061189804628,0.0540073808983286,2.66869915997165e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C8B,Complement component C8 beta chain,39979,-0.0145607270085706,0.00310310744445876,-0.0206428175997098,-0.00847863641743147,2.73292312195426e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITM2A,Integral membrane protein 2A,42119,0.0296485001644366,0.00634756570198137,0.0172072713885531,0.0420897289403201,3.02851194529297e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,0.0144019456305638,0.0030881674966751,0.00834913733708055,0.020454753924047,3.14291933781331e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.0579403166727543,0.0124357318466407,0.0335662822533386,0.08231435109217,3.20499420030512e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,0.0244097533884163,0.00524152483117576,0.0141363647193118,0.0346831420575208,3.2393738055988e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.0131251495842827,0.00282157239307945,0.00759486769384695,0.0186554314747184,3.32358764830725e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.0412494602616202,0.00888197343562133,0.0238407923278024,0.0586581281954381,3.45412935159072e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,0.024188429100761,0.00521353777139607,0.0139698950688247,0.0344069631326973,3.53221768018069e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDZD2,PDZ domain-containing protein 2,39575,0.0280885628551691,0.00605890688521302,0.0162131053601515,0.0399640203501866,3.59465387824687e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.0189022560776032,0.00408140034072139,0.0109027114097893,0.0269018007454172,3.67396175917601e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES2,Cocaine esterase,42070,0.0263735563493537,0.00569751807198924,0.0152064209282548,0.0375406917704526,3.70946559672927e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCN15,Lipocalin-15,39934,0.0288144914725506,0.00624050604377971,0.0165830996267424,0.0410458833183589,3.92978756599908e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,0.0261959734648692,0.00567612595862702,0.0150707665859602,0.0373211803437781,3.97332088640065e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD2,T-cell surface antigen CD2,39575,0.0184415493308162,0.00400117697205797,0.0105992424655826,0.0262838561960498,4.09112974772969e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.0148864131420919,0.00323215979730727,0.00855137993936963,0.0212214463448141,4.15523859128006e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA7,Thyroxine-binding globulin,39979,0.00867135119076458,0.00188424578365907,0.00497822945479279,0.0123644729267364,4.22922280803004e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDHB15,Protocadherin beta-15,39919,0.0188256054550382,0.00409743185544923,0.0107946390183577,0.0268565718917187,4.38497689430577e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0437946030339172,0.00953441480065754,0.0251071500246284,0.062482056043206,4.40954754625099e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNU13,NHP2-like protein 1,39575,0.0297759403888875,0.00648652114877864,0.0170623589372813,0.0424895218404936,4.47239853024156e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,0.013384033814682,0.00291748663126858,0.00766576001739557,0.0191023076119684,4.52561434231812e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.0199830186433423,0.00436105987299182,0.0114353412922784,0.0285306959944063,4.64406721464258e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,0.0134441490120626,0.00293517812219509,0.00769119989256023,0.019197098131565,4.69132609569776e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0182608195646039,0.00399075979294315,0.0104389303704353,0.0260827087587725,4.79634734147246e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA3,GDNF family receptor alpha-3,41989,0.0129869087638614,0.00284306053976922,0.00741451010591374,0.0185593074218091,4.969550594022e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD40LG,CD40 ligand,42296,0.0370322213357377,0.00810948368091685,0.0211376333211407,0.0529268093503348,5.00179416706756e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1B,Interleukin-1 beta,41825,0.0262540984633747,0.00576977590537359,0.0149453376888424,0.0375628592379069,5.40514660097286e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFIC,Nuclear factor 1 C-type,39934,0.0214180432732665,0.00470703606654025,0.0121922525828477,0.0306438339636854,5.41472394847955e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LXN,Latexin,41960,-0.0318131946187818,0.00700623389214733,-0.0455454130473906,-0.018080976190173,5.65583621264129e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,-0.016956708878281,0.00373464884263691,-0.0242766206098493,-0.00963679714671265,5.66427933525725e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARG1,Arginase-1,42015,0.0234345414260023,0.00517034618179871,0.0133006629096769,0.0335684199423278,5.87964767799822e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,0.0222586545450458,0.004911957220453,0.0126312183929579,0.0318860906971337,5.90693144221703e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPH1,Neurexophilin-1,41839,0.0179114838273325,0.00396554604216051,0.010139013584698,0.0256839540699671,6.33310255296979e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD33,Myeloid cell surface antigen CD33,42181,0.0366447199777527,0.00812218407028271,0.0207252391999986,0.0525642007555069,6.48548747364353e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK4,Serine/threonine-protein kinase 4,42145,0.0403463053074513,0.00894636692073244,0.0228114261428158,0.0578811844720869,6.54344794053283e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGA,Glycoprotein hormones alpha chain,42137,0.0284895677266013,0.00632042425259503,0.0161015361915151,0.0408775992616876,6.61335554537972e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRTN,Neurturin,41913,0.0228367042623685,0.0050712537014968,0.0128970470074348,0.0327763615173023,6.75170275247088e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LBP,Lipopolysaccharide-binding protein,42217,0.026986510771407,0.0059974093472532,0.0152315884507907,0.0387414330920233,6.86148059041173e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.0512264244518032,0.0113872381161682,0.0289074377441136,0.0735454111594928,6.89905093487823e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDK1,Cyclin-dependent kinase 1,39560,0.0168741364998617,0.0037522168044618,0.00951979156311653,0.0242284814366068,6.95907929248037e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC3B,Tetranectin,39726,-0.0096961865970341,0.00215753819649872,-0.0139249614621716,-0.00546741173189662,7.05710554092262e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0171643481353107,0.00382299044747099,0.0096712868582676,0.0246574094123539,7.20050170583138e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.0130136727841871,0.00289947945892188,0.00733069304470024,0.018696652523674,7.23929474238765e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,0.0338363731001456,0.00754424979577965,0.0190496435004175,0.0486231026998737,7.36085298693412e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0216353686089152,0.00482439249581734,0.0121795593171132,0.0310911779007172,7.37762315324833e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMP,Cartilage oligomeric matrix protein,42042,-0.0152549577061757,0.00340965675277509,-0.0219378849416149,-0.00857203047073651,7.73836539642178e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK13,Kallikrein-13,41839,0.0205387556854059,0.00459352727279628,0.0115354422307252,0.0295420691400867,7.84145948996211e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB37,Ras-related protein Rab-37,41913,0.037115575193022,0.0083110345596189,0.0208259474561689,0.053405202929875,8.04195525216904e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP1,Retinol-binding protein 1,39649,0.0322340664999772,0.00722464420207637,0.0180737638639075,0.0463943691360469,8.21228458773786e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,0.0174084197709204,0.00391017028683862,0.00974448600871676,0.0250723535331241,8.58524572579097e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST6,Cystatin-M,41864,0.0226451630762695,0.00508721275769375,0.0126742260711897,0.0326161000813492,8.60127215246309e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0389869858787579,0.00878925934356465,0.0217600375653712,0.0562139341921446,9.26374138778792e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BGLAP,Osteocalcin,39966,0.0383529600991889,0.00864976062898121,0.0213994292663857,0.0553064909319921,9.33726214739132e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,0.0288392682214674,0.00651209131261681,0.0160755692487384,0.0416029671941963,9.55976535165348e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VGF,Neurosecretory protein VGF,39934,0.0137213437868308,0.00310624283869701,0.00763310782298463,0.0198095797506769,1.00847930789912e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.0396472219219929,0.00897615825538771,0.022053951741433,0.0572404921025528,1.01047466184342e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,0.0494482465026603,0.0112083118303659,0.0274799553151432,0.0714165376901774,1.03333284886862e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLG,Plasminogen,39742,0.00990048661139357,0.00224450026133987,0.00550126609916742,0.0142997071236197,1.0386081575606e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIT,Vitrin,39958,0.0174234524497748,0.00395450546140099,0.00967262174542882,0.0251742831541207,1.0627428864303e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.0183515183336603,0.00416941737875264,0.0101794602713051,0.0265235763960155,1.08338316024592e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0273775144450272,0.00623710531763263,0.0151527880224673,0.0396022408675872,1.14509586068699e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,0.0352327916849639,0.00803100115581822,0.0194920294195602,0.0509735539503677,1.15760706073746e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEPD,Xaa-Pro dipeptidase,39990,-0.0118759109292998,0.00271444487895868,-0.0171962228920588,-0.00655559896654079,1.22468407618862e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0258775078372315,0.00591866573454423,0.0142769229975248,0.0374780926769382,1.23947022322337e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTD,Deoxycytidylate deaminase,39736,0.0430677522955591,0.00985468645890579,0.0237525668361038,0.0623829377550145,1.25211020341015e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.025843593784595,0.00592505684249254,0.0142304823733097,0.0374567051958804,1.30199605526237e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.0248315817511937,0.00571800267387149,0.0136242965104056,0.0360388669919818,1.41964525358199e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.0533081773930004,0.0122802344061403,0.0292389179569655,0.0773774368290353,1.42883887175068e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0326175742126878,0.00751588410326517,0.0178864413702881,0.0473487070550876,1.43658009586771e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.039817729344987,0.00917928265897222,0.0218263353334014,0.0578091233565726,1.45195150798388e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F3,Tissue factor,42174,-0.0115940155480657,0.00267443632367377,-0.0168359107424663,-0.00635212035366514,1.4672678225674e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,0.0294527713056993,0.00681201289658127,0.0161012260284,0.0428043165829986,1.54591269847358e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0434083066575853,0.0100436001641901,0.0237228503357727,0.0630937629793979,1.55993134314252e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL24,C-C motif chemokine 24,42166,0.0363969853735286,0.00842364251989068,0.0198866460345428,0.0529073247125143,1.56561696580455e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,0.037030561089053,0.00859246762736872,0.0201893245394103,0.0538717976386957,1.64685698435659e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.0387275904882258,0.00899676201845979,0.0210939369320446,0.056361244044407,1.68707402165699e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMNB1,Lamin-B1,39908,0.0270198893664285,0.00628362879166735,0.0147039769347605,0.0393358017980965,1.7219528551415e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0197642168525694,0.00460576322854852,0.0107369209246143,0.0287915127805245,1.79193501596093e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX5,Sorting nexin-5,39638,0.0131272011587247,0.00306752951400894,0.00711484331126713,0.0191395590061822,1.88974487330343e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPQ,Carboxypeptidase Q,39960,0.0164256531291681,0.0038449667045704,0.00888951838821009,0.0239617878701261,1.95315114083804e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,-0.0260183126038221,0.00609515544074163,-0.0379648172676757,-0.0140718079399685,1.98227318501891e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,0.0319464214283302,0.00748988478206452,0.0172662472554838,0.0466265956011767,2.01012845679496e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0267851234659259,0.00629691327471491,0.0144431734474847,0.0391270734843671,2.12008933918477e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0235783274019658,0.00554684850913416,0.0127065043240628,0.0344501504798687,2.14753534783014e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.013634353543276,0.00320788102049427,-0.0199218003434448,-0.00734690674310723,2.15282405359533e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.01770567674988,0.00417360614353447,0.00952540870855247,0.0258859447912076,2.23045907665423e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0255856871371729,0.00603452419724418,0.0137580197105743,0.0374133545637715,2.2545235228417e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSH,Pro-cathepsin H,41865,0.0323041581356122,0.00764237147169992,0.0173251100510803,0.047283206220144,2.38433158894188e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTX1,Neuronal pentraxin-1,42137,0.0179759868498708,0.00426676608268537,0.00961312532780749,0.0263388483719341,2.53606497233687e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,0.0336428009980611,0.00799946345275521,0.0179638526306609,0.0493217493654613,2.62355500491089e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.0201386429225384,0.00478857131790034,-0.0295242427056231,-0.0107530431394537,2.62499517191035e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.0233368752929547,0.00555171426377962,0.0124555153359467,0.0342182352499628,2.64836348342602e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0223346176242193,0.00531639775852342,0.0119144780175134,0.0327547572309252,2.67383338123841e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,0.0189401907106786,0.00451377157294869,0.0100931984276991,0.027787182993658,2.73634990955822e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB9,Serpin B9,42016,0.0140614930333534,0.00335500078359115,0.00748569149751478,0.0206372945691921,2.79255718245191e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SATB1,DNA-binding protein SATB1,39934,0.0126200276110232,0.00301258495996669,0.00671536108948851,0.0185246941325579,2.82180537402141e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.019856425988162,0.00474194059156305,0.0105622224286984,0.0291506295476256,2.83987176050401e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.0380366519658013,0.00910225230425936,0.020196237449453,0.0558770664821497,2.94901212707213e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM3,Paralemmin-3,39575,0.0325867543881618,0.00779901781525893,0.0173006794702543,0.0478728293060693,2.95950941857246e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,0.016626098481398,0.00398546731843409,0.00881458253726715,0.0244376144255288,3.04674882309303e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR1,TGF-beta receptor type-1,39657,0.00940473647543421,0.00226381357125485,0.0049676618757747,0.0138418110750937,3.28627102215704e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,0.0142866616472814,0.00344819894273967,0.00752819171951168,0.0210451315750512,3.44560446941691e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0212297303825794,0.00513563462762647,0.0111638865124315,0.0312955742527273,3.58998168855403e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6L,Seizure 6-like protein,42181,0.0116308350078385,0.00281381321693002,0.00611576110265562,0.0171459089130213,3.5945960320444e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MATN3,Matrilin-3,41992,-0.0139243805847028,0.00337309239378962,-0.0205356416765305,-0.00731311949287513,3.68027863799454e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,0.0408989471057742,0.00991053834768932,0.0214742919443031,0.0603236022672452,3.70525475627293e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PER3,Period circadian protein homolog 3,39657,0.0521768500176092,0.0126590931974787,0.027365027350551,0.0769886726846673,3.78848751068853e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,0.0116049881501895,0.00281583952107319,0.00608594268888609,0.017124033611493,3.79382458458633e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0296869871872113,0.00722180842127859,0.0155322426815052,0.0438417316929173,3.97175595218222e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARFIP1,Arfaptin-1,39934,0.0292916218386255,0.00712822241524732,0.0153203059047408,0.0432629377725103,3.99745950983875e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.0116605740186238,0.00283797655409708,0.0060981399725935,0.0172230080646541,4.00178024827978e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,0.0149369064440453,0.00364151988305547,0.0077995274732566,0.022074285414834,4.12800398657828e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,0.0176302438635374,0.00430232446031549,0.00919768792131899,0.0260627998057557,4.19976193154197e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,-0.0159317496986969,0.00389891534504169,-0.0235736237749786,-0.00828987562241517,4.41079112528381e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIM,Vimentin,41900,0.0480028613897272,0.0117532139076071,0.0249665621308173,0.0710391606486371,4.44817065049758e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RSPO1,R-spondin-1,42016,0.0141510752152385,0.00348359538392639,0.00732322826274282,0.0209789221677342,4.8888078260001e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.0533695036083355,0.0131565174698543,0.0275827293674211,0.07915627784925,5.01458334099262e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.0156058296215518,0.00384858804535297,0.00806259705265995,0.0231490621904436,5.0481089927863e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.0263338589041775,0.00649853061750421,0.0135967388938693,0.0390709789144858,5.10650025498417e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBQLN3,Ubiquilin-3,39575,0.0234296730211945,0.00578305263959992,0.0120948898475786,0.0347644561948103,5.12546151984944e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,-0.0189021913854971,0.00467498922769893,-0.028065170271787,-0.00973921249920715,5.30043652908476e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD109,CD109 antigen,42137,0.0140870784111541,0.00348647176008517,0.00725359376138715,0.020920563060921,5.36326942087678e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MB,Myoglobin,42310,0.0231354220572183,0.00573733079434688,0.0118902537002985,0.0343805904141382,5.5500328633216e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDRG1,Protein NDRG1,41839,0.0271976238494398,0.00674518702774942,0.013977057275051,0.0404181904238287,5.55779993392217e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,-0.0252577741390813,0.00627257641339526,-0.037552023909336,-0.0129635243688266,5.68743202902066e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,0.0163958181531274,0.00407305037672518,0.00841263941474609,0.0243789968915088,5.71856806470608e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,0.0317465012077301,0.00793014001465506,0.0162034267790061,0.047289575636454,6.28698514313717e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMCN2,Hemicentin-2,39721,0.0238451300620156,0.00596796201488567,0.0121479245128396,0.0355423356111915,6.49677152989109e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHNAK2,Protein AHNAK2,39638,0.012791410688353,0.00320731990329098,0.00650506367790267,0.0190777576988033,6.70079498824095e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0267287586988419,0.00670884931640169,0.0135794140386946,0.0398781033589892,6.81593663732542e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FZD8,Frizzled-8,39586,0.0176156236593213,0.00443685122613368,0.00891939525609933,0.0263118520625434,7.22399981892394e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLB,Beta-klotho,41839,-0.0302951949651789,0.00763251692700239,-0.0452549281421036,-0.0153354617882542,7.24867507258732e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRG3,Proteoglycan 3,39966,-0.0202629173587445,0.00511108749318129,-0.0302806488453799,-0.0102451858721092,7.39996852408702e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RILPL2,RILP-like protein 2,39958,0.0403110386117726,0.0101699787431459,0.0203778802752066,0.0602441969483385,7.4239894070444e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0282791101219283,0.00713880313111602,0.0142870559849409,0.0422711642589157,7.50067042157952e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,0.00776198939450176,0.00196815823416032,0.00390439925554754,0.011619579533456,8.0607558422355e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEO1,Neogenin,39934,0.00916196824408806,0.00232515391811195,0.00460466656458863,0.0137192699235875,8.1843999890545e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,0.0337314666876359,0.00856620212027872,0.0169417105318896,0.0505212228433822,8.26628395284067e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL26,C-C motif chemokine 26,42119,0.0361005081128351,0.00918569935709515,0.0180965373729286,0.0541044788527416,8.53414280971506e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCP1,Plastin-2,39966,0.0193307098639242,0.00492017976727276,0.00968715752006961,0.0289742622077788,8.58536909976063e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0233826621134372,0.00595370642370569,0.0117133975229741,0.0350519267039004,8.63016713948169e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP9,Caspase-9,39657,0.025809913947282,0.00657744024341003,0.0129181310701983,0.0387016968243656,8.76159524022134e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTP1,Glutathione S-transferase P,41759,-0.0279657629297285,0.00714153174496055,-0.0419631651498511,-0.0139683607096058,9.05095728365215e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PODXL2,Podocalyxin-like protein 2,42181,0.011435281816526,0.00292102120966993,0.00571008024557293,0.0171604833874791,9.09123368068556e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.0434303314310075,0.0111062456079325,0.0216620900394597,0.0651985728225553,9.26651123082746e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JCHAIN,Immunoglobulin J chain,41913,0.024502454728636,0.00627341081597015,0.0122065695293345,0.0367983399279375,9.43925515786601e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP8,Caspase-8,42224,0.0244038310268753,0.00625147397164766,0.0121509420424459,0.0366567200113047,9.5192516198074e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TF,Serotransferrin,39979,0.00856929585296197,0.00220068362181799,0.00425595595419871,0.0128826357517252,9.9199016316295e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRGN,Neurogranin,39990,0.0370418350378618,0.00951382771498406,0.0183947327164931,0.0556889373592306,9.93829554666879e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.0474494036596834,0.0122061681433138,0.0235253140987884,0.0713734932205785,0.00010183547356643
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0294279058910606,0.0075738510084006,0.0145831579145954,0.0442726538675257,0.000102732503235912
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD84,SLAM family member 5,42119,0.0126637571267452,0.00325981407082388,0.00627452154793039,0.01905299270556,0.000102898183035191
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP7,Dipeptidyl peptidase 2,42054,0.0250124256425608,0.00643855137416669,0.0123928649491941,0.0376319863359275,0.000102908482822012
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BDNF,Brain-derived neurotrophic factor,39966,0.033481556073623,0.00862721633427377,0.0165722120584464,0.0503909000887996,0.000104648949257204
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSMB,Beta-microseminoprotein,42103,0.0276139947971712,0.0071357431833301,0.0136279381578442,0.0416000514364982,0.000109430851088567
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCT,Secretin,39649,0.0191019265748535,0.00495375766432719,0.00939256155277217,0.0288112915969348,0.00011588854931864
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.0334978169985514,0.00870493671995648,0.0164361410274367,0.0505594929696661,0.000119671136338857
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.0158091559702776,0.00410990908479529,0.00775373416407885,0.0238645777764764,0.000120443737826534
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOC,Brother of CDO,41900,-0.00915111113064815,0.00237961454596232,-0.0138151556407343,-0.00448706662056201,0.000120804961770498
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB2A2,Mammaglobin-A,39575,-0.0122918382559031,0.00320252390906197,-0.0185687851176645,-0.00601489139414161,0.000124649033499602
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAP,Cartilage-associated protein,39649,0.0194751363602783,0.0050750322363757,0.00952807317698194,0.0294221995435747,0.00012501551723476
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,0.0268088787561826,0.00700784464871289,0.0130735032447054,0.0405442542676599,0.000131061287705407
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0223475960130787,0.00584389681522472,0.0108935582552382,0.0338016337709191,0.000131982481360869
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMM2,Phosphomannomutase 2,39575,0.0235938705800201,0.00617248587090526,0.0114957982730458,0.0356919428869944,0.000132875162197969
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.0131880886904624,0.00345831183474172,0.00640979749436866,0.0199663798865562,0.00013765259791552
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,0.0131244512277552,0.0034510291936461,0.00636043400820881,0.0198884684473015,0.000143671452015818
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHCY,Adenosylhomocysteinase,42145,0.0261409471895448,0.00688634887620369,0.0126437033921856,0.039638190986904,0.000147658812523212
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.00930877664458377,0.00245376503363233,0.00449939717866439,0.0141181561105031,0.0001490921504465
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FMR1,Synaptic functional regulator FMR1,41843,0.0140464726729482,0.00370502506048922,0.00678462355438933,0.0213083217915071,0.000150589420230413
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL7,Interleukin-7,42119,0.0250308800267185,0.00660640789481646,0.0120823205528782,0.0379794395005587,0.000151984861433901
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,0.0580518418305882,0.0153474217577366,0.0279708951854244,0.088132788475752,0.000155921208239308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCN1,Transcobalamin-1,39806,0.0138507140014904,0.00366810268887274,0.00666123273129983,0.021040195271681,0.000160197680561508
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.0188096351957534,0.00498346183758741,0.00904204999408209,0.0285772203974247,0.000161068437389521
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNL1,Thioredoxin-like protein 1,39570,0.0393836570840888,0.01048135502894,0.0188402012273665,0.0599271129408112,0.00017251081063832
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,-0.0189686430925796,0.00505364987958289,-0.0288737968565621,-0.00906348932859717,0.000175302851483324
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRNN,Cornulin,41749,-0.0258421755575477,0.0068872511453289,-0.0393411878023924,-0.0123431633127031,0.000176060126832699
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDI2,Protein DDI1 homolog 2,39736,0.0289109094528134,0.00770611934324812,0.013806915540047,0.0440149033655797,0.000176543420313155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,0.0131149309668523,0.00350552092828987,0.00624410994740413,0.0199857519863004,0.000183887822377742
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLPS,Colipase,42115,0.0281571927780203,0.00753446224592333,0.0133896467760106,0.0429247387800301,0.000186906469814662
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.0214304889046585,0.00573667059996054,0.0101866145287358,0.0326743632805811,0.00018797424339429
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.0309619537180222,0.00832923934133989,0.014636644608996,0.0472872628270484,0.000202389445387922
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX18,Sorting nexin-18,39930,0.0167128374789513,0.00450083714500808,0.0078911966747355,0.0255344782831672,0.00020557745425353
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PADI2,Protein-arginine deiminase type-2,41913,0.0216669850586597,0.00583676833553846,0.0102269191210043,0.033107050996315,0.000206340483528566
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.0138476946844008,0.00373874156566816,0.00651976121569121,0.0211756281531104,0.000213395604654569
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FADD,FAS-associated death domain protein,42145,0.0288983419661486,0.00781236787210148,0.0135861009368297,0.0442105829954675,0.000217263460305913
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,0.0136244491696633,0.00369660782240673,0.00637909783774608,0.0208698005015805,0.000229013756519953
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA1,Annexin A1,39699,0.0168199828132297,0.00457038628218904,0.00786202570013917,0.0257779399263202,0.000234145232484914
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,0.0153611597073603,0.00417420849655431,0.00717971105411386,0.0235426083606068,0.000234299827048082
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,0.0223992723286027,0.00608744466070538,0.0104678807936202,0.0343306638635853,0.00023473156649475
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0200127594185997,0.00544586993349293,0.00933885434895354,0.0306866644882458,0.000238911761488356
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.0138840520043777,0.00378280948438497,0.0064697454149832,0.0212983585937723,0.000243396283236325
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0171454524208296,0.0046741986940894,0.00798402298041439,0.0263068818612449,0.000245478021768339
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0390486240281558,0.0107033982322453,0.018069963492955,0.0600272845633566,0.000265222659592016
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBN2,Fibrillin-2,39649,0.0224836647760626,0.00618118081159672,0.0103685503853331,0.0345987791667922,0.000276616597136176
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOSB,Protein fosB,41839,0.0142945773502369,0.00393042199062262,0.00659095024861659,0.0219982044518572,0.000276979603664526
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO2,Gamma-enolase,42249,0.0241840144806094,0.00665636145367077,0.0111375460314146,0.0372304829298041,0.000280934776797641
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD6,Programmed cell death protein 6,42145,-0.0262174075072087,0.00722654375091352,-0.0403814332589992,-0.0120533817554182,0.000286751117032017
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,0.0125936302730573,0.00347305424212352,0.00578644395849522,0.0194008165876194,0.000289033726156079
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.0141983555048464,0.00392035513776292,0.00651445943483108,0.0218822515748617,0.000293981864298651
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1F,Protein phosphatase 1F,39958,0.0198217687474782,0.00549024846554561,0.00906088175500885,0.0305826557399476,0.000307090046415838
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.0260024024009941,0.00720461319813007,0.0118813605326591,0.040123444269329,0.000308546957697429
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.0377734852140157,0.0104971119391044,0.0171991458133711,0.0583478246146603,0.000321502474212333
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,0.0238797897087564,0.00664254008830846,0.0108604111356718,0.0368991682818409,0.000325830512523584
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.0106829360767106,0.00297834453446932,0.00484538078915074,0.0165204913642705,0.000336081642215482
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCP2,Non-specific lipid-transfer protein,41843,0.0272857521552183,0.00761192480490918,0.0123663795375963,0.0422051247728403,0.000338800859148577
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0236390356700931,0.00660694284810691,0.0106894276878035,0.0365886436523826,0.000347795754234721
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,-0.00566032155346071,0.00158282891444026,-0.00876266622576361,-0.0025579768811578,0.000350232551017667
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM3,Myomesin-3,39736,-0.0356518157970273,0.00997946367027032,-0.0552115645907572,-0.0160920670032975,0.000355057678294944
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANSC1,MANSC domain-containing protein 1,42181,0.0100564163927986,0.00284158485202191,0.00448691008283563,0.0156259227027615,0.000402962301089908
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTF4,Neurotrophin-4,41843,0.0137223666645325,0.00388351341664021,0.00611068036791773,0.0213340529611474,0.00041150439435828
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,0.0176984282956555,0.00501098673374866,0.00787689429750814,0.0275199622938029,0.000413950188662378
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,0.0500737932486404,0.0142414895461199,0.0221604737382454,0.0779871127590353,0.000439725104593641
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARTN,Artemin,41913,0.0162678376732319,0.00462748051804775,0.00719797585785833,0.0253376994886055,0.000440411178573439
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MKI67,Proliferation marker protein Ki-67,39657,0.0147092943681143,0.00419218298998089,0.00649261570775175,0.0229259730284768,0.000452018862837481
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC2,Mucin-2,39966,0.0334030726824568,0.00953032502357117,0.0147236356362573,0.0520825097286563,0.000458495316588805
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTC,Probetacellulin,41843,0.0262241712128487,0.00752242690693188,0.0114802144752623,0.0409681279504352,0.000491647034915933
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PZP,Pregnancy zone protein,39979,0.0118802517615221,0.00340789176492401,0.005200783902271,0.0185597196207731,0.000491965542797288
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.0165192061365316,0.00474885400455117,0.00721145228761125,0.0258269599854519,0.000506057550679396
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0255383125060676,0.00735097762399238,0.0111303963630425,0.0399462286490926,0.000514463607770032
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN2,Dynactin subunit 2,42070,0.0337360639273868,0.00971508625824628,0.014694494861224,0.0527776329935495,0.000517168695424322
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELENOP,Selenoprotein P,39979,-0.00804703783638585,0.00232199939137571,-0.0125981566434822,-0.00349591902928947,0.000531071787699498
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1,Integrin beta-1,42167,-0.00747653951851828,0.0021577888937984,-0.0117058057503631,-0.00324727328667342,0.000532052644164947
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA4,Apolipoprotein A-IV,39979,0.0122403982707992,0.00353277772436703,0.00531615393103987,0.0191646426105586,0.00053256457583001
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.0185319254180535,0.00534970697414012,0.00804649974873887,0.0290173510873681,0.000533976122265924
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,0.0275374680892805,0.00795987581724138,0.0119361114874874,0.0431388246910736,0.000543153299545653
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0524893595409214,0.0151990924440041,0.0226991383506734,0.0822795807311694,0.000555189081124515
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.0142190892554161,0.00411789615622422,0.00614801278921664,0.0222901657216156,0.000556125073434423
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.0350859270176463,0.0101617971980144,0.0151688045095382,0.0550030495257545,0.000556645979587696
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.01567955688815,0.00454852426344411,0.00676444933179951,0.0245946644445004,0.000568594158035596
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0122593818681454,0.00356316843236523,0.00527557174070957,0.0192431919955813,0.000582554223044523
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.017439569048441,0.00507211112785719,0.00749823123784092,0.0273809068590411,0.000587428184565917
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0133567846265763,0.0038862339255557,0.00573976613248713,0.0209738031206655,0.000590421192066623
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRZB,Secreted frizzled-related protein 3,41973,0.0086569263600826,0.00252435798000315,0.00370918471927642,0.0136046680008888,0.00060683719269653
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.019637550706153,0.00575197394679587,0.0083636817704331,0.0309114196418729,0.000642280802003547
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POMC,Pro-opiomelanocortin,39638,0.0256144048012049,0.00756420488367736,0.0107885632291973,0.0404402463732126,0.000710979857457188
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0218253760160788,0.00647437361817957,0.00913560372444685,0.0345151483077108,0.000751342888815553
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,-0.00921923346968626,0.00273985536605825,-0.0145893499871604,-0.0038491169522121,0.000767958926157356
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0113787556126963,0.00338948381037053,-0.0180221438810225,-0.00473536734437003,0.000790297713041827
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.0214622706771298,0.00639909958700513,0.00892003548659969,0.0340045058676598,0.000798928564316014
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPMT,Thiopurine S-methyltransferase,41843,0.0245982546839207,0.00733567727036816,0.0102203272339991,0.0389761821338423,0.000800965446910726
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX1B,Syntaxin-1B,39649,0.0138358472489219,0.00413165226030485,0.00573780881872443,0.0219338856791194,0.000814500711973518
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,0.0122312990714695,0.00366011949073767,0.00505746486962362,0.0194051332733153,0.000835138250200094
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIP1,Huntingtin-interacting protein 1,39575,0.0113245994139802,0.00338897962359186,0.00468219935174012,0.0179669994762202,0.000835764898202251
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP6,Platelet glycoprotein VI,42115,0.0300655219802405,0.00899963862957759,0.0124262302662684,0.0477048136942125,0.00083779436949031
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD2,Sushi domain-containing protein 2,42137,-0.00963828580109169,0.00289794202461037,-0.015318252169328,-0.00395831943285537,0.000883657446908697
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOP56,Nucleolar protein 56,39575,0.0383220347191326,0.0115227913557025,0.0157373636619557,0.0609067057763094,0.00088467240027453
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,0.0145165222405797,0.0043777608829048,0.00593611091008634,0.0230969335710731,0.000916221309519082
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA4,Carboxypeptidase A4,39518,0.0150197131017647,0.00453024473915657,0.00614043341301785,0.0238989927905116,0.000918003108456152
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPS10,40S ribosomal protein S10,39575,-0.0141150623569887,0.00429509929347221,-0.0225334569721942,-0.00569666774178319,0.00101824967841047
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH5,Cadherin-5,42310,-0.0102064812395235,0.00310746694168178,-0.0162971164452198,-0.0041158460338272,0.00102418943556409
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00702800505802019,0.00214168252350578,-0.0112257028040915,-0.00283030731194887,0.0010356625208219
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CORO1A,Coronin-1A,41883,0.0297363390358098,0.00907864944099116,0.0119421861314672,0.0475304919401525,0.0010577734957597
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1R,Complement C1r subcomponent,39979,0.00627474526647577,0.00193103732769086,0.00248991210420168,0.0100595784287499,0.0011597766237462
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPA33,Cell surface A33 antigen,42070,0.0444859560902432,0.0136958320880824,0.0176421251976016,0.0713297869828848,0.00116447303126176
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.0104148009910954,0.00322197993281565,-0.0167298816594141,-0.00409972032277673,0.00123107805714283
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA4C,Semaphorin-4C,42070,0.00921626966263007,0.00285178895538294,0.00362676331007951,0.0148057760151806,0.00123330279732396
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSD1,Tryptase delta,39934,0.0121558192647462,0.00376439056372728,0.00477761375984076,0.0195340247696517,0.00124508103617337
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0254160978442603,0.00788442449242523,0.00996262583910683,0.0408695698494137,0.00126965497904316
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLN4,Cerebellin-4,42262,0.0104275182818622,0.00324704393120928,0.00406331217669206,0.0167917243870324,0.00132401232906704
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTB,Lymphotoxin-beta,39919,0.0113082314936027,0.00353998932516173,0.00436985241628571,0.0182466105709197,0.00140493549658244
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB2B,Ras-related protein Rab-2B,39919,0.0204885688994225,0.00641674159484335,0.00791175537352957,0.0330653824253155,0.00141194851099916
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,0.0343545731894343,0.0107795148349628,0.0132267241129072,0.0554824222659613,0.00144144700411978
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN1,Contactin-1,42310,-0.00869888544021175,0.00273206619081095,-0.0140537351742012,-0.00334403570622229,0.00145582165617719
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.0127324006184825,0.00400534457877579,0.00488192524408194,0.0205828759928831,0.00148199340707817
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F13B,Coagulation factor XIII B chain,39925,0.00836539074193282,0.00263171978193893,0.00320721996933251,0.0135235615145331,0.0014834612595486
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMB,Granzyme B,42119,0.0220595130295256,0.00694088103450387,0.00845538620189798,0.0356636398571532,0.00148525830709169
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.0354016379132623,0.0111589141118346,0.0135301662540664,0.0572731095724581,0.00151555685404886
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.0157693079481241,0.00497353473100188,0.00602117987536039,0.0255174360208878,0.00152506991967122
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0100681419945941,0.00318612623771785,0.00382333456866714,0.0163129494205211,0.00158186083214575
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,0.013842284922653,0.00438171716251675,0.00525411928412022,0.0224304505611859,0.0015868311402932
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,0.00796814300206036,0.00253197650560034,0.0030054690510837,0.012930816953037,0.00165379532794302
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM171B,Protein FAM171B,39919,0.00858779681567006,0.00273190973459635,0.00323325373586122,0.0139423398954789,0.0016736360552623
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,0.0155829691213658,0.00496173073302018,0.00585797688464625,0.0253079613580854,0.00169031062943646
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.0257081713023753,0.00819029496780574,-0.0417611494392745,-0.00965519316547605,0.00169971839709323
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,-0.00829330760552227,0.00264360573659344,-0.0134747748492454,-0.00311184036179913,0.00171053352595007
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.00751168590577756,0.00239588462084297,-0.0122076197626298,-0.00281575204892534,0.00172076581076759
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACRV1,Acrosomal protein SP-10,39657,0.0343223908354831,0.0109494569052593,0.0128614553011749,0.0557833263697912,0.00172526985630139
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.0120730621146263,0.00386596100241972,0.00449577854988361,0.0196503456793689,0.00179534296349075
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB7,Integrin beta-7,42262,0.0147338394364565,0.00472000204204131,0.0054826354340555,0.0239850434388575,0.00180261719495295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCN,Decorin,41900,0.00734168028671048,0.00235490393183449,0.00272606858031487,0.0119572919931061,0.00182710523288057
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.011910216158623,0.00382343741169458,-0.0194041534855444,-0.00441627883170165,0.00184384778993554
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,-0.00553477487653546,0.0017811132545794,-0.00902575685551109,-0.00204379289755983,0.00189081068777614
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0214525004340928,0.00691876275317147,0.00789172543787673,0.0350132754303089,0.0019350493963126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0150417826519922,0.00486522568300973,0.00550594031329316,0.0245776249906913,0.00199432131432599
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COPB2,Coatomer subunit beta',39575,0.013682577964517,0.00442680015246381,0.00500604966568791,0.022359106263346,0.00200083776709193
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,0.02222310576791,0.00723774697529918,0.00803712169632364,0.0364090898394964,0.00214262233939093
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0201499962303068,0.00657592365576542,0.00726118586500659,0.033038806595607,0.00218769049436149
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGT,Angiotensinogen,39990,0.00685649426380448,0.00224214771993192,0.00246188473273792,0.011251103794871,0.00223334349085113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK7,Kallikrein-7,39475,0.0124713444776069,0.00408060128621396,0.00447336595662753,0.0204693229985862,0.00224666519983341
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.0156061847024673,0.00511661229708292,0.00557762460018477,0.0256347448047498,0.00229305934040937
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,0.0756079914777723,0.0247983569482894,0.0270032118591252,0.124212771096419,0.00230202163784388
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,-0.00825382592434887,0.00271487248189961,-0.0135749759888721,-0.00293267585982563,0.00236848221086009
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C4BPB,C4b-binding protein beta chain,42181,0.0118505736630981,0.00390612747610478,0.00419456380993268,0.0195065835162634,0.00241917165601725
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.00817339117089375,0.00269875416045494,-0.0134629493253854,-0.00288383301640208,0.00246269306021261
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,-0.0124947475351497,0.00412904886385271,-0.020587683308301,-0.00440181176199844,0.00248318244187614
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APPL2,DCC-interacting protein 13-beta,39736,0.0351329658516929,0.0116223829548364,0.0123530952602136,0.0579128364431722,0.00250958410569211
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD3,Extracellular superoxide dismutase,39990,-0.0188869611847704,0.0062537787656704,-0.0311443675654844,-0.0066295548040564,0.00253261493223912
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHGA,Chromogranin-A,39966,0.0263748117817641,0.0087367028726679,0.00925087415133503,0.0434987494121932,0.00254297303030882
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,0.00414347945236906,0.00137572660921999,0.00144705529829789,0.00683990360644024,0.00260242785833006
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,0.0124807186927287,0.0041467795186873,0.0043530308361016,0.0206084065493558,0.00262057663227232
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,0.0149823532335644,0.00498913974489067,0.00520363933357866,0.0247610671335501,0.00267825128254504
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAU,Urokinase-type plasminogen activator,42137,0.00873810132990546,0.00291890918935693,0.00301703931876587,0.0144591633410451,0.00276188011362901
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MST1,Hepatocyte growth factor-like protein,39854,0.0206814893015551,0.00693809298227176,0.00708282705630244,0.0342801515468077,0.00288054168347541
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,0.0305418626096941,0.0102661304848223,0.0104202468594423,0.0506634783599459,0.0029361490606506
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,0.0169755353292107,0.00570616978637697,0.0057914425479118,0.0281596281105095,0.0029367582436981
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GC,Vitamin D-binding protein,39979,0.0078764576644858,0.0026523703700017,0.00267781173928246,0.0130751035896891,0.00298817648103759
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.0261720506117992,0.00881562737970217,0.00889342094758296,0.0434506802760155,0.0029958293812734
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,0.00733828566734014,0.00248665412428331,0.00246444358374485,0.0122121277509354,0.00317325391451856
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKAP12,A-kinase anchor protein 12,39736,-0.00645050291457481,0.00218723358868939,-0.010737480748406,-0.0021635250807436,0.00319300808067558
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,-0.0152457381835725,0.00517415866605999,-0.0253870891690501,-0.00510438719809491,0.00322030885976984
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMBN,Ameloblastin,41913,-0.00824534876807003,0.00280092086563445,-0.0137351536647135,-0.00275554387142651,0.00324770180799223
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.00837395415368064,0.00285253727533608,0.00278298109402192,0.0139649272133394,0.00333572614919442
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,0.0161388009643242,0.00550094410574206,0.00535695051706978,0.0269206514115787,0.00335389638648472
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.0115363658974961,0.00395323376018388,-0.0192847040674565,-0.00378802772753569,0.00352623165201298
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNW1,Interferon omega-1,39575,-0.0105698568109697,0.00363002254768825,-0.0176847010044387,-0.00345501261750077,0.00360089845087056
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NINJ1,Ninjurin-1,41843,0.0161571930518493,0.0055724955052847,0.00523510186149124,0.0270792842422073,0.00374427681249491
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,-0.00877856074083696,0.00303598482647012,-0.0147290910007184,-0.00282803048095553,0.00384011510615403
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC16,Mucin-16,42070,0.0563370199005283,0.0195519371927528,0.0180152230027329,0.0946588167983237,0.00396533678819935
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.0142950952840242,0.00497642230116551,0.00454130757373984,0.0240488829943086,0.00407935097290908
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,0.0223912564679695,0.00780512413534308,0.00709321316269704,0.0376892997732419,0.00412831502930703
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.00768229304680448,0.0026834139506359,-0.0129417843900509,-0.00242280170355811,0.00420605089837575
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,0.0262529657923896,0.00917680718780142,0.00826642370429887,0.0442395078804804,0.00423353760022536
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNB2,Ephrin-B2,39649,0.0170124723767881,0.00595342730719261,0.00534375485469063,0.0286811898988856,0.00427665003244295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK14,Kallikrein-14,42262,-0.0135282817006938,0.00473954068569441,-0.0228177814446548,-0.00423878195673276,0.00431906316811772
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEDD9,Enhancer of filamentation 1,39657,0.00991294022431049,0.00348823500314041,0.00307599961815528,0.0167498808304657,0.00449387228960794
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOX9,Transcription factor SOX-9,39649,0.00807761051247643,0.00284391724295478,0.00250353271628505,0.0136516883086678,0.00451518914182722
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100G,Protein S100-G,39934,-0.014282450236696,0.00503653093001914,-0.0241540508595335,-0.00441084961385846,0.00457961407837474
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_DRA,,42060,0.0105359444379645,0.00372716102126358,0.00323070883628791,0.0178411800396411,0.00470847859231449
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,0.0290233378353688,0.0103174051152416,0.00880122380949531,0.0492454518612424,0.00491591440414355
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0207254199461942,0.00737158392977625,0.00627711544383279,0.0351737244485557,0.00493783197325326
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,0.0116588106761036,0.00414857072034931,0.00352761206421892,0.0197900092879882,0.00495641026132699
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCG3,Secretogranin-3,42144,0.00955884148764044,0.00340420693635607,0.00288659589238255,0.0162310870828983,0.00499293470461837
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMOX1,Heme oxygenase 1,42007,-0.0141305243063377,0.00504354324613687,-0.024015869068766,-0.00424517954390942,0.00509060761219863
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,-0.0110031806220058,0.00393884377461656,-0.0187233144202543,-0.00328304682375734,0.0052214480762489
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.010907621050799,0.00390627464413713,0.00325132274829019,0.0185639193533077,0.00524057313197627
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,-0.0124125899097996,0.00447181020965289,-0.0211773379207193,-0.00364784189887996,0.00551512923853784
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,-0.00925724317595919,0.00334991278618164,-0.0158230722368752,-0.00269141411504318,0.00572745090912404
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRDT,Bromodomain testis-specific protein,39575,0.010398472329657,0.00376391232153599,0.00302120417944645,0.0177757404798675,0.00574249916358706
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0161134092131912,0.00583547499909067,0.00467587821497351,0.0275509402114089,0.00576537094686021
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.0103088221060415,0.00374226794561149,0.00297397693264297,0.01764366727944,0.00588422092556012
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL28,C-C motif chemokine 28,42075,0.0165976159727668,0.00602946988272654,0.00477985500262281,0.0284153769429108,0.00591763196458234
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,0.0131427120394045,0.00477694859990711,0.00377989278358661,0.0225055312952225,0.00594439901005966
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRR4,Proline-rich protein 4,39652,0.0200764474570679,0.00731370661299714,0.00574158249559353,0.0344113124185423,0.00606005073365292
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.0112614839863966,0.00411221454327382,-0.0193214244912133,-0.00320154348157992,0.00618107209867885
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.0117719875244383,0.00431729236810343,-0.020233880565921,-0.00331009448295559,0.00640683622374416
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,0.0330287958959363,0.0121392881372364,0.00923579114695291,0.0568218006449197,0.00652199398986333
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.0160134328412606,0.00589827444304395,-0.0275740507496268,-0.0044528149328945,0.00663923978730972
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,0.00959369575356764,0.00354137262663724,0.00265260540535865,0.0165347861017766,0.00675659918293111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,0.0275761362097536,0.0101842392958103,0.0076150271899653,0.0475372452295418,0.00678474336282382
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,0.00981092201976952,0.00362611227945809,0.00270374195203166,0.0169181020875074,0.00682601055549684
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDSN,Corneodesmosin,42246,0.0120905548673367,0.00448363301936371,0.0033026341493838,0.0208784755852895,0.00701378043682417
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,0.0112734681598037,0.00419641202171326,0.00304850059724572,0.0194984357223617,0.00723198656891174
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGF,Beta-nerve growth factor,42016,-0.00334018241113153,0.00124540077186359,-0.00578116792398417,-0.000899196898278898,0.00732699782176323
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,0.040381519825192,0.0150985132109449,0.01078843393174,0.0699746057186439,0.00749437466660702
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRH,Corticoliberin,41830,-0.023330918351527,0.00879137905316581,-0.040562021295732,-0.00609981540732204,0.00796765621228581
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,0.0153219881455697,0.00581470131364997,0.00392517357081578,0.0267188027203237,0.00842502948991245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.0234223954276131,0.00890258762977433,0.00597332367325538,0.0408714671819707,0.00852609281963236
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.013695366977388,0.00522995239470732,0.00344466028376165,0.0239460736710143,0.00884021524084091
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PI16,Peptidase inhibitor 16,39990,-0.00650386508455624,0.00248615823926332,-0.0113767352335123,-0.00163099493560014,0.00890760558951582
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP10,Bone morphogenetic protein 10,39736,-0.00759098814299969,0.0029099580676731,-0.013294505955639,-0.00188747033036042,0.00910283604325679
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GKN1,Gastrokine-1,41538,0.00756679778689545,0.00290144291060249,0.00187996968211456,0.0132536258916763,0.0091192753212991
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,0.0236047611107354,0.00906312259929217,0.00584104081612279,0.0413684814053481,0.00921359338297926
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPB41L5,Band 4.1-like protein 5,39649,0.0166591193776564,0.00640015920611531,0.00411480733367038,0.0292034314216424,0.00925562952227001
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.0123337662305987,0.00474905821800038,0.00302561212331794,0.0216419203378794,0.00941369244468998
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.00731626013444131,0.00282556565164302,0.00177815145722099,0.0128543688116616,0.00962715871701837
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.0113721638740563,0.00439190419768944,-0.0199802961015276,-0.00276403164658497,0.00962850977044315
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.0134565317652299,0.00519776951002582,0.0032689035255793,0.0236441600048805,0.0096407820822194
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0174936978068075,0.00676127738403786,0.00424159413409327,0.0307458014795217,0.0096823202321835
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.0184350739475511,0.00713361945670801,0.0044531798124034,0.0324169680826988,0.00977161708319868
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.0148115598265572,0.00575711703102161,0.00352761044575487,0.0260955092073596,0.0101004677871994
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RYR1,Ryanodine receptor 1,39575,-0.00893153218797161,0.00347359836960974,-0.0157397849924067,-0.00212327938353652,0.0101459060699012
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.0204004539294009,0.00793852600760528,0.0048409429544946,0.0359599649043073,0.0101886034582512
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBX2,Chromobox protein homolog 2,39575,-0.0104000882114647,0.00406120977245492,-0.0183600593654763,-0.00244011705745302,0.0104553468988278
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASN,Vasorin,41975,-0.00718873154437562,0.00280934436073041,-0.0126950464914072,-0.00168241659734401,0.0105123736741374
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,-0.00694485453577775,0.00271753719198888,-0.012271227432076,-0.00161848163947955,0.0106147839937705
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA13,Carbonic anhydrase 13,41967,0.0276059381322331,0.010810717031085,0.00641693275130657,0.0487949435131597,0.0106734404648812
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.0179104870834837,0.00701630455750363,0.0041585301507766,0.0316624440161908,0.0107004194811736
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,-0.011612486401953,0.0045629717397459,-0.020555911011855,-0.00266906179205107,0.0109406871699876
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0062572111455219,0.00246160633782735,0.00143246272338029,0.0110819595676635,0.0110355291877466
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAND5,DAN domain family member 5,39657,-0.014315617693571,0.00563438342390334,-0.0253590092044215,-0.00327222618272045,0.0110747243613873
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL14,C-X-C motif chemokine 14,41913,0.0148300440024687,0.00585329146700581,0.00335759272713733,0.0263024952778001,0.0113003285063281
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYTL1,Cytokine-like protein 1,39966,0.00664460858429529,0.00262315300115996,0.00150322870202177,0.0117859884665688,0.0113204349542675
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.0149304042121502,0.00592204473518782,-0.0265376118931183,-0.00332319653118208,0.01171100010635
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRING1,SREBP regulating gene protein,39560,0.0160299433257143,0.00638817225954012,0.00350912569701563,0.0285507609544129,0.012110826127172
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNC,Tenascin,42217,-0.0123690843517324,0.00494342652160942,-0.0220582003340868,-0.00267996836937789,0.0123565720658677
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,0.00842245921802296,0.0033747954335397,0.00180786016828515,0.0150370582677608,0.0125856380491423
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,0.00772984240606475,0.00309811633612156,0.0016575343872665,0.013802150424863,0.0126093173260996
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.0129222058443552,0.00519902656630308,-0.0231122979143092,-0.00273211377440115,0.0129513432392651
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEX101,Testis-expressed protein 101,39649,0.0157175363105432,0.00633915844115138,0.00329278576588655,0.0281422868551999,0.0131738409064573
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL6B,Myosin light chain 6B,39649,0.0232340130947229,0.00939175690621642,0.00482616955853868,0.0416418566309071,0.0133806356471065
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1A,Protein phosphatase 1A,41843,0.00795026577929249,0.00321621315979184,0.00164648798610048,0.0142540435724845,0.0134509174815
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYGD,Gamma-crystallin D,39929,0.0248698642220722,0.0100782852132856,0.00511642520403256,0.0446233032401119,0.0136142983393038
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,-0.0130262972277287,0.00528451770714965,-0.023383951933742,-0.0026686425217154,0.0137162806860255
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,0.0133424225478858,0.00541429638871894,0.00273040162599667,0.0239544434697749,0.0137432768832849
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLASP1,CLIP-associating protein 1,39560,0.0190521943024623,0.00773265305198165,0.00389619432057825,0.0342081942843463,0.0137601217737568
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,-0.0116962887957729,0.00476341733221995,-0.021032586766924,-0.00235999082462184,0.0140865914113283
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA7,Carbonic anhydrase 7,39757,-0.00847498036288907,0.00345987594473032,-0.0152563372145605,-0.00169362351121763,0.0143205725934647
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK3,Prostate-specific antigen,39966,-0.0287854898794625,0.011767085013518,-0.0518489765059578,-0.00572200325296718,0.0144492576718423
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCUN1D1,DCN1-like protein 1,39586,0.0190098962508582,0.0077711949974637,0.0037783540558293,0.034241438445887,0.0144526653303177
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RALB,Ras-related protein Ral-B,39657,0.00747352924648143,0.00305531845098107,0.00148510508255853,0.0134619534104043,0.0144576853287366
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN2,Contactin-2,42262,0.0110086894120794,0.00450385456205963,0.0021811344704425,0.0198362443537163,0.0145266407064649
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.0117444740274475,0.00481897832223608,-0.0211896715390302,-0.00229927651586476,0.014820176053781
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,0.0118917465120223,0.00489634475883799,0.00229491078469986,0.0214885822393448,0.0151662796203559
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00813245677311536,0.00335807185971697,0.0015506359280701,0.0147142776181606,0.0154614851338081
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OBP2B,Odorant-binding protein 2b,41979,-0.0141853925243873,0.00585886223359275,-0.0256687625022291,-0.00270202254654551,0.0154831939031478
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVI2B,Protein EVI2B,39560,-0.00995137607770066,0.00411206745207866,-0.0180110282837748,-0.00189172387162649,0.0155348692202885
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,0.0119887452743305,0.00495788980185039,0.00227128126270373,0.0217062092859573,0.0156168338506489
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMOD1,Leiomodin-1,39934,0.00863552704302411,0.00357232879332608,0.00163376260810499,0.0156372914779432,0.0156501586395734
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,-0.00787949414078099,0.00326357269509437,-0.014276096623166,-0.00148289165839602,0.0157784062075826
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.0155272886452769,0.00645076179871832,0.00288379551978896,0.0281707817707648,0.0160983730041229
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.0276805394956138,0.011524216008731,-0.0502680028727266,-0.00509307611850109,0.0163216444143688
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.0109391681201536,0.00456614851831483,0.00198951702425649,0.0198888192160506,0.0166047268050852
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB118,Beta-defensin 118,39586,0.0140718982562736,0.00587400001116245,0.00255885823439515,0.025584938278152,0.0166087100007206
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNR,Tenascin-R,42016,-0.0102291446381719,0.00428169864467613,-0.0186212739817372,-0.00183701529460671,0.0169062453988311
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,-0.0267410252132592,0.0112274768228022,-0.0487468797859514,-0.00473517064056691,0.0172443539650354
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA4,Annexin A4,42088,0.0175600516967693,0.00741921989296838,0.00301838070655124,0.0321017226869873,0.0179550851248506
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,-0.0136877103032822,0.00579514762791253,-0.0250461996539908,-0.00232922095257366,0.0181944111102116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.0211267427312486,0.00898211653885763,0.00352179431508763,0.0387316911474095,0.018685846919876
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THPO,Thrombopoietin,41900,-0.00938494161899565,0.00399078544924253,-0.017206881099511,-0.00156300213848029,0.0187047179748324
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,0.0254257724332584,0.0108625291929813,0.00413521521501507,0.0467163296515017,0.0192660273797069
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.0106238630829099,0.00454017638639036,0.0017251173655848,0.019522608800235,0.0193001366049124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53BP1,TP53-binding protein 1,39657,0.0207279940082984,0.0088599388806411,0.00336251380224184,0.038093474214355,0.0193262999424734
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NENF,Neudesin,39919,0.0269868484841791,0.0115667266845154,0.00431606418252886,0.0496576327858294,0.0196579695427832
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDNRB,Endothelin receptor type B,39657,0.0105063730244038,0.00451524563879601,0.00165649157236358,0.0193562544764439,0.0199903500077291
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX5,Syntaxin-5,39657,0.00952075513141994,0.00409833665477374,0.00148801528806342,0.0175534949747765,0.0201930190138502
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD99L2,CD99 antigen-like protein 2,42137,0.00581651777025323,0.00251365936223061,0.000889745420281239,0.0107432901202252,0.0206845844804567
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNLZ,DNL-type zinc finger protein,39586,-0.0199742627469409,0.00870646387566859,-0.0370389319432514,-0.00290959355063048,0.0217984934534969
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB2,Integrin beta-2,42079,0.00672213393871356,0.00294006565129377,0.000959605262177777,0.0124846626152493,0.022246945528298
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRAS,GTPase Hras,39750,0.0233271654965773,0.0102203814600531,0.0032952178348733,0.0433591131582813,0.0224835177220645
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,-0.00557768361815267,0.0024445017171026,-0.0103689069836738,-0.000786460252631575,0.0225209535621924
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.0117642768621227,0.0051902190436025,0.00159144753666181,0.0219371061875836,0.0234324307865787
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,0.0142743258076908,0.00634317401103059,0.00184170474607081,0.0267069468693107,0.024446840895112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG3,Desmoglein-3,42196,0.00804519103594592,0.00359226190800796,0.00100435769625033,0.0150860243756415,0.0251337026910524
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.00766574518314883,0.00342758077718655,-0.0143838035064345,-0.000947686859863197,0.0253397753852428
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL33,Interleukin-33,41913,0.00903282328076358,0.00403920421815866,0.0011159830131726,0.0169496635483546,0.0253494208568625
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,0.0106856666357168,0.0047802469172939,0.00131638267782071,0.0200549505936128,0.0254124680411283
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.00601839279123039,0.00269320176362542,0.000739717334524561,0.0112970682479362,0.0254590358844065
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA4,Carbonic anhydrase 4,42310,0.00553124862673147,0.00248218099588212,0.000666173874802519,0.0103963233786604,0.025871173511099
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,0.0105487992684167,0.00473711443615445,0.001264054973554,0.0198335435632794,0.0259744545530803
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTN,Titin,39575,0.0158037829645509,0.00712558669922321,0.00183763303407338,0.0297699328950284,0.02658258182049
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSTN,Osteocrin,39649,0.00918973446778326,0.00416448645408199,0.00102734101778255,0.017352127917784,0.0273561498416635
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR3,Folate receptor gamma,42132,0.0433117019292686,0.0196403591048695,0.00481659808372435,0.0818068057748128,0.0274540248983091
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0152937144870547,0.00693881259492285,0.00169364180100588,0.0288937871731035,0.0275385790526979
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.010128742567152,0.00460539244825425,0.00110217336857365,0.0191553117657303,0.02787563540038
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0160442594089568,0.0073122846398088,-0.0303763373029821,-0.00171218151493155,0.0282447627361955
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRK1,Protein BRICK1,41839,0.0101768160847332,0.00464258035010323,0.00107735859853085,0.0192762735709355,0.0283925028416252
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHD,SH2 domain-containing adapter protein D,39554,0.0185960853452392,0.00848730243605215,0.00196097257057697,0.0352311981199014,0.0284693239705709
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTF,Ciliary neurotrophic factor,39586,-0.00779129808338652,0.00356179325642563,-0.0147724128659808,-0.000810183300792274,0.0287295983252094
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPLX2,Complexin-2,39560,-0.00689917630785744,0.00315488693633185,-0.0130827547030679,-0.000715597912647017,0.0287765830716423
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00877993476916259,0.00401964665825495,-0.0166584422193423,-0.000901427318982892,0.0289646070982759
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,0.0127907164174922,0.00588335008549507,0.00125935024992186,0.0243220825850625,0.0297222751966153
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAD2,Glutamate decarboxylase 2,39657,-0.0101458461207034,0.00466802834111088,-0.0192951816692807,-0.000996510572126097,0.0297656845884393
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,-0.00670924710541041,0.00310152925751213,-0.0127882444501342,-0.000630249760686631,0.0305431608150507
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK15,Kallikrein-15,39900,0.0116865984338216,0.00541136258333261,0.00108032777048973,0.0222928690971535,0.0308214696293889
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.0186178246265883,0.00862089280545108,-0.0355147745252725,-0.00172087472790424,0.0308239391683278
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.0081391891702026,0.00379061145242871,0.000709590723442317,0.0155687876169629,0.0317956126286585
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,0.01438760395726,0.00671930788971029,0.0012177604934278,0.0275574474210921,0.0322733526608372
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHPK,Sedoheptulokinase,39757,0.00880848343016727,0.00412152520501657,0.000730294028334803,0.0168866728319997,0.0326042007107526
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.00556883480329922,0.00261514525257961,-0.0106945194983553,-0.000443150108243187,0.0332388350664022
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUK1,Guanylate kinase,39575,-0.00881825064492545,0.00414152908366094,-0.0169356476489009,-0.000700853640950006,0.0332577781511148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP4,Dipeptidyl peptidase 4,41948,-0.00603312878919095,0.00285811680841652,-0.0116350377336873,-0.000431219844694567,0.034801558997324
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERVV_1,,39575,-0.00943666852115324,0.00448417508423704,-0.0182256516862578,-0.000647685356048647,0.035362937154298
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.00509957037488231,0.00243244121237153,-0.00986715515113052,-0.00033198559863411,0.0360621170826508
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB5,Serpin B5,41900,0.0104258709678946,0.00498545427242036,0.000654380593950734,0.0201973613418386,0.036523870800288
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYB5A,Cytochrome b5,39560,0.0153144391369215,0.00732647244170038,0.000954553151188709,0.0296743251226542,0.0366149003622666
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,-0.00317784555432531,0.00152780114646941,-0.00617233580140535,-0.000183355307245273,0.0375467640263334
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEG1,Protein LEG1 homolog,39398,0.0150775650752315,0.00725346028072988,0.000860782925000907,0.029294347225462,0.0376710587120831
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.0127033377456317,0.00612358390410582,0.00070111329358429,0.0247055621976791,0.038056745182797
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD4,Sushi domain-containing protein 4,39919,0.00820394966623187,0.00396557315233292,0.000431426287659341,0.0159764730448044,0.0385881731113716
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.0119958915561485,0.00580355301244727,0.000620927651751906,0.0233708554605452,0.0387576674947886
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,0.00595433977119769,0.00288585530889481,0.000298063365763856,0.0116106161766315,0.0391083605125844
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.0109519788213926,0.0053164858516921,0.000531666552076034,0.0213722910907091,0.0394213579207263
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEPACAM2,HEPACAM family member 2,39929,-0.00924653938912324,0.00449125748383626,-0.0180494040574423,-0.000443674720804163,0.0395375250935571
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCND2,G1/S-specific cyclin-D2,39757,-0.00785824562370522,0.0038286640381117,-0.0153624271384041,-0.000354064109006291,0.0401465861270549
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGS10,Regulator of G-protein signaling 10,39934,0.0125825421727479,0.00613156582787036,0.000564673150122036,0.0246004111953738,0.0401835634766123
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0173408407516935,0.00845257957875929,0.00077378477732527,0.0339078967260617,0.0402374997615007
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BEX3,Protein BEX3,39560,-0.00984860108811169,0.00481400353465041,-0.0192840480160265,-0.000413154160196891,0.0407975662172035
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA6,Integrin alpha-6,42119,0.0106547186945381,0.00521163155300444,0.000439920850649395,0.0208695165384268,0.0409322568872905
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.0100678967463982,0.00492766882847159,0.000409665842593908,0.0197261276502025,0.0410628277449162
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL5,Interleukin-5,41913,0.0288615654966087,0.0141460583448365,0.00113529114072916,0.0565878398524883,0.0413446309766442
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.00679269584291614,0.00334229659663118,-0.0133435971723132,-0.000241794513519031,0.0421428659935329
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.00810463428847527,0.00398916901795831,0.000285863013276988,0.0159234055636735,0.0422121507069835
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CENPJ,Centromere protein J,39757,0.0146762475744637,0.00724576367862593,0.000474550764356877,0.0288779443845705,0.0428404681151536
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP9,Fatty acid-binding protein 9,42119,0.0116125895114629,0.00576892913152948,0.000305488413665142,0.0229196906092607,0.0441392455662165
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PODXL,Podocalyxin,42070,-0.00311936875950423,0.0015502770681166,-0.00615791181301276,-8.08257059957008e-05,0.0442254415937108
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.0107303029127765,0.00534062940765375,0.00026266927377519,0.0211979365517779,0.0445421807803142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REST,RE1-silencing transcription factor,39560,-0.00707299342867383,0.00352302465577099,-0.013978121753985,-0.000167865103362686,0.0447052087172816
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.0155007630735572,0.00773363834149823,0.000342831924220646,0.0306586942228937,0.0450550555641279
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH4,Myosin-4,39575,-0.00943610738008801,0.00471499662801886,-0.018677500771005,-0.000194713989171043,0.0453849968510838
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.00753864191143844,0.00377023124391736,0.000148988673360418,0.0149282951495165,0.0455721494305988
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,-0.00851844738379616,0.00426290383539666,-0.0168737389011736,-0.000163155866418702,0.0457116299418985
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,0.0188479158363025,0.00943903555554054,0.000347406147443045,0.037348425525162,0.0458708124238144
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA11,Serpin A11,42310,0.00851642914488593,0.004273940288716,0.000139506179002567,0.0168933521107693,0.0463205514789101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRG2,Bone marrow proteoglycan,39966,0.0104937673043225,0.00526995931023846,0.000164647056255164,0.0208228875523899,0.0464781229054103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,-0.0125051600590597,0.00629153937534901,-0.0248365772347437,-0.000173742883375618,0.0468741804296888
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,-0.008348886417922,0.00420154718610216,-0.0165839189026822,-0.00011385393316176,0.0469355911343736
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDM1,Nuclear protein MDM1,39649,0.00643349501246398,0.00323810036789368,8.68182913923675e-05,0.0127801717335356,0.0469679479096776
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLHL41,Kelch-like protein 41,39934,0.0107308299216285,0.00540133777852536,0.0001442078757188,0.0213174519675382,0.0469798515563746
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0081996318819027,0.00413457868491274,9.585765947372e-05,0.0163034061043317,0.0473717218001541
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP2BP,LRP2-binding protein,39649,0.01585036183048,0.00799787849554828,0.000174519979205347,0.0315262036817546,0.0475240426999384
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPTC,Opticin,42070,-0.00920134487594108,0.00464881193431794,-0.0183130162672042,-8.9673484677923e-05,0.0478037435998617
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVPL,Envoplakin,39757,-0.00678653409584037,0.00344334988158694,-0.0135354998637508,-3.75683279299748e-05,0.0487588042922187
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.016877199027556,0.0086182442639119,-1.45597297113546e-05,0.0337689577848233,0.0502189069321082
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFAP,Glial fibrillary acidic protein,41820,-0.00911929592426907,0.00467300050345453,-0.01827837691104,3.97850625018115e-05,0.05102032704153
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,0.0105631271589817,0.00542604072209447,-7.19126563234508e-05,0.0211981669742869,0.0515857625952282
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,-0.0174347837449138,0.00900320680139236,-0.0350810690756428,0.000211501585815208,0.0528309382252067
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPC1,Glypican-1,42262,0.00585345020764837,0.003024322904793,-7.42226857459154e-05,0.0117811231010426,0.0529547167249397
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,-0.00430461964029133,0.00222715111784214,-0.00866983583126193,6.05965506792743e-05,0.0532873877677694
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,0.00867854442910226,0.00449060212164811,-0.000123035729328024,0.0174801245875326,0.0533110405443318
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF5,Fibroblast growth factor 5,41913,0.00673666678045076,0.00349116767058228,-0.000106021853890513,0.013579355414792,0.0536737476525889
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00428528574600573,0.0022275998655425,-8.08099904575721e-05,0.00865138148246904,0.0544103696494296
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAD1,Glutamate decarboxylase 1,39560,-0.00520605828936208,0.00271044702965644,-0.0105185344674887,0.000106417888764534,0.0547906757166462
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,-0.00589555739341528,0.00307805644059495,-0.0119285480169814,0.000137433230150818,0.0554735678546557
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,0.0100942128374612,0.00527079830569379,-0.000236551841698572,0.0204249775166211,0.0555029526273813
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.00577757526846579,0.00303222095201487,-0.0117207283344149,0.000165577797483362,0.0567549691460435
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,0.00739747718116896,0.00388699156972163,-0.000221026295485435,0.0150159806578233,0.0570488556384573
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNPY2,Protein canopy homolog 2,41900,0.0118187110940585,0.00623505423228797,-0.000401995201225892,0.0240394173893429,0.0580443319063171
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,0.0102273530007785,0.00539796557819136,-0.000352659532476608,0.0208073655340335,0.058162271748562
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,0.0150962852199621,0.00797047589223477,-0.000525847528818065,0.0307184179687422,0.0582477082720834
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA6C,Semaphorin-6C,39657,0.00503248433037726,0.00265915598270518,-0.000179461395724886,0.0102444300564794,0.0584489061575046
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.00944399434035014,0.00499989314808537,-0.000355796229897185,0.0192437849105975,0.0589396902217211
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSLNL,Mesothelin-like protein,39649,-0.0073318627423627,0.00390319371224656,-0.014982122418366,0.000318396933640562,0.0603491442421659
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.0134589086162763,0.00717096382068292,-0.000596180472262228,0.0275139977048148,0.060558247114771
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CORO6,Coronin-6,39586,0.00755023729481142,0.00402494852035281,-0.00033866180508009,0.0154391363947029,0.0607010917623937
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,-0.00979212161023404,0.00522559222026967,-0.0200342823619626,0.000450039141494505,0.0609738092544084
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.00723363524068256,0.0038606343555533,-0.014800478577567,0.000333208096201907,0.060999573418467
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRX,Cone-rod homeobox protein,41900,0.0205256846190248,0.0110110996351455,-0.00105607066586024,0.0421074399039099,0.0623310323621431
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.00562627884657054,0.00304468024958902,-0.000341294442623933,0.011593852135765,0.0646428240312503
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSLP,Thymic stromal lymphopoietin,41900,0.011389821483889,0.00616647808495524,-0.000696475562623245,0.0234761185304013,0.0647614295436739
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRR1B,Cornifin-B,39757,0.0164040523425384,0.00890972904832291,-0.0010590165921745,0.0338671212772513,0.0656276800651678
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,0.00743811615968348,0.00405321637834817,-0.00050618794187893,0.0153824202612459,0.0665157723484574
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWF,von Willebrand factor,42310,0.0138960048347627,0.00757659208989134,-0.000954115661424351,0.0287461253309497,0.0666651756316814
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDC4,Syndecan-4,42145,-0.0088911874473863,0.00484960975854607,-0.0183964225741366,0.000614047679364,0.0667677081609915
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,0.00692053627553309,0.00377773902195129,-0.000483832207491441,0.0143249047585576,0.0669894316375679
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM1,Myomesin-1,39586,0.00922229776695733,0.00504818249563165,-0.000672139924480701,0.0191167354583954,0.0677486827222999
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.0177813968027084,0.00979543602118539,-0.00141765779881497,0.0369804514042318,0.0695091861124428
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYT1,Synaptotagmin-1,39929,0.00746876716191471,0.00411813970717841,-0.000602786664154977,0.0155403209879844,0.0697616997635245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,-0.0110975002124334,0.00613495795936391,-0.0231220178127867,0.000927017387919865,0.0704943496177608
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENSA,Alpha-endosulfine,39919,0.00986290255168565,0.00545573970802052,-0.000830347276034564,0.0205561523794059,0.0706637020432516
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,0.0186525362685785,0.0104137419930704,-0.00175839803783949,0.0390634705749965,0.0732973538601395
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPN1,Epsin-1,39757,0.00798746606653898,0.00446104569145491,-0.000756183488712639,0.0167311156217906,0.0734019753024936
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA2,Integrin alpha-2,39736,-0.00634292923688169,0.003563018791964,-0.0133264460691311,0.000640587595367758,0.0750685110173587
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEB,Nebulin,39575,0.00729027979057565,0.00409580095424212,-0.000737490079738899,0.0153180496608902,0.0751134479271072
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC4A1,Band 3 anion transport protein,39966,0.00869429519327864,0.00489467943788136,-0.000899276504968823,0.0182878668915261,0.0757143978411391
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3GL3,Endophilin-A3,39690,0.0155654115316413,0.00877970913392307,-0.0016428183708479,0.0327736414341305,0.0762752666069063
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL12,Stromal cell-derived factor 1,41913,0.00716372785665155,0.00404378763381402,-0.000762095905623925,0.015089551618927,0.0764939704240361
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB5,Integrin beta-5,42181,-0.00695924845375534,0.00393043847375166,-0.0146629078623086,0.000744410954797923,0.0766490730900037
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,0.00811690572891531,0.0046004635647618,-0.000900002858017826,0.0171338143158484,0.0776975830899351
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHIT1,Chitotriosidase-1,42207,0.0282025201132986,0.0160117585137469,-0.00318052657364525,0.0595855668002424,0.0781994273930667
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,0.0108673752291926,0.00618066954147594,-0.00124673707210029,0.0229814875304854,0.0787261424736143
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL36G,Interleukin-36 gamma,39624,0.0120999389075968,0.00692319444341297,-0.00146952220149266,0.0256694000166862,0.0805370228975581
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,0.0101060267274589,0.00578267927539284,-0.00122802465231111,0.0214400781072288,0.080554608166017
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLNS1A,Methylosome subunit pICln,39649,0.00602588822355445,0.00345750125779423,-0.000750814241722236,0.0128025906888311,0.0813885406472294
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.0133924566277317,0.00770360776994892,-0.00170661460136814,0.0284915278568316,0.0821568329951895
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HCG22,Protein PBMUCL2,39575,-0.0103857893319494,0.00597675390083391,-0.0221002269775839,0.00132864831368503,0.0822922085618909
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,0.00791871741764586,0.00456447352026001,-0.00102765068206376,0.0168650855173555,0.082788515951631
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,0.0152018892819904,0.00877866915761183,-0.00200430226692879,0.0324080808309096,0.0833529655740335
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPC5,Glypican-5,42016,0.00995771638084864,0.00575992383312769,-0.00133173433208164,0.0212471670937789,0.0838691436672926
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,0.0164977587093922,0.00957049399981154,-0.0022604095302384,0.0352559269490228,0.0847641435491096
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRXN3,Neurexin-3,39649,0.00636926532516765,0.00370176949517405,-0.000886202885373492,0.0136247335357088,0.0853513955037305
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.00537672553009026,0.0031342601919577,-0.0115198755063274,0.000766424446146834,0.0862875771422323
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,0.00609579304987168,0.00357077275010938,-0.0009029215403427,0.0130945076400861,0.0878242531016049
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.00812594671668645,0.0047655046640894,-0.0174663358583017,0.00121444242492877,0.0881873906073276
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00606334574758631,0.00355861074179952,-0.0130382228015134,0.000911531306340758,0.0884370351791638
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,0.00523503535247609,0.00307930871878366,-0.000800409736339881,0.0112704804412921,0.0891459905977483
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.0107956664302988,0.00638911653466299,-0.0233183348382382,0.00172700197764069,0.0911144488583381
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G1B,Phospholipase A2,42299,0.00766857779697216,0.00455811106189933,-0.00126531988435052,0.0166024754782948,0.0925135918843481
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,0.00829884902782571,0.00495796658102996,-0.00141876547099302,0.0180164635266444,0.0941849361686511
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.00778858275605341,0.0046536690981259,-0.00133260867627336,0.0169097741883802,0.0942287277766506
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENG,Endoglin,42310,0.00295807802531906,0.00176815622166306,-0.000507508169140535,0.00642366421977866,0.0943553811158877
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCLRE1C,Protein artemis,39560,-0.00523616189984063,0.00313339039457045,-0.0113776070731987,0.000905283273517455,0.0947334262666062
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCC,Netrin receptor DCC,39649,0.00384102787501473,0.00230120919940967,-0.000669342155828222,0.00835139790585767,0.0951190398515413
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MELTF,Melanotransferrin,39958,0.00516711604486639,0.00309641979233353,-0.000901866748107334,0.0112360988378401,0.0951967052736181
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,0.0186036049981721,0.0112006679049015,-0.00334970409543487,0.0405569140917791,0.0967546131383667
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,0.00547701352475128,0.00330215475217623,-0.000995209789514124,0.0119492368390167,0.0972159328463937
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,-0.0129031194969033,0.00778038367810069,-0.0281526715059806,0.00234643251217406,0.0972610630568895
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,0.0140011518616459,0.00848317718541714,-0.00262587542177165,0.0306281791450635,0.0988772986732095
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRP1,Neuropilin-1,42230,-0.00458157670882946,0.00279553443991743,-0.0100608242110676,0.000897670793408693,0.101259006857094
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PVALB,Parvalbumin alpha,42208,0.018716299781774,0.0114335284849226,-0.00369341604867427,0.0411260156122223,0.101660653513265
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR4,Toll-like receptor 4,39657,0.00477772033139027,0.00292526700851109,-0.000955803005291462,0.010511243668072,0.102442888564936
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF12,Fibroblast growth factor 12,39657,0.00762717502290304,0.00467166921880242,-0.0015292966459497,0.0167836466917558,0.102572262226714
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RELB,Transcription factor RelB,39657,0.00789127983268162,0.00483361698483283,-0.00158260945759073,0.017365169122954,0.1025852509222
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXK,Tyrosine-protein kinase TXK,39757,0.0123173112322574,0.00755138640998264,-0.00248340613130861,0.0271180285958233,0.102890604660348
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,-0.00439954493079774,0.00270516472082384,-0.00970166778361248,0.00090257792201699,0.103903907900047
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN2B,Sodium channel subunit beta-2,39649,-0.00471688497627371,0.00290371554742676,-0.0104081674492302,0.000974397496682744,0.104312421343435
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDAC9,Histone deacetylase 9,39586,0.0111519540504817,0.00687799603939204,-0.00232891818672674,0.0246328262876901,0.104961473143956
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOX2,Transcription factor SOX-2,39915,-0.00409162913526236,0.00252831066864754,-0.00904711804581153,0.000863859775286822,0.105620381958497
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP5,Platelet glycoprotein V,39736,0.00608611243141821,0.00376592052735238,-0.00129509180219245,0.0134673166650289,0.106100546324734
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD93,Complement component C1q receptor,41654,0.00520183343467417,0.00322930290624448,-0.00112760026156501,0.0115312671309133,0.10724261612359
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EP300,Histone acetyltransferase p300,39657,0.00509267223885952,0.00317283165179323,-0.00112607779865521,0.0113114222763742,0.108503120987419
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL25,Interleukin-25,39510,-0.00567146036597432,0.0035346634609999,-0.0125994007495341,0.00125648001758549,0.10862704398758
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNM1,Dynamin-1,39930,0.0190828454455061,0.0119134665771609,-0.00426754904572928,0.0424332399367414,0.109230419049699
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,-0.00884563551522489,0.00552509967318653,-0.0196748308746705,0.0019835598442207,0.109407233276155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,0.00944619873176363,0.0059097359877248,-0.00213688380417699,0.0210292812677042,0.109979923304655
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,0.0126768293829779,0.00794158840308947,-0.00288868388707742,0.0282423426530333,0.110459883098501
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,-0.00688876406443761,0.00432890291456978,-0.0153734137769944,0.00159588564811915,0.111561010154296
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRMD7,FERM domain-containing protein 7,39649,-0.00554908850646309,0.00349859580260141,-0.0124063362795619,0.00130815926663568,0.112747466693417
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCAN,Versican core protein,42249,0.00487808589641751,0.00307751413613747,-0.00115384181041193,0.0109100136032469,0.112972817526252
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGS8,Regulator of G-protein signaling 8,41913,-0.0103363858151239,0.00654386995849246,-0.0231623709337691,0.00248959930352131,0.114233153756153
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.0100710710551374,0.00637617249877487,-0.00242622704246132,0.0225683691527362,0.114253563665373
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CX3CL1,Fractalkine,42016,-0.00539329257922922,0.00341736477307238,-0.0120913275344511,0.00130474237599265,0.114542742964899
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,0.0127043882596691,0.00806522572829643,-0.00310345416779192,0.0285122306871301,0.115236918862784
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB39B,Ras-related protein Rab-39B,39575,0.014943227734674,0.00950124216592478,-0.00367920691053852,0.0335656623798866,0.115801907439449
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTN4,Alpha-actinin-4,41913,0.00507595497361723,0.00323061130940609,-0.00125604319281872,0.0114079531400532,0.11615863600175
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPK3A,Uroplakin-3a,39586,-0.00784639607690817,0.00499395770029369,-0.0176345531694838,0.00194176101566746,0.116170125219082
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLC,Galectin-10,42119,0.0108085875896763,0.0068809073740048,-0.00267799086337309,0.0242951660427257,0.116250546536441
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELL,L-selectin,39979,-0.00375500805184214,0.00239260592181727,-0.00844451565860399,0.000934499554919713,0.116577477070479
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRP2,Neuropilin-2,42137,0.00449860773425221,0.00287509092966811,-0.00113657048789728,0.0101337859564017,0.117680481762223
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDAN1,Codanin-1,39929,-0.00351489850034298,0.00224743832297675,-0.00791987761337742,0.000890080612691455,0.117855430302469
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG4,Desmoglein-4,42018,-0.00766924619693184,0.00490818937964146,-0.0172892973810291,0.00195080498716542,0.118184223267166
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0037572651428924,0.00240580067654775,-0.000958104183141186,0.00847263446892599,0.118369713435615
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSB,Lupus La protein,41839,0.0093741937943162,0.00601821823191011,-0.00242151394022763,0.02116990152886,0.119343446182193
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.00659566512780068,0.00423487390804896,-0.00170468773197528,0.0148960179875766,0.119388642440788
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOC,Myocilin,42137,0.00709050668517982,0.00457223401812592,-0.00187107199034698,0.0160520853607066,0.12097896575103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.00826029884707822,0.0053634371601034,-0.00225203798672445,0.0187726356808809,0.12355673144731
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPB2,Carboxypeptidase B2,39959,0.00355056466470186,0.00231000563394518,-0.00097704637783069,0.00807817570723441,0.124312045179226
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,0.00869847910605341,0.00566060863026235,-0.00239631380926079,0.0197932720213676,0.124403301209616
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00430939617352207,0.00282030053446463,-0.00983718522107275,0.00121839287402861,0.126542914696722
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00728571549407939,0.00477635780056405,-0.00207594579502614,0.0166473767831849,0.127189871329975
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD5,Sushi domain-containing protein 5,39695,-0.00538924548578223,0.00354384944730316,-0.0123351904024964,0.00155669943093196,0.128355585190184
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0192449315413755,0.0126985036917299,-0.00564413569441505,0.044133998777166,0.129662738805267
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RUVBL1,RuvB-like 1,41843,0.0153771238850723,0.0101537939026291,-0.00452431216408073,0.0352785599342253,0.129942832683904
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NME1,Nucleoside diphosphate kinase A,39657,-0.00342097386235153,0.00226084908477096,-0.00785223806850262,0.00101029034379956,0.130273504476816
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEBP1,Heme-binding protein 1,41900,-0.00805112299284226,0.00532619347043421,-0.0184904621948933,0.0023882162092088,0.130657071117047
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAPPA,Pappalysin-1,41913,-0.00730688156837311,0.00485796521888179,-0.0168284933973814,0.00221473026063519,0.132578489675146
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GH2,Growth hormone variant,41843,0.025006283421056,0.0166306048757509,-0.0075897021354157,0.0576022689775278,0.132700399644453
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF9,Fibroblast growth factor 9,39539,-0.00635821379954397,0.00424010770984747,-0.014668824910845,0.00195239731175706,0.133762293980329
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECE1,Endothelin-converting enzyme 1,41839,0.00541126346531961,0.00361071202910243,-0.00166573211172115,0.0124882590423604,0.133983273614751
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00827359313563854,0.00553093431745553,-0.0191142243978514,0.00256703812657429,0.134714638421708
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.0105732126284069,0.0071148535459587,-0.00337190032167217,0.0245183255784859,0.137287568872867
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF16,Fibroblast growth factor 16,39657,0.00711133266970085,0.0047921131444342,-0.00228120909339017,0.0165038744327919,0.137846461875858
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.00717056062736447,0.00485105024043761,-0.00233749784389324,0.0166786190986222,0.139396522102013
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,0.0061181315044153,0.00414849552261593,-0.00201291971991191,0.0142491827287425,0.140299523489777
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANSC4,MANSC domain-containing protein 4,39575,0.0103002339449506,0.00699395480124714,-0.00340791746549376,0.024008385355395,0.140851493238353
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARB1,Scavenger receptor class B member 1,41839,0.00828504462615211,0.00567927340782902,-0.00284633125319276,0.019416420505497,0.144638041222721
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FZD10,Frizzled-10,39649,0.00890575665952559,0.00614030807694517,-0.00312924717128694,0.0209407604903381,0.146982027923228
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.004473847822273,0.00308705761567911,-0.00157678510445805,0.0105244807490041,0.147297833415009
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP73,Tumor protein p73,39649,-0.00508230525213841,0.00352761483737641,-0.0119964303333962,0.00183181982911935,0.149692138180948
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.00528234012902431,0.00368946367235577,-0.0125136889268416,0.001949008668793,0.152247507005575
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHP1,Calcineurin B homologous protein 1,39586,0.0108788977898552,0.00760895060856725,-0.00403464540293659,0.025792440982647,0.15281719569372
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,-0.00368349749452209,0.00258286290449493,-0.00874590878733215,0.00137891379828796,0.153853954064124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTKN2,Rhotekin-2,39575,-0.0074641600493834,0.00524037900555291,-0.0177353029002671,0.0028069828015003,0.154372165120839
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.0105977891171977,0.00744235348613741,-0.025184801950027,0.00398922371563164,0.154478765988492
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD3,Bromodomain-containing protein 3,39575,0.00695243440045772,0.00488768919556712,-0.00262743642285383,0.0165323052237693,0.154927584604101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,0.00674288070173028,0.00474996481880655,-0.00256705034313057,0.0160528117465911,0.155758089209159
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,0.00825311735870764,0.00582504176680282,-0.00316396450422589,0.0196701992216412,0.156554502743989
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,-0.00814771689662751,0.00575936682858422,-0.0194360758806526,0.00314064208739756,0.157187838810894
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC44A4,Choline transporter-like protein 4,39649,-0.00998051017126894,0.00708317937744393,-0.0238635417510591,0.00390252140852116,0.158850351127354
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD2,Bromodomain-containing protein 2,39586,0.00507685187229307,0.00361151259814637,-0.0020017128200738,0.01215541656466,0.15982928290141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,-0.00696691858920124,0.00496190545320738,-0.0166922532774877,0.00275841609908523,0.160322980805851
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL3,Insulin-like 3,39929,-0.0129953124393632,0.00926075582353747,-0.0311463938534966,0.00515576897477028,0.160564660889916
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,0.00639689608129196,0.00456906337626154,-0.00255846813618066,0.0153522602987646,0.161527996118741
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPN3,Calpain-3,39919,-0.00561641627320074,0.00401536189889015,-0.0134865255950254,0.00225369304862395,0.161920681446677
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,0.00576854944604089,0.00414388390635511,-0.00235346301041512,0.0138905619024969,0.163931222290706
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFAP1,Actin filament-associated protein 1,39736,0.0119778072792123,0.00860503559346613,-0.00488806248398134,0.0288436770424059,0.163964352838557
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUCL3,Mucin-like protein 3,39560,-0.00609006889880969,0.00438611338186752,-0.01468685112727,0.00250671332965066,0.165016498773777
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCUN1D2,DCN1-like protein 2,39560,-0.0113999394052137,0.00821446265430994,-0.0275002862076612,0.00470040739723381,0.165229573317689
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN1,Nectin-1,39657,0.00470212559342504,0.00340090588009045,-0.00196364993155225,0.0113679011184023,0.166812484237179
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00561781252666801,0.00406378957050871,-0.0135828400848651,0.00234721503152906,0.166874794097684
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO4,Roundabout homolog 4,39638,0.00259501992903214,0.00187955335628688,-0.00108890464929015,0.00627894450735443,0.167412169613256
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.00529790528539616,0.00384240105936805,-0.00223320079096522,0.0128290113617575,0.167983903738806
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,0.00734167680666641,0.00533433408536237,-0.00311361800064384,0.0177969716139767,0.168755574226665
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC1A4,Neutral amino acid transporter A,39649,0.00719512561641529,0.00522984756895118,-0.00305537561872902,0.0174456268515596,0.168917291110073
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,0.00748360771440192,0.00546931364724197,-0.00323624703419234,0.0182034624629962,0.171248841734386
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLN1,Cerebellin-1,39586,-0.0130120663921698,0.00955188576440057,-0.0317337624903949,0.00570962970605531,0.173146598507577
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSPN,Claspin,41820,0.00493583668114742,0.00363139709923181,-0.00218170163334693,0.0120533749956418,0.174102765090068
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,0.00822143296253454,0.00606480793706571,-0.00366559059411425,0.0201084565191833,0.175255423526148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPH3,Neurexophilin-3,39657,0.00418045579967511,0.00309232146095973,-0.00188049426380596,0.0102414058631562,0.176440503949372
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.00506111674147964,0.00375030593891433,-0.0124117163817517,0.00228948289879245,0.17719750567764
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,0.00501900847073048,0.00372673350657791,-0.00228538920216221,0.0123234061436232,0.178081084601498
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,0.00617229524500549,0.00458687509987615,-0.00281797995075176,0.0151625704407627,0.178445526644162
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.00766576250781392,0.005701148226639,-0.0188400130320264,0.00350848801639852,0.178782310535952
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.00964429734513917,0.00717670278074748,-0.0044220401051259,0.0237106347954042,0.179024403865409
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,0.00565823755586556,0.00424950988824945,-0.00267080182510335,0.0139872769368345,0.183050869894936
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.00736292606528894,0.00553343329001434,-0.018208455313717,0.00348260318313916,0.183340085266312
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREML1,Trem-like transcript 1 protein,39990,-0.00726405949930611,0.00545954436638001,-0.0179647664574109,0.0034366474587987,0.183372038067417
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,-0.00737719607910304,0.00555441453156754,-0.0182638485609754,0.00350945640276934,0.184145476097792
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.0141682955896259,0.0106782430077007,-0.00676106070546756,0.0350976518847193,0.184589790232329
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.00939442796323244,0.00712186961775851,-0.00456443648757423,0.0233532924140391,0.187159616238595
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP1,DNA topoisomerase 1,39930,0.0163701094553172,0.0124187104994306,-0.00797056312356666,0.0407107820342011,0.187469679479737
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEP1B,Meprin A subunit beta,42145,-0.0154582833840452,0.0117430031150787,-0.0384745694895995,0.00755800272150909,0.188067979335436
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.00899186882629083,0.00683340649719863,-0.00440160790821849,0.0223853455608001,0.188240747946274
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,-0.00484165677057445,0.00367992163729902,-0.0120543031796805,0.00237098963853163,0.188303708344251
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL36A,Interleukin-36 alpha,39657,-0.00777787599772354,0.00591971971365657,-0.0193805266364904,0.00382477464104334,0.188909603868197
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,0.01027535975332,0.00782585885314849,-0.00506332359885102,0.025614043105491,0.189210068074291
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.00646367471572439,0.00494866535873501,-0.00323570938739624,0.016163058818845,0.191530165549671
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.00430326424845526,0.00329729418851528,-0.00215943236103468,0.0107659608579452,0.19188440314222
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSP90B1,Endoplasmin,41774,0.0084729917575874,0.0064941985477925,-0.00425563739608591,0.0212016209112607,0.192017239496912
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,-0.00356944404761172,0.00273649642985152,-0.00893297705012071,0.00179408895489727,0.192129890504563
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYO6,Unconventional myosin-VI,39934,0.00502656715009861,0.00385384829087429,-0.00252697550001499,0.0125801098002122,0.192158435528286
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,-0.00676694728209138,0.00520620356142682,-0.0169711062624879,0.00343721169830518,0.193697167594529
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBZ,Hemoglobin subunit zeta,39958,0.0143174587449645,0.0110550456693453,-0.00735043076695225,0.0359853482568813,0.195309902875605
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEX33,Testis-expressed protein 33,39757,-0.00511552947464288,0.00397747734016801,-0.0129113850613722,0.00268032611208642,0.19842644297263
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGR,Progesterone receptor,39657,0.0132750884930421,0.0103274080462901,-0.00696663127768647,0.0335168082637706,0.198671407916847
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,-0.00639999311853847,0.00497978001564872,-0.01616036194921,0.00336037571213302,0.198750975264352
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00645660402506522,0.00502575365326546,-0.00339387313533509,0.0163070811854655,0.19892297907826
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,-0.00808811101860686,0.0063233016561289,-0.0204817822646195,0.00430556022740578,0.200889408474295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,0.00407230489099207,0.00319068413818113,-0.00218143601984295,0.0103260458018271,0.201872451440866
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM25,RNA-binding protein 25,39560,-0.00611757594668295,0.00481938414284548,-0.0155635688666601,0.00332841697329418,0.204336506055155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,-0.00401375720254006,0.00316521717830931,-0.0102175828720263,0.00219006846694618,0.204790588088173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,-0.00595589834318679,0.00472669719101387,-0.015220224837574,0.0033084281512004,0.207671122347806
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,0.00794176045913192,0.00630818069671859,-0.00442227370643651,0.0203057946247004,0.208069963966559
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTOA,Otoancorin,39586,-0.00679962121156202,0.00541715527435973,-0.0174172455493071,0.00381800312618304,0.209432334099632
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAEP,Glycodelin,42016,0.0133935584781923,0.0107100778127163,-0.00759819403473158,0.0343853109911163,0.211118103725147
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,-0.00453022127521836,0.00362273677290458,-0.0116307853501113,0.00257034279967461,0.211140164056065
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCIN,Adseverin,39586,0.00945322835461814,0.00760724159213335,-0.00545696516596323,0.0243634218751995,0.214019017225788
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0146800747790902,0.0118610990793328,-0.00856767941640203,0.0379278289745824,0.215861892070612
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.00516918027507773,0.00420344623867696,-0.00306957435272912,0.0134079349028846,0.218817591921349
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,-0.00370329470228084,0.00301555036262771,-0.00961377341303115,0.00220718400846948,0.219443946398502
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SULT1A1,Sulfotransferase 1A1,42249,-0.016132647004834,0.0131474839482818,-0.0419017155434664,0.00963642153379834,0.219824196381399
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,-0.00512513647582083,0.00419941738314919,-0.0133559945467932,0.00310572159515159,0.222324210222648
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00396387685717811,0.00325017301475693,-0.0103342159661017,0.00240646225174547,0.222646713787412
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,-0.00419461422656323,0.00344041622797759,-0.0109378300333993,0.00254860158027286,0.222788049535369
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,-0.00505949084848055,0.00415494135855943,-0.013203175911257,0.00308419421429593,0.22336246057311
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,-0.00230646419983336,0.0019023422791373,-0.00603505506694247,0.00142212666727575,0.225371560794005
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,0.00816774593589111,0.00677627096873965,-0.00511374516283861,0.0214492370346208,0.22809561658287
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNG,Uracil-DNA glycosylase,39919,0.0043690574863958,0.00362523715512716,-0.00273640733765343,0.011474522310445,0.228159637188693
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,-0.00480976447919182,0.00399993423784099,-0.0126496355853602,0.00303010662697651,0.229210952430382
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00385951714188734,0.00321136613388112,-0.00243476048051964,0.0101537947642943,0.229455248585509
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.00540153966092554,0.00450700105124715,-0.01423526172137,0.00343218239951888,0.230756218039753
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STEAP4,Metalloreductase STEAP4,39586,0.00896593433802097,0.00750557761749771,-0.00574499779227453,0.0236768664683165,0.232281048798339
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN2,Prefoldin subunit 2,41839,0.00672817471212618,0.00564070609856293,-0.00432760924105717,0.0177839586653095,0.232973220579842
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.00659785239315398,0.00562435374209762,-0.00442588094135735,0.0176215857276653,0.240786483244649
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,0.00367136498899834,0.00313121348626363,-0.00246581344407837,0.00980854342207504,0.241015261889747
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTR,Methionine synthase,39575,0.00782243259162391,0.00672292853617045,-0.00535450733927017,0.020999372522518,0.244633583662551
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPEP2,Dipeptidase 2,42070,0.00357759253093564,0.00308175539071109,-0.0024626480348581,0.00961783309672939,0.245705425003567
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP6,Guanylate-binding protein 6,39575,-0.00532703379466061,0.00460155320348471,-0.0143460780734906,0.00369201048416942,0.247028031919482
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYBB2,Beta-crystallin B2,39929,0.00831676102186395,0.00719033487689827,-0.00577629533685666,0.0224098173805846,0.247436352918057
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A3,Protein S100-A3,39919,0.00508002761055828,0.00439377753305599,-0.00353177635423146,0.013691831575348,0.247629157814794
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.00784100564842712,0.00678921711525372,-0.0211478711943244,0.00546585989747018,0.248148151232805
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPA1,Inositol monophosphatase 1,42016,0.00720838794561898,0.00625185355760271,-0.00504524502728233,0.0194620209185203,0.248930874545668
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOB,Apolipoprotein B-100,39990,0.00269445883170722,0.00234886422957047,-0.00190931505825091,0.00729823272166535,0.251350899980972
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,0.00640222764603902,0.00558305693711335,-0.00454056395070314,0.0173450192427812,0.251520354443402
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD200,OX-2 membrane glycoprotein,42119,-0.00318677326775984,0.00278340682505827,-0.00864225064487404,0.00226870410935437,0.25226329249742
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,0.00696625614938266,0.00609610972555662,-0.00498211891270831,0.0189146312114736,0.253167418379397
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FST,Follistatin,42166,0.00569723995546067,0.00498697415018127,-0.00407722937889461,0.0154717092898159,0.253297898928145
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD82,CD82 antigen,39757,-0.00487715666009361,0.00427353940896109,-0.0132532939016573,0.00349898058147013,0.253792362646922
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.00720091184537487,0.00641983714490269,-0.0053819689586344,0.0197837926493841,0.262028916032379
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN3B,Sodium channel subunit beta-3,39586,-0.00534952316589981,0.00480295699265074,-0.0147633188714953,0.00406427253969564,0.265390287493838
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPHS2,Podocin,39657,-0.0116738958795721,0.0105004250692455,-0.0322547290152934,0.00890693725614912,0.266267848975561
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,0.0115003311331145,0.010362655744741,-0.00881047412657781,0.0318111363928069,0.267115151348777
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.00632617204713651,0.00571769731532925,-0.00488051469090882,0.0175328587851818,0.268568826126202
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,-0.0047851512337089,0.0043252772427001,-0.0132626946294011,0.00369239216198329,0.268611072975785
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00574600017419346,0.0052061536859089,-0.00445806105018798,0.0159500613985749,0.2697459939109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.00601379598114275,0.00545212068075695,-0.0166999525154264,0.00467236055314087,0.270042484380974
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN4,Prefoldin subunit 4,39560,-0.00597466404826221,0.0054326033142648,-0.0166225665442212,0.00467323844769681,0.271452499051895
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP2,Retinol-binding protein 2,42070,-0.00867274338840492,0.00798231947165652,-0.0243180895528517,0.00697260277604185,0.277279871068822
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QL2,Complement C1q-like protein 2,39657,0.00481738122467866,0.00443781487827464,-0.00388073593673963,0.013515498386097,0.277710646107289
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,0.0071551141020431,0.00660778769325025,-0.00579614977672738,0.0201063779808136,0.278907483371034
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,-0.00324024476017116,0.00299652041228282,-0.00911342476824548,0.00263293524790316,0.279571356832436
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,-0.00465666531477117,0.00432009188092369,-0.0131240454013816,0.00381071477183925,0.281097946164725
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.0181889738024134,0.0170971507060795,-0.0516993891863292,0.0153214415815023,0.287414823627399
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KHDC3L,KH domain-containing protein 3,39560,-0.00734102392869595,0.00690715212246201,-0.0208790420887215,0.0061969942313296,0.287889335127641
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2,Interleukin-2,41913,-0.00347812509796563,0.00327515498035109,-0.00989742885945377,0.00294117866352251,0.288267353672437
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00394446730971828,0.0037265313805081,-0.0112484688155142,0.0033595341960776,0.289858779804982
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF830,Zinc finger protein 830,39919,0.00844095589041728,0.00798864284050394,-0.00721678407697044,0.024098695857805,0.290707822787805
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00197755215955,0.0018853628394805,-0.00171775900583179,0.00567286332493178,0.294247624283644
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,0.0287883728719647,0.0274653955791674,-0.0250438024632035,0.0826205482071329,0.294583756520581
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,-0.00516236918037542,0.00494061649608831,-0.0148459775127085,0.00452123915195766,0.296095839425154
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TG,Thyroglobulin,39919,0.0112391489738991,0.0107819069559478,-0.00989338865975859,0.0323716866075569,0.297244697224043
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH23,Cadherin-23,39929,-0.00286755811654713,0.0027513481244487,-0.00826020044046657,0.00252508420737232,0.29732383353725
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUMF1,Formylglycine-generating enzyme,39657,0.00706571809432003,0.00680874463645574,-0.00627942139313322,0.0204108575817733,0.299413028000904
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL31,Interleukin-31,39657,-0.00594188919433779,0.00572934177816381,-0.0171713990795389,0.00528762069086329,0.299712842677139
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.00696415274551672,0.00673304031159402,-0.00623260626520757,0.020160911756241,0.301006986140418
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAX,Integrin alpha-X,39757,0.00545477236575573,0.00532620846263142,-0.00498459622100184,0.0158941409525133,0.305792312721714
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERC2,ERC protein 2,39649,0.00776203582210234,0.00758979983437947,-0.00711397185328141,0.0226380434974861,0.306475371424668
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,0.00563088609428733,0.00552884354616187,-0.00520564725618993,0.0164674194447646,0.308482878552482
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMP,Olfactory marker protein,39586,0.00502956855188097,0.00494338427612554,-0.00465946462932509,0.014718601733087,0.308969293568916
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,-0.00484087198823685,0.0047704045487863,-0.014190864903858,0.00450912092738429,0.310236991538378
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,0.00422874212192553,0.00417173053762402,-0.00394784973181755,0.0124053339756686,0.310764417319135
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,-0.0077806639112484,0.0076900971050059,-0.02285325423706,0.00729192641456318,0.311666961345002
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL21R,Interleukin-21 receptor,39657,0.00557549605845583,0.00557949797715637,-0.00536031997677064,0.0165113120936823,0.317679609156025
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAT1,Diamine acetyltransferase 1,39575,-0.00497342197390236,0.00497794580516868,-0.014730195752033,0.00478335180422826,0.317772528350371
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPA,Apolipoprotein(a),39775,-0.0186420662429376,0.0187530709558799,-0.0553980853164622,0.0181139528305871,0.320205095640902
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,0.0032562160553804,0.00328203724242017,-0.00317657693976312,0.00968900905052393,0.321150368146885
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSCA,Prostate stem cell antigen,39930,0.0264529399174481,0.0267502649349391,-0.0259775793550327,0.0788834591899288,0.322740451386219
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKKL1,Dickkopf-like protein 1,42070,0.0084760497789736,0.00858040604131719,-0.00834154606200809,0.0252936456199553,0.323249815234568
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,0.00654303061938796,0.0066318487980815,-0.00645539302485179,0.0195414542636277,0.323856780707763
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,0.00445252513688082,0.00453954256783267,-0.0044449782960712,0.0133500285698329,0.326696936418587
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,0.0052609536219579,0.00536484763027892,-0.00525414773338879,0.0157760549773046,0.32679475703254
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR2,Toll-like receptor 2,39757,0.00233953421528615,0.00238712391946144,-0.00233922866685828,0.00701829709743058,0.327075779148339
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO1,Alpha-enolase,42119,0.00785176799049326,0.00804538865061827,-0.00791719376471855,0.0236207297457051,0.329114655173195
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,0.0052485156967166,0.00539077574679085,-0.00531740476699346,0.0158144361604267,0.330267769801263
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.00586730890731364,0.00605691390906659,-0.00600424235445687,0.0177388601690842,0.33271816197212
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.00339071575498076,0.00352928607369767,-0.00352668494946667,0.0103081164594282,0.336704868175979
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NLGN1,Neuroligin-1,39649,-0.00662970570229519,0.00691513905051798,-0.0201833782413104,0.00692396683672005,0.337719078852887
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYTH3,Cytohesin-3,39560,0.00717524621102728,0.00752397859032327,-0.00757175182600633,0.0219222442480609,0.34028159788999
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.00375848697122458,0.00394926093353522,-0.00398206445850444,0.0114990384009536,0.341272619998397
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00435918709685699,0.00458716165471608,-0.00463164974638652,0.0133500239401005,0.341976369447579
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCL2,Phosducin-like protein 2,39560,0.00510650047407731,0.00537493776708575,-0.00542837754941077,0.0156413784975654,0.34210393477558
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP15,Matrix metalloproteinase-15,39958,0.00473099069108163,0.00500749177676162,-0.00508369319137115,0.0145456745735344,0.344790015745772
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAG,Myelin-associated glycoprotein,39649,-0.00472736429835588,0.00500801331679651,-0.014543070399277,0.00508834180256528,0.345210724588421
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZPR1,Zinc finger protein ZPR1,39586,0.00932246100972003,0.00993508654313884,-0.0101503086148321,0.0287952306342722,0.348091790928319
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.00789423882544018,0.00844453564517626,-0.0244455286899856,0.00865705103910529,0.349894099448155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLKB1,Plasma kallikrein,39759,0.00233879454844874,0.00251657627040283,-0.00259369494154081,0.0072712840384383,0.352724870874274
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.00479095832602396,0.0051618906956649,-0.00532634743747925,0.0149082640895272,0.353355233690188
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN2,Calsyntenin-2,42296,0.00380492262070425,0.00410052979641773,-0.00423211578027451,0.011841961021683,0.353470606412032
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,0.00452376416934415,0.00489055925493391,-0.0050617319703263,0.0141092603090146,0.354986443041537
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.00657480759100324,0.00711235782824147,-0.00736541375235003,0.0205150289343565,0.355287548915248
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP1,Methionine aminopeptidase 1,41839,0.00274001412198037,0.00296828208470643,-0.00307781876404422,0.00855784700800497,0.355973158649107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,0.00477928893648363,0.0051988597674831,-0.00541047620778325,0.0149690540807505,0.357961179571145
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF7,Fibroblast growth factor 7,39560,-0.00731575833175672,0.00800003186361803,-0.0229958207844481,0.00836430412093462,0.360492074447014
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,-0.0157941296920807,0.0172829373748751,-0.0496686869468359,0.0180804275626744,0.36080862186159
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,0.00560623890618759,0.00613531463349494,-0.00641897777546249,0.0176314555878377,0.360860126111847
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA8,Carbonic anhydrase-related protein,39657,0.0024985309911869,0.00274536503296391,-0.00288238447342237,0.00787944645579617,0.362794554083228
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,0.00452341517507487,0.00497616531291932,-0.00522986883824699,0.0142766991883967,0.363361566651714
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNC5D,Netrin receptor UNC5D,39657,-0.00244503985907602,0.00269098290733069,-0.00771936635744418,0.00282928663929214,0.363578600178623
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,0.00278191680422556,0.003110226702524,-0.00331412753272148,0.00887796114117261,0.371104489887629
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP13,Collagenase 3,41839,-0.00294651786366764,0.00329868534020006,-0.00941194113045975,0.00351890540312447,0.371744870193662
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL3,Myosin light chain 3,39638,0.00721709762350312,0.00809639957548113,-0.00865184554443988,0.0230860407914461,0.372736230826702
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,0.00520442563652627,0.00584618198677341,-0.00625409105754961,0.0166629423306022,0.373363725451853
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.00443017933873179,0.00503197079587067,-0.0142928420986383,0.00543248342117473,0.378658490188687
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP29,Dual specificity phosphatase 29,39649,0.00610025254027793,0.00693293532733933,-0.00748830070130716,0.019688805781863,0.378935532650938
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.015535701146976,0.0177191925559525,-0.0191939162626909,0.0502653185566429,0.380628796003762
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.00638268031123639,0.00729342161952824,-0.0206777866855117,0.00791242606303896,0.381523183720706
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEF,Thyrotroph embryonic factor,39575,0.00385227283885269,0.00440757191283944,-0.00478656811031261,0.012491113788018,0.382130583764257
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,0.00643132842004537,0.00736648596661663,-0.00800698407452323,0.020869640914614,0.38265346396462
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENOPH1,Enolase-phosphatase E1,39919,-0.0047864839059751,0.00548743767246941,-0.0155418617440151,0.00596889393206496,0.383083910525279
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,0.00319714494344164,0.00367184227122479,-0.00399966590815895,0.0103939557950422,0.383922636896312
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.00552317204251715,0.00634360809160801,-0.0179566439020689,0.00691029981703455,0.38395486975208
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00403923737209708,0.00465422118609617,-0.00508303615265142,0.0131615108968456,0.38548687588727
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.00763997987473902,0.00884619054921773,-0.00969855360172774,0.0249785133512058,0.387797571187719
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00620770934863697,0.00719251938489136,-0.00788962864575009,0.020305047343024,0.388113002695379
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NLGN2,Neuroligin-2,39586,-0.00415929695616898,0.00481995491571197,-0.0136064085909644,0.00528781467862649,0.388193279604158
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TUBB3,Tubulin beta-3 chain,39586,-0.00254472186012646,0.00295104299864998,-0.00832876613748042,0.00323932241722751,0.388534287441008
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,0.00424446908714478,0.00496309827789402,-0.00548320353752749,0.0139721417118171,0.392452531616272
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,-0.00315610660187516,0.00372865857204564,-0.0104642774030846,0.0041520641993343,0.397322565300427
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS53,Serine protease 53,39929,-0.00330928010878385,0.00392716064917648,-0.0110065149811697,0.00438795476360205,0.399433718868778
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANK2,Ankyrin-2,39575,-0.00597370354324336,0.0071934208114124,-0.0200728083336117,0.00812540124712494,0.406308187642773
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRC,Chymotrypsin-C,42122,-0.00555113168565468,0.006689833694168,-0.018663205726224,0.0075609423549146,0.406674322614864
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGFAC,Hepatocyte growth factor activator,39897,-0.00230622792978166,0.00278881594610213,-0.00777230718414183,0.00315985132457851,0.408279497596548
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,-0.00252280134878348,0.0030570184269884,-0.00851455746568075,0.00346895476811379,0.409245530669171
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,-0.00492644231123166,0.00599081911083837,-0.0166684477684749,0.00681556314601154,0.410905811547882
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,-0.00497241096315899,0.00605087671747413,-0.0168321293294083,0.0068873074030903,0.41122737966878
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,0.00383123009278139,0.00467160250295808,-0.00532511081301644,0.0129875709985792,0.412170930665707
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD177,CD177 antigen,42123,0.0107840329251143,0.0131638231307647,-0.0150170604111845,0.0365851262614131,0.412676827628425
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,-0.0029123271671222,0.00355679775500433,-0.00988365076693069,0.00405899643268629,0.412914897612155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTNL10,Butyrophilin-like protein 10,39560,-0.00335850629371267,0.00410510058224696,-0.0114045034349167,0.00468749084749138,0.413300697174545
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDAC8,Histone deacetylase 8,39657,0.00504617333634421,0.00620474327767661,-0.00711512348790195,0.0172074701605904,0.416076925985799
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.00746122023464892,0.00919705197244719,-0.0105650016313476,0.0254874421006454,0.417229369267231
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,-0.0036168407146086,0.00449340233832684,-0.0124239092977292,0.00519022786851202,0.420881284750731
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB6B,Ras-related protein Rab-6B,41839,0.00389466648535285,0.00484176765173466,-0.00559519811204709,0.0133845310827528,0.421186575821267
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPGN,Epigen,39919,-0.00382286721327365,0.00476663426275412,-0.0131654703682717,0.00551973594172443,0.422566575091997
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP4,Bone morphogenetic protein 4,41992,-0.00385711791201611,0.00484136033389844,-0.013346184166457,0.00563194834242483,0.425638671351589
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPEP,Glutamyl aminopeptidase,39575,0.0034416469109454,0.00436726886321195,-0.00511820006095002,0.0120014938828408,0.430681709876813
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,-0.00314750656615557,0.00402586718807229,-0.0110382062547773,0.00474319312246612,0.434336689690604
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BSND,Barttin,39560,0.00269913620246237,0.00345392215428861,-0.0040705512199433,0.00946882362486804,0.434543053165391
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0100517027095184,0.0129564932791035,-0.0153430241175246,0.0354464295365613,0.437878420865678
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,-0.00205432673670601,0.00265883736959365,-0.00726564798110957,0.00315699450769754,0.439748435514816
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,-0.00220433008293355,0.00285552544654208,-0.00780115995815603,0.00339249979228893,0.440155864623189
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAS6,Growth arrest-specific protein 6,42236,0.00197699325550033,0.00257849890693027,-0.003076864602083,0.00703085111308365,0.443259767240805
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSHB,Follitropin subunit beta,39638,0.00321635498957062,0.00422668557781199,-0.00506794874294088,0.0115006587220821,0.446694906796722
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLINT1,Clathrin interactor 1,39560,-0.00390867302424941,0.00514411483300601,-0.0139911380969412,0.00617379204844237,0.447370197872967
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.00239059400686791,0.00314784119209275,-0.00377917472963388,0.0085603627433697,0.447605671098112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAM,Signal transducing adapter molecule 1,39919,0.00282666897669809,0.00372311095028697,-0.00447062848586437,0.0101239664392606,0.447735379630528
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,0.00534610492368572,0.00705807543340013,-0.00848772292577854,0.01917993277315,0.448799218442605
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTN2,Alpha-actinin-2,39575,-0.00502672799568611,0.00664874169747212,-0.0180582617227315,0.00800480573135924,0.449640239158192
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.00201111894296348,0.0026767321475496,-0.00725751395216069,0.00323527606623373,0.452467436636156
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,0.0047863915988885,0.00637424671170597,-0.00770713195605519,0.0172799151538322,0.452728969173037
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,0.00230238256836575,0.00307294445158901,-0.00372058855674871,0.0083253536934802,0.453723523035414
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALLD,Palladin,39657,-0.00293680439432184,0.00392934754479537,-0.0106383255821208,0.00476471679347709,0.4548364973565
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1B,Protein phosphatase 1B,39657,0.00472543713764533,0.00635733378406205,-0.00773493707911629,0.017185811354407,0.457312918941045
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP10,Stromelysin-2,42124,-0.00437484061206192,0.00589438572746174,-0.0159278366378869,0.00717815541376309,0.457976229561764
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCLN,Nicalin,41913,0.00388551297295997,0.00524473606276115,-0.00639416971005188,0.0141651956559718,0.458803211871568
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY2A,Pancreatic alpha-amylase,41665,0.0036977675875713,0.00500526474155151,-0.00611255130586966,0.0135080864810123,0.460056526535754
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A16,Protein S100-A16,41814,-0.00458614727627457,0.00622238542955558,-0.0167820227182035,0.00760972816565436,0.461111079338905
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.00384760116059064,0.0052635613319833,-0.00646897905009663,0.0141641813712779,0.464799300521321
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,0.00503490591924234,0.0069068079162087,-0.00850243759652672,0.0185722494350114,0.46603112718503
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00372948751409275,0.00512316969220904,-0.0137709001108225,0.00631192508263697,0.466650626846941
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,0.00144806385817427,0.00198953983959688,-0.00245143422743562,0.00534756194378416,0.466727378631949
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUOX2,Dual oxidase 2,41900,-0.00520580075546025,0.00719751447145322,-0.0193129291195086,0.00890132760858806,0.469522091550279
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMMD9,COMM domain-containing protein 9,39919,-0.00296275045236965,0.00410303875321708,-0.0110047064086751,0.00507920550393583,0.470255980825665
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGM2,Phosphoglucomutase-2,39649,0.00445612067926418,0.00624863568421592,-0.00779120526179903,0.0167034466203274,0.475777297117403
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,0.00333350281358177,0.00467694086036708,-0.00583330127273769,0.0125003068999012,0.476013773209711
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTN,Neuroplastin,41843,0.00569420011897601,0.00803483628158648,-0.0100540789929335,0.0214424792308855,0.478529964701763
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICOSLG,ICOS ligand,42070,-0.00138472636773462,0.0019588874342647,-0.00522414573889343,0.00245469300342419,0.479644392549325
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKIV2L,Helicase SKI2W,39575,0.00287646155431081,0.00407279309957405,-0.00510621292085433,0.0108591360294759,0.480039822425867
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTX3,Pentraxin-related protein PTX3,42119,0.00358810207700779,0.00508963616700418,-0.0063875848103204,0.013563788964336,0.480833559661949
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPHS1,Nephrin,39657,-0.00241007211601895,0.00343201100646709,-0.00913681368869444,0.00431666945665655,0.482548518047106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBR1,T-box brain protein 1,39649,-0.00345248588320218,0.00493874774612308,-0.0131324314656034,0.00622745969919905,0.48452863165368
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABO,Histo-blood group ABO system transferase,39990,-0.0103703429148776,0.0149327680252665,-0.0396385682443999,0.0188978824146448,0.487402365454596
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPP1,Osteopontin,42286,0.00309841279027085,0.00449943888267176,-0.0057204874197658,0.0119173130003075,0.491072819023162
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17F,Interleukin-17F,41913,0.00514122533791393,0.00751626042094367,-0.00959064508713567,0.0198730957629635,0.49397840057233
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFD,Vascular endothelial growth factor D,42275,-0.0026741552992365,0.00395221486222058,-0.0104204964291888,0.00507218583071585,0.498657297260031
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F11,Coagulation factor XI,39822,-0.00218195449101061,0.00323112772889841,-0.00851496483965149,0.00415105585763027,0.4995042214683
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,0.00271537941120681,0.00406409803256862,-0.00525025273262769,0.0106810115550413,0.504059158936641
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN15,Tetraspanin-15,39575,-0.00345792884425866,0.00517564401946491,-0.0136021911224099,0.00668633343389255,0.504073813219738
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,0.00630433682898968,0.00947716735947547,-0.0122709111955822,0.0248795848535616,0.505928103101125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,0.00465310110772406,0.00702219255211399,-0.00911039629441935,0.0184165985098675,0.50758277492073
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRN1,Neuritin,39934,-0.00236136138873956,0.0035816788392662,-0.0093814519137013,0.00465872913622219,0.509723612121922
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.00365631098505523,0.00554607314675349,-0.0072139923825816,0.0145266143526921,0.509741642663601
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.00425257115302816,0.00646908358513596,-0.00842683267383832,0.0169319749798946,0.510957848034339
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,-0.00274854879717156,0.0041840511574704,-0.0109492890658135,0.00545219147147042,0.51125189339898
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.002731096764025,0.00417796697567534,-0.00545771850829867,0.0109199120363487,0.513322547896547
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.00265702950646532,0.00406966060639667,-0.00531950528207216,0.0106335642950028,0.513840070499818
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,0.00214262933471824,0.0032836209643854,-0.00429326775547714,0.00857852642491361,0.514076608292294
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,0.00457018206701314,0.00703881324010483,-0.00922589188359232,0.0183662560176186,0.516168810742711
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAG,S-arrestin,39586,-0.00349877608031411,0.0053907274206395,-0.0140646018247675,0.00706704966413932,0.516328684649295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.0127592520527943,0.0196790301876248,-0.0258116471149503,0.0513301512205389,0.51675804789726
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.0035978315047875,0.00555063927580683,-0.0144770844853689,0.00728142147579388,0.516880001355672
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,0.00254260904875061,0.00393275648814755,-0.00516559366801858,0.0102508117655198,0.517955621212808
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,-0.00146045404329082,0.00226110752243038,-0.00589222478725437,0.00297131670067272,0.518355814662976
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,-0.0026328270878606,0.0041231807036605,-0.0107142612670352,0.00544860709131399,0.523133786436115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR5,Complement factor H-related protein 5,39864,-0.00273286780128035,0.0042938744497375,-0.0111488617227658,0.00568312612020515,0.524491326958256
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.0044558854281805,0.00702514729872042,-0.0182251741336725,0.00931340327731153,0.525913666509646
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,0.00196962150926731,0.00312775115894932,-0.00416077076227336,0.00810001378080797,0.528887553629336
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLL4,Delta-like protein 4,39638,0.00568594437257523,0.00908614847995822,-0.0121229066481429,0.0234947953932933,0.531471152369259
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RLN1,Prorelaxin H1,39934,0.00285577242925229,0.00456433435380699,-0.00609032290420941,0.011801867762714,0.531543242965983
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B4,Protein ATP1B4,39560,-0.00263432075906798,0.00431102790998498,-0.0110839354626385,0.00581529394450257,0.541168839867843
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.00225382102355069,0.0037317564910002,-0.00956806374591107,0.00506042169880969,0.545884217425073
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBH,Dopamine beta-hydroxylase,39978,-0.00704676692526762,0.0117441213568698,-0.0300652447847324,0.0159717109341971,0.548501494958032
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN4,Contactin-4,42137,-0.0014333935075793,0.00240295407625251,-0.00614318349703423,0.00327639648187562,0.55084250161021
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTXR,Neuronal pentraxin receptor,42145,0.00207934813055887,0.0034978401153224,-0.00477641849547303,0.00893511475659076,0.552210193494757
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.00148651159037363,0.00250817759470757,-0.00640253967600047,0.00342951649525321,0.553414472520037
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COPE,Coatomer subunit epsilon,41839,0.00280948191978352,0.00474257781740233,-0.00648597060232504,0.0121049344418921,0.553595873279446
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPT1,Translationally-controlled tumor protein,41913,-0.00388412621352522,0.00656153339579172,-0.016744731669277,0.00897647924222655,0.553891416270748
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,-0.00714950836677504,0.0121151964167108,-0.0308952933435283,0.0165962766099782,0.555117432934475
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK1,Kallikrein-1,42016,-0.00765395074676818,0.0130714062672642,-0.033273907030606,0.0179660055370696,0.558188381664161
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN7,Tetraspanin-7,39586,0.00585039524570087,0.0100583307572403,-0.0138639330384902,0.0255647235298919,0.560816590368224
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF174,Zinc finger protein 174,39657,0.00219899142912407,0.00378979166902276,-0.00522900024216054,0.00962698310040869,0.561764124293732
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLGAP5,Disks large-associated protein 5,39934,-0.00294409918595013,0.00508946428017062,-0.0129194491750845,0.00703125080318428,0.562958766382001
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNL2,Interferon lambda-2,39586,0.00348006856632998,0.00603499803509835,-0.00834852758246278,0.0153086647151227,0.564189190886796
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.0024470632865691,0.0042611815979132,-0.00590485264534077,0.010798979218479,0.565795732023248
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM25,Transmembrane protein 25,39934,0.00275847140056439,0.00482679888828203,-0.00670205442046838,0.0122189972215972,0.56767829320285
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESR1,Estrogen receptor,39657,0.00336154336962384,0.00589014753594808,-0.0081831458008344,0.0149062325400821,0.568210453049684
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.0036909829852053,0.00653645672535533,-0.00912047219649114,0.0165024381669017,0.572305431774973
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,0.00422093954752202,0.00765994716946017,-0.0107925569046199,0.019234435999664,0.581616913972811
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MN1,Transcriptional activator MN1,39649,-0.00333185296056057,0.00606372512566976,-0.0152167542068733,0.00855304828575216,0.582692024980191
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISM2,Isthmin-2,39966,-0.0024320135010274,0.00446178380131458,-0.011177109751604,0.00631308274954919,0.58571159909675
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSG1,Tryptase gamma,39657,0.0014702952604598,0.00270023306848733,-0.00382216155377537,0.00676275207469497,0.58610375269511
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00195152884477149,0.00358628468922002,-0.00507758914609974,0.00898064683564272,0.586339146972476
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.00312056767188722,0.00578044867646701,-0.00820911173398813,0.0144502470777626,0.589312350285781
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGMA,Repulsive guidance molecule A,42249,0.00175653547859705,0.00329031804192824,-0.00469248788358229,0.0082055588407764,0.59345418117916
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK3,Dickkopf-related protein 3,42310,0.00158048678014746,0.00301696565566666,-0.00433276590495918,0.00749373946525411,0.600379970286828
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TJP3,Tight junction protein ZO-3,39586,-0.00223780942736743,0.00428846186316384,-0.0106431946791686,0.00616757582443369,0.601805491751648
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,0.00280495577322365,0.00538704316005676,-0.00775364882048759,0.0133635603669349,0.602596304387238
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF75D,Zinc finger protein 75D,39757,0.00327062949617147,0.00630837625304711,-0.00909378795980085,0.0156350469521438,0.604148887796649
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD1,Bromodomain-containing protein 1,39757,0.0016213096277271,0.00313798740552401,-0.00452914568709995,0.00777176494255416,0.605395519722876
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL3,Interleukin-3,39560,-0.0032202236207876,0.00630406917692831,-0.0155761992075671,0.00913575196599188,0.609489724335731
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,0.00343273222181092,0.00673657785370847,-0.00977096037145768,0.0166364248150795,0.610365503375162
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,0.00439947977453625,0.00865392743044547,-0.0125622179891369,0.0213611775382094,0.611195748083561
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN6,Prefoldin subunit 6,39649,-0.00339193469650899,0.00667604320047397,-0.016476979369438,0.00969310997641998,0.611410464472966
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINI1,Neuroserpin,39713,0.00151325497452421,0.00298099995067213,-0.00432950492879317,0.0073560148778416,0.611720575950747
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,0.00164656081878486,0.00326287661048292,-0.00474867733776166,0.00804179897533138,0.613823816734216
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,0.00447756399386556,0.00888708889114388,-0.0129411302327764,0.0218962582205076,0.614392215659851
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00136769162632905,0.0027452986033695,-0.00401309363627517,0.00674847688893328,0.618357221868367
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.00365003613409067,0.00746038870840189,-0.0182723980025584,0.010972325734377,0.624670596207257
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY2B,Alpha-amylase 2B,41300,0.00250206397306177,0.00512047208752505,-0.00753406131848732,0.0125381892646109,0.625105511266512
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,-0.00430864555491597,0.00882015147464007,-0.0215961424452105,0.0129788513353786,0.625205374057591
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,-0.0029937281217189,0.00617292974989709,-0.0150926704315172,0.00910521418807939,0.627700780295623
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.00245896171488703,0.00511309138670382,-0.00756269740305246,0.0124806208328265,0.630586585712949
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.00174931588339081,0.00364100677203923,-0.0088856891565877,0.00538705738980607,0.630918160868864
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.0022649349411191,0.00472763447394782,-0.0115310985100568,0.00700122862781862,0.631888209545348
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.00450094457238341,0.00942156918702733,-0.0139653310341902,0.022967220178957,0.632853553832899
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.00207015612520249,0.0043502906825172,-0.00645641361253121,0.0105967258629362,0.634179048755916
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,H2AP,Huntingtin-interacting protein M,39560,-0.00245417613731483,0.00518583559316909,-0.0126184138999263,0.00771006162529659,0.636047082442194
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,0.0021219791504879,0.00450535557913658,-0.00670851778461979,0.0109524760855956,0.637656954085966
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,-0.00118954783999057,0.00253055232466317,-0.00614943039633039,0.00377033471634925,0.63830941862287
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRR5,Proline-rich protein 5,39657,-0.00226307769671921,0.00486273519484495,-0.0117940386786153,0.00726788328517688,0.641659981028006
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.00203754431565146,0.00439963254896288,-0.0106608241116187,0.00658573548031579,0.643289670718149
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,-0.00129275272067272,0.00279441345246845,-0.00676980308751089,0.00418429764616544,0.643645351442899
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,0.00420701767380135,0.00913750712734726,-0.0137024962957993,0.022116531643402,0.64522959732677
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.00295998196804127,0.00653093234205518,-0.00984064542238688,0.0157606093584694,0.650395528876356
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOH,Beta-2-glycoprotein 1,42137,-0.00169509213876469,0.00374149560205224,-0.00902842351878708,0.00563823924125769,0.65051854502767
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00135394378726164,0.00303349862929977,-0.00459171352616592,0.00729960110068919,0.655367071201359
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,0.00348621716788949,0.00786511445928703,-0.0119294071723131,0.0189018415080921,0.657593034667143
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMCH,Pro-MCH,39575,0.00375171246853597,0.00849277491127281,-0.0128941263575587,0.0203975512946307,0.658676343117039
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,0.00266899423533262,0.00606307870625134,-0.00921464002892,0.0145526284995852,0.659797640780092
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.00275557464023162,0.00633419884793691,-0.015170604382188,0.00965945510172472,0.663548275933946
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMOD2,Leiomodin-2,39586,0.00273401185717939,0.00633970305978174,-0.00969180613999281,0.0151598298543516,0.666293353287701
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,0.00272646414695883,0.00633183588663405,-0.00968393419084391,0.0151368624847616,0.666770359748204
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTPN,Myotrophin,41900,-0.00142831819195612,0.00332749180534943,-0.007950202130441,0.00509356574652876,0.667749928729794
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB6,Integrin beta-6,41913,0.00134912433208937,0.00314664247823859,-0.00481829492525826,0.007516543589437,0.66811178964097
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB116,Beta-defensin 116,39586,0.00329253498918679,0.00774090090320284,-0.0118796307810908,0.0184647007594644,0.670595267448992
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,0.00238993157193472,0.00566545547317461,-0.00871436115548752,0.013494224299357,0.673148040518277
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,0.00188154838644385,0.00453638922330655,-0.00700977449123698,0.0107728712641247,0.678319720724636
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.00104897720921256,0.00253050432631321,-0.00391081127036133,0.00600876568878644,0.678491944788663
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00176567901637027,0.00426319546244603,-0.0101215421227645,0.00659018409002395,0.678759130137702
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.00445640348412671,0.0109041700564559,-0.0258285767947803,0.0169157698265269,0.682776613034681
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,-0.00168491143114122,0.00415305474591931,-0.00982489873314307,0.00645507587086062,0.684967913826196
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMI,N-myc-interactor,39875,0.00300279811760325,0.00749436764589041,-0.011686162468342,0.0176917587035484,0.688667761646148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,-0.00320362357930374,0.00814648140791055,-0.0191707271388084,0.0127634799802009,0.694140565690699
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL4,Interleukin-4,41913,0.00377082500820668,0.00966655486571567,-0.015175622528596,0.0227172725450094,0.696476343384901
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,-0.00196207401033001,0.00503691863452176,-0.0118344345339927,0.00791028651333265,0.69688534579447
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MLLT1,Protein ENL,39560,-0.00265212235756739,0.00682971023912153,-0.0160383544262456,0.0107341097111108,0.69778577566335
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPE4,NXPE family member 4,39575,-0.001276201003519,0.00329283632338172,-0.00773016019734717,0.00517775819030918,0.698342591804947
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL24,Interleukin-24,41913,0.00189388326459329,0.0049386629231091,-0.00778589606470056,0.0115736625938871,0.7013692985449
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCNA,Proliferating cell nuclear antigen,39560,-0.00254001891682203,0.00663682197424951,-0.0155481899863511,0.010468152152707,0.701937664347822
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.00128797037604039,0.00338965273944451,-0.00535574899327085,0.00793168974535164,0.703972870399709
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFP,Alpha-fetoprotein,41976,0.00252303407836996,0.00666792002990316,-0.0105460891802402,0.0155921573369802,0.705151376649202
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAGLN3,Transgelin-3,39560,0.00233300378238453,0.00617764391513312,-0.00977517829127638,0.0144411858560454,0.705695937419302
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH4,Cadherin-4,39586,0.00180847471981961,0.00479633202699162,-0.00759233605308396,0.0112092854927232,0.706140983571941
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,0.00280969383336026,0.00745530792413055,-0.0118027096979356,0.0174220973646561,0.706276194403823
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,-0.000947006896424463,0.0025168606017481,-0.00588005367585075,0.00398603988300182,0.70672681056634
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK12,Kallikrein-12,41843,0.00511582928628628,0.013688058913152,-0.0217127661834916,0.0319444247560641,0.70860080221662
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPT,Microtubule-associated protein tau,41839,0.00198254794600425,0.00540151633608571,-0.00860442407272374,0.0125695199647322,0.713598446125115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.00127686959541913,0.00348586109906778,-0.00810915734959198,0.00555541815875371,0.714148533686609
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF6,Fibroblast growth factor 6,39657,0.00144735392080289,0.00402673456931272,-0.00644504583505003,0.00933975367665582,0.719275708532945
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH7B,Myosin-7B,39560,-0.00158546704764681,0.00441494537154096,-0.0102387599758671,0.00706782588057348,0.719517005247329
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNPO1,Transportin-1,39757,0.00131008207902415,0.00365937883072429,-0.00586230042919547,0.00848246458724377,0.720345084553706
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTNNA1,Catenin alpha-1,39586,0.00124819929420286,0.00348669094419784,-0.00558571495642491,0.00808211354483064,0.72035793178654
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASA1,Ras GTPase-activating protein 1,41839,0.00118822092591115,0.00333242359677917,-0.00534332932377603,0.00771977117559832,0.721424220261317
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,0.0018363822738469,0.00523542229362821,-0.00842504542166439,0.0120978099693582,0.72577305525968
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL11,Interleukin-11,41913,0.00214944656580516,0.00623937362395422,-0.0100797257371451,0.0143786188687554,0.730477864290725
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINC1,Antithrombin-III,39959,0.000500377386622795,0.00148699075406679,-0.00241412449134812,0.00341487926459371,0.736497533603082
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.00160426620882203,0.00479761999841809,-0.00779906898807742,0.0110076014057215,0.738093237590911
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,-0.00265235389900535,0.00794795139565616,-0.0182303386344914,0.0129256308364807,0.738600649146402
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,-0.00200170282774984,0.00610398690288126,-0.0139655171573971,0.00996211150189742,0.742967880476933
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTO1,Protein LTO1 homolog,41913,-0.00136339702446154,0.00423025037576991,-0.00965468776097058,0.00692789371204749,0.747232763026431
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASQ2,Calsequestrin-2,39575,-0.00157148559156582,0.00489721271786904,-0.0111700225185891,0.0080270513354575,0.748296921655259
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAP,Prolyl endopeptidase FAP,42310,0.000891348658767946,0.00281615008907286,-0.00462830551581486,0.00641100283335075,0.75161783119089
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,-0.0011040274716205,0.00349927984527534,-0.00796261596836015,0.00575456102511916,0.752386844509042
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIPF,Gastric triacylglycerol lipase,39638,-0.002021499580131,0.00647722415040031,-0.0147168589149156,0.0106738597546536,0.754975358357351
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN1,Calsyntenin-1,41839,0.00159475829347216,0.00518082052188189,-0.00855964992941635,0.0117491665163607,0.758224420680918
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHH,Sonic hedgehog protein,39657,-0.00135168329038037,0.00439650406482289,-0.00996883125743322,0.00726546467667249,0.758510453925853
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1A,Interleukin-1 alpha,41913,0.00181751501658489,0.00592671700558759,-0.00979885031436679,0.0134338803475366,0.759103381275214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN7,Septin-7,39757,-0.00166414646986442,0.00548765142953273,-0.0124199432717486,0.00909165033201973,0.761702755567623
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKCQ,Protein kinase C theta type,41913,0.00132716413403682,0.00438040078464354,-0.00725842140386452,0.00991274967193817,0.761911524092263
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PXDNL,Peroxidasin-like protein,39919,0.00177371998139293,0.00588971876359034,-0.00977012879524414,0.01331756875803,0.763301610776155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.00177418875092553,0.00589178060137494,-0.0133220787296204,0.00977370122776935,0.763321470954904
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMA1,Laminin subunit alpha-1,39575,0.00160018813986633,0.00531933210568795,-0.00882570278728205,0.0120260790670147,0.763553633639636
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,0.00218376336790616,0.00731004345131765,-0.0121439217966764,0.0165114485324888,0.765148156941386
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORN4,MORN repeat-containing protein 4,39560,-0.00239698139326777,0.00805661587110611,-0.0181879485006357,0.0133939857141002,0.766077355432914
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM171A2,Protein FAM171A2,39934,0.00473258459092537,0.0160859908093879,-0.026795957395475,0.0362611265773257,0.768606378756168
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,0.00152671798641335,0.00522209581998681,-0.00870858982076079,0.0117620257935875,0.770018919478248
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F2,Prothrombin,39979,0.000437004929200821,0.00152783529858316,-0.00255755225602217,0.00343156211442381,0.774861254050014
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARG2,"Arginase-2, mitochondrial",39919,0.00122826441810891,0.00434080247730921,-0.00727970843741715,0.00973623727363497,0.777214272447541
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.0010665559715779,0.00379820108069748,-0.00851103008974497,0.00637791814658916,0.778864641183885
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLI2,Zinc finger protein GLI2,39657,-0.000950519762409886,0.00342062697475643,-0.00765494863293248,0.00575390910811271,0.781110584158002
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DENND2B,DENN domain-containing protein 2B,39575,0.00139615492060454,0.00504276675721351,-0.00848766792353394,0.011279977764743,0.781890611263606
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,0.00118979944342752,0.00432858038210098,-0.00729421810549039,0.00967381699234544,0.783420843978585
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,-0.000229814614873079,0.000838003722896694,-0.0018723019117506,0.00141267268200444,0.783904815779447
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,0.000956579486623495,0.00350138483758904,-0.00590613479505102,0.00781929376829801,0.784704368253308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,-0.000830423090705064,0.00304857383690377,-0.00680562781103645,0.00514478162962633,0.785321728222954
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,-0.000867021507964859,0.00330491245659172,-0.00734464992288463,0.00561060690695491,0.793060893472809
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAGE2A,G antigen 2A,39560,-0.0017559903421571,0.00672761500868931,-0.0149421157591881,0.011430135074874,0.794087917356104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00102182937823686,0.00394280490912398,-0.00670606824364614,0.00874972700011986,0.795514156133557
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.00102432361284286,0.00396820240619932,-0.0067533531033078,0.00880200032899353,0.796308350188472
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,-0.00105650977062558,0.00411396020915164,-0.0091198717805628,0.00700685223931163,0.797329585746069
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,0.000869978208125288,0.00345373837714191,-0.00589934901107285,0.00763930542732343,0.801127220606775
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGLON5,IgLON family member 5,39560,0.00236510827033169,0.00953736210097689,-0.016328121447583,0.0210583379882464,0.804151832262257
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00164705148700798,0.00670168223537086,-0.0114882456943189,0.0147823486683349,0.805867293201731
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.00206302650486856,0.00840037135830103,-0.0185277543671386,0.0144017013574015,0.80600613690157
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,-0.00116157438838614,0.00473427237945375,-0.0104407482521155,0.00811759947534322,0.806186503690857
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,-0.00101435016814537,0.00416476983450177,-0.00917729904376883,0.0071485987074781,0.807580070142245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,-0.00137765716955203,0.00567454383346055,-0.0124997630831347,0.00974444874403065,0.808181533792392
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPS,Calcyphosin,39929,0.002359809982788,0.00976696583160456,-0.0167834430471569,0.0215030630127329,0.809085684936792
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,-0.00140657679568344,0.00597321821733664,-0.0131140845016633,0.0103009309102964,0.813839387892848
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6,Seizure protein 6 homolog,39649,0.000758668100338418,0.00322366680324998,-0.00555971883403154,0.00707705503470838,0.813946719891852
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALMS1,Alstrom syndrome protein 1,39757,0.00107120347802294,0.00457983449985825,-0.00790527214169923,0.0100476790977451,0.815070263006148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EXTL1,Exostosin-like 1,39575,0.00113213346698242,0.00489846856365998,-0.00846886491779115,0.010733131851756,0.817225979443079
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,0.00111237030569973,0.0048760051600009,-0.00844459980790204,0.0106693404193015,0.819548272656537
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00137946081417284,0.00605587020652167,-0.0104900447906096,0.0132489664189553,0.819814496831799
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20,Interleukin-20,41913,-0.00108052328389605,0.00477829285738038,-0.0104459772843616,0.00828493071656949,0.821102494587266
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,0.000617203397686098,0.00273409735109628,-0.00474162741046261,0.00597603420583481,0.821405349355047
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PITHD1,PITH domain-containing protein 1,39539,-0.00176210238790312,0.00794766256831503,-0.0173395210218006,0.0138153162459943,0.824541225013602
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRP15,RRP15-like protein,39586,-0.00199334613709843,0.00940226794377585,-0.0204217913068991,0.0164350990327022,0.832105546271039
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,-0.00156074637717805,0.00770759876160023,-0.0166676399499145,0.0135461471955584,0.839533905420566
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.00110778921151794,0.00551570669697268,-0.00970299591454851,0.0119185743375844,0.840824671816019
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSC1,Hamartin,39657,-0.00151543047599929,0.00762608325743068,-0.0164625536605634,0.0134316927085648,0.842487974711721
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EXOSC10,Exosome component 10,39575,-0.00117351353370453,0.00599943577698816,-0.0129324076566013,0.0105853805891923,0.844923763674957
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL9,Interleukin-9,39757,0.00112647609345733,0.00579129799997657,-0.0102244679864967,0.0124774201734114,0.845778658703433
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00106110517166189,0.00557630652879166,-0.00986845562476976,0.0119906659680935,0.849086846490665
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,-0.000703837511351012,0.00372837424907693,-0.00801145103954179,0.00660377601683977,0.850269761620936
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,0.0014829609435191,0.00825758663556526,-0.0147019088621888,0.017667830749227,0.857479527484574
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,0.000524040330383258,0.00293682332320227,-0.00523213338309319,0.00628021404385971,0.85838232894696
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMOD4,Tropomodulin-4,39560,-0.000700399220622186,0.0041220876855463,-0.00877969108429293,0.00737889264304856,0.865081133224032
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.000441876132955802,0.0026392278211113,-0.00561476266233396,0.00473101039642235,0.867037704692446
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,0.00117318154142593,0.00715148432927495,-0.012843727743953,0.0151900908268048,0.86969694592069
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,-0.000742719923942578,0.0045288327948506,-0.00961923220184975,0.00813379235396459,0.869735672220112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLU,Clusterin,39979,0.000485311967359921,0.00309240167570879,-0.0055757953170293,0.00654641925174914,0.875297353594171
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDF2,Growth/differentiation factor 2,42145,-0.00056480959115884,0.00362019760804874,-0.00766039690293437,0.00653077772061669,0.876022551352945
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.000677851027477685,0.00438535136466751,-0.009273139702226,0.00791743764727063,0.877161858026217
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF3,Fibroblast growth factor 3,39657,-0.000470036241625574,0.00305263367953117,-0.00645319825350666,0.00551312577025551,0.877630457173918
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA10,Ephrin type-A receptor 10,41839,-0.00102294588756653,0.00672196527090172,-0.0141979978185339,0.0121521060434009,0.879047613911209
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTTG1,Securin,39757,-0.000651465811189987,0.00429218229326347,-0.00906414310598639,0.00776121148360642,0.879363498534512
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,-0.00127495933303969,0.00858269100204065,-0.0180970336970393,0.01554711503096,0.881911402017376
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,0.000821071271386889,0.00554980384224393,-0.0100565442594112,0.011698686802185,0.882388101115686
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAP1,Antigen peptide transporter 1,39757,0.000888800188481294,0.00601718731408137,-0.0109048869471182,0.0126824873240808,0.882574118284977
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,-0.0011298986853817,0.00778174767949167,-0.0163821241371854,0.014122326766422,0.884556290086867
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH22,Cadherin-22,39757,0.000398123382166512,0.0028430466406102,-0.00517424803342948,0.0059704947977625,0.88863560220618
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTX2,Neuronal pentraxin-2,39966,-0.0004923827882506,0.00351858501293416,-0.00738880941360156,0.00640404383710036,0.888711672425295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,0.000548801816431543,0.00403047200995245,-0.00735092332307527,0.00844852695593835,0.89169479309034
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.000509136456453361,0.00377540106959084,-0.00689064963994468,0.00790892255285141,0.892727564164102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCP11,T-complex protein 11 homolog,39757,-0.000793899714409254,0.0059652658990795,-0.0124858208766051,0.0108980214477866,0.89412692707741
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IKZF2,Zinc finger protein Helios,41843,-0.00121170431238148,0.00912061731307454,-0.0190881142460076,0.0166647056212446,0.894311401394933
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.000675548261050787,0.00509310563552146,-0.00930693878457128,0.0106580353066729,0.894480725390854
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,-0.00111159848655054,0.00869197532654817,-0.018147870126585,0.0159246731534839,0.898239627856325
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YY1,Transcriptional repressor protein YY1,39657,0.000367063196163356,0.00287467008553581,-0.00526729017148683,0.00600141656381355,0.898397569695509
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.000396758821238303,0.00312476145484906,-0.00652129127274246,0.00572777363026585,0.898964475919984
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,0.000478701859571715,0.00377901150179694,-0.00692816068395029,0.00788556440309372,0.899200864774582
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HK2,Hexokinase-2,41900,-0.000348814591720496,0.00279536768883431,-0.00582773526183574,0.00513010607839475,0.900697168244305
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.000853571726640791,0.0071465684427267,-0.0148608458743851,0.0131537024211035,0.90493055375175
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD70,CD70 antigen,42119,-0.000527176331203936,0.00452459511149133,-0.00939538274972693,0.00834103008731906,0.907247332433429
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,-0.000279623468484981,0.00247855793641414,-0.0051375970238567,0.00457835008688673,0.91017732222208
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,-0.000395983972399285,0.00353966850074221,-0.00733373423385401,0.00654176628905544,0.910928247991455
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LHB,Lutropin subunit beta,41843,-0.000973091292168758,0.0090781861175148,-0.0187663360824978,0.0168201534981602,0.914639826647858
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.000322680836392075,0.00310124100146345,-0.00575575152647628,0.00640111319926043,0.917132399935387
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESPL1,Separin,39560,-0.000569121838490251,0.00549379059408156,-0.0113369514028901,0.0101987077259096,0.917493719852102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOS,Proto-oncogene c-Fos,39539,0.000375169265767575,0.0037151881470943,-0.00690659950253726,0.00765693803407241,0.919566143280781
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.000428960632338852,0.00428937044673824,-0.00797820544326809,0.0088361267079458,0.920341728434238
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM19,Probable RNA-binding protein 19,39575,0.000477805645900141,0.00494915963144827,-0.00922254723173846,0.0101781585235387,0.923091259191677
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,-0.000299432848480172,0.00324330244989691,-0.00665630565027812,0.00605743995331778,0.926442736967983
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,-0.000862045451966196,0.00937377013057902,-0.0192346349079011,0.0175105440039687,0.926728339101407
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM2,Myomesin-2,39575,-0.000514033602404414,0.0057362653972957,-0.011757113781104,0.0107290465762952,0.928597822310612
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD99,CD99 antigen,42137,-0.000177363910834911,0.00203777797719526,-0.00417140874613762,0.0038166809244678,0.930642675840982
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF20,Fibroblast growth factor 20,39657,0.000353029666903704,0.00444787775107255,-0.00836481072519849,0.0090708700590059,0.93673947834244
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM132A,Transmembrane protein 132A,39638,0.000511575425784452,0.00646655705676524,-0.0121628764054754,0.0131860272570443,0.936945813730555
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP4,Caspase-4,39757,-0.00125804727233238,0.0171179591849456,-0.0348092472748258,0.032293152730161,0.941415266571754
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13,Interleukin-13,41913,-0.00036540366843944,0.00497716668746295,-0.0101206503758668,0.00938984303898794,0.941476188915871
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,0.000406838182043783,0.00556902652212579,-0.0105084538013228,0.0113221301654103,0.941764680524593
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,-0.000237837816552854,0.00355599697768957,-0.00720759189282442,0.00673191625971871,0.946675358457998
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,-0.000382636806346138,0.00575474562348787,-0.0116619382283824,0.0108966646156901,0.946988407316412
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,-0.000406372434609684,0.00624622865948485,-0.0126489806072,0.0118362357379806,0.948128330068573
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GJA8,Gap junction alpha-8 protein,39560,-0.000379152684970534,0.00642371630354687,-0.0129696366399224,0.0122113312699813,0.952934160796707
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECM1,Extracellular matrix protein 1,39720,0.000189409982368219,0.00374836407115251,-0.0071573835970907,0.00753620356182714,0.959699857009994
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.000171532292054445,0.00353941803313445,-0.00676572705288907,0.00710879163699796,0.961347794483017
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSAP,Gamma-secretase-activating protein,41843,0.000418698744678887,0.00864400178855293,-0.0165235447608849,0.0173609422502426,0.961367851621783
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAP1A,Ras-related protein Rap-1A,39657,0.000309733654519825,0.00712725955009192,-0.0136596950636603,0.0142791623727,0.965337540889515
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,0.000295392077741615,0.00682199409460932,-0.0130757163476927,0.0136665005031759,0.965463197227432
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,-0.00010968498032191,0.00288436305680466,-0.00576303657165904,0.00554366661101522,0.969666480108785
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,0.000237194115188249,0.00639540239939362,-0.0122977945876232,0.0127721828179997,0.970415326794152
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,0.000152557089715055,0.00430261117990567,-0.00828056082290006,0.00858567500233018,0.971716084583939
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.000129851583268868,0.00376421696254686,-0.00750771682986072,0.00724801366332299,0.972482010465696
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,0.000209240117548939,0.0064615209481651,-0.0124553409408547,0.0128738211759525,0.974167618242422
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-9.34572560514437e-05,0.00377700732452451,-0.00749639161211948,0.00730947710001659,0.980259819693589
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,0.000126942390866122,0.00552816741402671,-0.0107082657406262,0.0109621505223585,0.981680265334417
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-7.25322565132638e-05,0.00323008191114174,-0.00640349280235108,0.00625842828932455,0.982085223763034
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP350,Centrosome-associated protein 350,39560,8.21377739640532e-05,0.00376284552035266,-0.00729303944592716,0.00745731499385527,0.982585051150101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-8.05944091984107e-05,0.00515363290836994,-0.0101817149096035,0.0100205260912067,0.987523179965415
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-2.47370036424973e-05,0.00260705298596279,-0.00513456085612957,0.00508508684884458,0.992429558711667
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHC1,SHC-transforming protein 1,39560,-1.62060472911792e-05,0.0120426692367143,-0.0236198377512511,0.0235874256566688,0.998926296502658
